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AIM OF THE STUDY 
 
 Aim of the study 
Fungi, members of eukaryotic organisms, are distributed worldwide; they can grow on a 
wide range of substrates and under various conditions. Fungi not only play an important role 
in most ecosystems, but they have a direct impact on society due to production of secondary 
metabolites. Secondary metabolites are organic compounds which are, in contrast to 
primary metabolites, not vital for the fungal growth, development or reproduction. 
From a big array of secondary metabolites produced by fungi, some compounds are 
important for the society (e.g., antibiotics), while others (e.g., mycotoxins) represent a 
threat to human and animal health and cause economic losses. Considering that about 30 % 
of prescribed medications are of fungal origin and that only about 5 % of fungi have been 
studied, fungi and their metabolites represent a great source of new, possibly bioactive 
compounds. In this respect, two research directions in the field of secondary fungal 
metabolites can be distinguished: 1) discovery of novel compounds possibly possessing 
bioactivity; 2) detection and monitoring of known secondary metabolites.  
The ultimate aim of the study is to extend knowledge of secondary fungal metabolites by 
performing targeted and untargeted investigation of these compounds in selected samples. 
As an analytical tool, such a powerful analytical technique as liquid chromatography - mass 
spectrometry (LC-MS) will be utilized in the doctoral research. As the area of fungi 
accumulation is diverse, the set of samples for the study is broad, from foods and feeds to 
biological material and samples from mouldy indoor environments.  
The main objectives of the targeted part of the PhD dissertation are development and 
validation of multi-analyte LC-MS methods and their further application for quantification of 
known toxic metabolites. In this regard, an LC-MS/MS method will be developed and applied 
to study occurrence of toxic metabolites of Claviceps spp., ergot alkaloids, in grain and grain 
products for human consumption and animal feeding. As epimerization is a specific feature 
of this group of compounds, a care will be taken throughout the whole analysis with a major 
concern being extraction procedure. Method parameters will be determined in a thorough 
validation study. Furthermore, in order to investigate prevention of digestive absorption of 
these feed-borne metabolites, the developed method will be adapted for quantification of 
ergot alkaloids in buffered solutions and used in an in vitro efficacy testing of a mycotoxin 
binder.  
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Through careful investigation of ionization conditions, another important contaminant, 
mycotoxin patulin, will be included in a single run multi-analyte LC-MS/MS method, which 
previously was not possible. The established method will be validated for fluids from 
transdermal penetration studies with the prospect of assessing exposure to mycotoxins 
through dermal route.  
The goal of this part is to make available sensitive analytical tools for control of 
contamination and to extend the information on the toxin occurrence. Such data are of 
great importance for risk assessment and setting regulatory limits in order to promote 
human and animal health. 
The untargeted part is focused on the development of suitable tools for detection of less 
studied (or novel) organic compounds produced by fungi. Considering the chemical diversity 
of secondary fungal metabolites and their broad abundance in the samples, development of 
a generic extraction procedure is the first objective of the untargeted part. For investigation 
of a wider range of metabolites, establishing a workflow for identification of untargeted 
compounds is another objective of the study.  
Two approaches for executing untargeted analysis will be used, namely simple screening of 
mouldy samples and gene manipulation experiments to observe changes in metabolic profile 
of a fungus. Application of modern sophisticated instrumentation will be the key element. As 
concerns the first approach, untargeted analysis of ergot alkaloid derivatives will be 
performed in mouldy cereal samples. Untargeted metabolite screening will also be carried 
out in samples from mouldy buildings with the intention to gather more information on 
secondary fungal metabolite occurrence in indoor environments. Regarding the gene 
manipulating experiments, Aspergillus flavus, a prevalent contaminant of food and feed, will 
be investigated. Inactivation of the cluster 27 polyketide synthase (pks) gene in the species 
will be performed. A comparative metabolomics approach, based on high resolution MS, will 
be applied to identify the metabolites associated with the cluster 27 pks gene.  
The obtained information will assist in achieving the research goals of this part of the 
dissertation such as completing some missing blocks in a scheme of fungal metabolism, 
investigating occurrence of less studied metabolites and discovery of novel organic 
compounds. 
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CHAPTER   1 
 
 
Introduction to secondary fungal 
metabolites  
 
 Chapter 1 
1.1. General information 
Secondary metabolites are low-molecular weight organic compounds (150-1,000 Da) 
produced by many organisms including fungi. Scientific attention to secondary fungal 
metabolites and understanding of their importance started to grow since the first half of the 
20th century after Fleming’s discovery of penicillin from Penicillium sp. Since that time, many 
other beneficial secondary metabolites were discovered (e.g., antiviral drugs, anti-tumor 
drugs). Along with this, production of numerous toxic secondary metabolites (e.g., 
aflatoxins, zearalenone) was revealed. 
Although secondary metabolites are structurally diverse, they usually contain C, H, O and N, 
and less frequently S, P, Cl, Br and F, and basic functional groups such as hydroxyl, carboxyl, 
carbonyl, amino. The metabolites possess unusual chemical linkages, such as β-lactam rings, 
cyclic peptides made of normal and modified amino acids, unsaturated bonds of 
polyacetylenes and polyenes, and large macrolide rings. 
Considering that about 1.5 million different species of fungi are known (Deacon, 2006), and 
that a single species is able to produce more than one secondary metabolite, the diversity of 
these products of fungal metabolism seems to be enormous. Though great number of 
secondary metabolites is yielded, they have no obvious role in the life cycle of fungi. 
Plausible reasons of their production include necessity of secondary metabolism, regardless 
the end compound, for removing the intermediates of the basic metabolic pathways of an 
organism, when growth is temporarily restricted. These intermediates could be taken into 
secondary metabolism and afterwards exported from the cell or accumulate as inactive 
compounds (Deacon, 2006). Another explanation could be the use of these metabolites by 
fungus as cell-signaling molecules for communication, self-defense or inhibition of 
competitor’s growth (Brakhage and Schroeckh, 2011; Brakhage, 2013; Yim et al., 2007). For 
instance, antibiotics could be useful in defense of territory, mycotoxins as animal 
antifeedants, melanin for protection against UV damage, ﬂavour or odour components for 
attracting insects for spore dispersal (Deacon, 2006). 
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1.2. Classification of secondary fungal metabolites 
 
1.2.1. Classification challenges  
Secondary fungal metabolites comprise an enormous group of chemicals. Due to diversity in 
chemical structures of the metabolites, their biosynthetic origins and biological effects, 
classification of these chemicals becomes a challenging task. Such groups as teratogens, 
mutagens, carcinogens, and allergens are identified by cell biologists, while clinicians simply 
classify secondary fungal metabolites by the organs they have effect on (e.g., hepatotoxins, 
nephrotoxins, neurotoxins, immunotoxins). From the point of view of organic chemists, 
division of the metabolites into groups is based on chemical structures (e.g., lactones). 
Mycologists list secondary metabolites by the fungi that produce them (e.g., Aspergillus 
metabolites, Penicillium metabolites, Fusarium metabolites). Considering the above, a single 
secondary metabolite can be assigned to different groups at the same time making all types 
of classifications insufficient and not uniform (Bennett and Klich, 2003; Bhatnagar et al., 
2002). 
Owing to their complexity and diversity, only exemplary classifications of secondary fungal 
metabolites will be discussed in this chapter. 
 
1.2.2. Classification based on biosynthetic origin 
Despite their structural diversity, secondary fungal metabolites can be grouped based on 
biosynthetic origin (Table 1.1). The major route for secondary metabolite production is the 
polyketide metabolic pathway. A polyketide is formed by polymerisation of acetate. Further 
cyclization, lactonization or formation of thioesters or amides can occur in the chain 
resulting in a range of products (Deacon, 2006). Polyketide metabolites include antibiotic 
griseofulvin (Penicillium griseofulvum), sterigmatocyctin, carcinogenic aflatoxins, ochratoxins 
(Aspergillus spp., Penicillium spp.), fumonisins (Fusarium spp.), antibiotic patulin (Penicillium 
spp.) (Abarca et al., 1994; Deacon, 2006; Schroeder and Kelton, 1975; Seydametova et al., 
2010; Sommer et al., 1976; Torres et al., 1987). 
The mevalonate pathway is intended for synthesis of sterols. Initially, mevalonic acid (a 6-
carbon compound) is formed and then converted to 5-carbon isoprene units, which, in turn, 
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condense head-to-tail to form chains of various lengths. The chains further undergo 
cyclization and other modifications. Following this synthesis, the secondary metabolites of 
Fusarium spp. (trichothecenes) are produced among other compounds (Deacon, 2006).  
 
Table 1.1. Examples of secondary fungal metabolites derived from different metabolic 
pathways of fungi (summarized from Ballio et al., 1964; Deacon, 2006; Griffin, 1994; Hanson, 
2008; Kozlovskii et al., 2000; Moore, 1998). 
Pathway 
Secondary metabolite 
(or group of metabolites) 
Representative producer Bioactivity 
Polyketide 
Aflatoxins Aspergillus parasiticus,   
A. flavus 
 
Carcinogenic, 
mycotoxin 
Citrinin Penicillium citrinum 
Anti-bacterial, 
nephrotoxic, 
mycotoxin 
Cladosporin Cladosporium spp. Anti-fungal 
Fumonisins Fusarium spp. Mycotoxin 
Gladiolic acid Penicillium gladioli Anti-bacterial 
Griseofulvin Penicillium griseofulvum Anti-fungal, 
mycotoxin 
Mycophenolic acid Penicillium spp. 
Anti-fungal,         
anti-bacterial,            
anti-viral, mycotoxin 
Ochratoxins Aspergillus ochraceus, 
Penicillium spp. 
Nephrotoxic, 
mycotoxin 
Patulin Penicillium spp. Anti-bacterial, 
mycotoxin 
Penicillic acid Penicillium spp. Mycotoxin 
Sterigmatocystin Aspergillus spp. Mycotoxin 
Mevalonate 
Cephalosporins Cephalosporium spp. Anti-bacterial 
Fusicoccin Fusicoccum amygdali Phytotoxic 
Trichothecenes Fusarium spp. Mycotoxin 
Continue 
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Table 1.1 (continued) 
Pathway 
Secondary metabolite 
(or group of metabolites) 
Representative producer Bioactivity 
Amino acid 
AM-toxin Alternaria alternata Phytotoxic 
Beauvericin Beauveria bassiana Insect pathogen, 
mycotoxin 
Cephalosporins Cephalosporium spp. Anti-bacterial 
Cyclopenin-viridicatin group Penicillium spp. Mycotoxin 
Cyclosporins Tolypocladium spp. Immunosupressive 
Ergot alkaloids Claviceps spp. Anti-migraine, 
mycotoxin 
Fusaric acid Fusarium spp. Phytotoxic 
Gliotoxin 
Gliocladum spp., 
Trichoderma spp., 
Aspergillus fumigatus, 
Penicillium terlikowski 
Anti-fungal,         
anti-bacterial, 
mycotoxin 
Lysergic acid Claviceps spp. Psychedelic drug 
precursor 
Penicillins Penicillium spp. Anti-bacterial 
Pulcheriminic acid Candida spp. Mycotoxin 
Roquefortine C Penicillium roqueforti Neurotoxic 
Shikimate 
Ergot alkaloids Claviceps spp. Anti-migraine, 
mycotoxin 
Gallic acid Penicillium spp., 
Alternaria spp. 
Anti-fungal,        
anti-viral 
Lysergic acid Claviceps spp. Psychedelic drug 
precursor 
 
The shikimate pathway, used normally for production of primary metabolites, such as 
aromatic amino acids, also provides the precursors for hallucinogenic secondary 
metabolites, e.g., lysergic acid (Deacon, 2006; Griffin, 1994). 
The precursors of metabolites formed through the amino acid pathway are amino acids. 
Among others, cyclic peptides and indole alkaloids are formed through this route. 
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Metabolites derived from this pathway include, e.g., penicillins, cephalosporins, gliotoxin 
and ergot alkaloids (Griffin, 1994).  
It has to be mentioned that biosynthetic routes are interrelated, therefore a secondary 
metabolite can be derived from a combination of pathways, as in the case of ergot alkaloids. 
These compounds are mainly formed through the amino acid pathway. However, the 
shikimic acid pathway contributes to the formation of the indole ring structure of the 
precursor amino acid, tryptophan (Trp), whereas some other parts of the molecular 
structure of ergot alkaloids are formed through the mevalonic acid pathway (Griffin, 1994).  
 
1.2.3. Classification based on structure 
Though many classes of secondary fungal metabolites can be distinguished (Zhong and Xiao, 
2009), only a part will be discussed in the present work. 
 
1.2.3.1. Terpenoids 
Numerous secondary fungal metabolites are referred to a class of terpenoids. Terpenoids 
are formed from C5 isoprene units leading to their characteristic branched structure 
(Hanson, 2008). They are sub-divided into several groups depending on the number of 
isoprene units: monoterpenoids (C10), sesquiterpenoids (C15), diterpenoids (C20), 
sesterterpenoids (C25), triterpenoids (C30) and caroterpenoids (C40). Additionally to these 
sub-groups, there are compounds containing the isoprene unit attached to a carbon 
skeleton which is derived from another biosynthetic route. For instance, the lysergic moiety 
of the ergot alkaloids bears an isoprene unit linked to the indole of Trp. 
Among all terpenoids, sesquiterpenoids are the most common to fungal metabolism with 
trichothecenes representing a major group (Hanson, 2008; Moore, 1998). The 
trichothecenes are a family of more than sixty sesquiterpenoid metabolites produced by 
several fungi, including Fusarium, Myrothecium, Phomopsis, Stachybotrys, Trichoderma, 
Trichothecium (Bennet and Klich, 2003). The name “trichothecene” is derived from 
trichothecin, which was one of the first members of the family identified (Bennett and Klich, 
2003).  
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As a common feature, all trichothecenes contain a C9-C10 double bond, a C12-C13-epoxide 
ring, and various hydroxyl and acetoxy groups (Fig. 1.1). Trichothecenes are classified 
according to their characteristic functional groups; thus, there are four types (A-D) of 
trichothecenes. Type A trichothecenes have an oxygen function at C8, which is different 
from a keto-group. HT-2 toxin, T-2 toxin and diacetoxyscirpenol are representative members 
of this group. Nivalenol, deoxynivalenol, fusarenon X, 3-acetyldeoxynivalenol and 15-
acetyldeoxynivalenol belong to the type B trichothecenes, which have a keto-group at 
position C8. Type C trichothecenes are characterized by a second epoxide group. Type D 
trichothecenes are macrocyclic compounds which possess a macrocylic ester or an ester-
ether bridge between C4 and C15 (e.g., verrucarins, roridins, satratoxins) (Bennett and Klich, 
2003; Berthiller et al., 2005a).  
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Trichothecene R1 R2 R3 R4 R5 
Nivalenol -OH -OH -OH -OH =O 
Deoxynivalenol -OH -H -OH -OH =O 
Fusarenon X -OH -OCOCH3 -OH -OH =O 
3-Acetyldeoxynivalenol -OCOCH3 -H -OH -OH =O 
15-Acetyldeoxynivalenol -OH -H -OCOCH3 -OH =O 
Diacetoxyscirpenol -OH -OCOCH3 -OCOCH3 -H -H 
HT-2 toxin -OH -OH -OCOCH3 -H -OCOCH2CH(CH3)2 
T-2 toxin -OH -OCOCH3 -OCOCH3 -H -OCOCH2CH(CH3)2 
Macrocyclics -H -O-R´-O- -H -H 
R´ - Macrocyclic ester or ester-ether bridge between C4 and C15 
 
Figure 1.1. Basic trichothecene structure with examples of most prevalent metabolites. 
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1.2.3.2. Polyketides 
Polyketides are a major class of fungal metabolites. They are formed through a condensation 
of acetyl-coenzyme A (acetyl-CoA) (as starter unit) with the appropriate number of malonyl-
CoA units (as extending unit) followed by modification of the completed poly-β-ketone and 
release of the end product. Other building blocks, such as propionyl-CoA, butyryl-CoA, 
methylmalonyl-CoA and ethylmalonyl-CoA, can also be used in the biosynthesis. These 
sequential reactions are catalysed by a collection of enzyme complexes called polyketide 
synthases (PKSs). The formed poly-β-ketones may undergo modification by alkylation, 
cyclization,  oxidation or reduction (Herbert, 1989; Shen et al., 2000; Zhou et al., 2010). 
Aflatoxins, patulin, bikaverin and zearalenone, secondary metabolites of Aspergillus, 
Penicillium and Fusarium spp., respectively, are members of the aromatic polyketide class 
(Fig. 1.2).  
 
                O O
O
OCH3
O O
            O O
O
OCH3
O
O
O
           
O
HO
OH O
O
CH3H
     
 
               
          
O
O OH O
O
OHO
O
        
O
O
O
OH
      
O
O COOH
COOH
OH
O
O COOH
COOH
OH OH
NH2
2
 
                                
 
Figure 1.2. Examples of polyketide fungal metabolites. 
 
Linear polyketides, fumonisins, are frequently produced by Fusarium species. Fumonisins 
consist of a linear 19- or 20-carbon backbone with hydroxyl, methyl, and tricarballylic acid 
moieties at various positions along the backbone. Fumonisins belonging to the B-series 
possess an amino group at the C2-position (Fig. 1.2), whereas in other series this amino 
Aflatoxin B1 Aflatoxin G1 
Fumonisin B1  
Zearalenone 
Bikaverin Patulin 
9 
8 
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group can be acetylated or substituted with hydroxypyridine (Bezuidenhout et al., 1988; 
Musser et al., 1996; Musser and Plattner, 1997; Proctor et al., 1999). 
        
1.2.3.3. Non-ribosomal peptides 
Non-ribosomal peptides are polypeptides which are formed via a mechanism independent 
on mRNA, i.e., not through the traditional translation mechanism (Rohlfs et al., 2009). Non-
ribosomal peptides usually have cyclic and/or branched structures, can contain non-
proteogenic amino acids, carry modifications like N-methyl and N-formyl groups, or are 
glycosylated, acrylated, halogenated or hydroxylated. Non-ribosomal peptides are often 
dimers or trimers of identical sequences chained together, cyclized or branched and consist 
of two and up to 40 amino acids (Eisfeld, 2009). A great part of non-ribosomal peptides are 
cyclic peptides, including macrocyclic lactones (Hanson, 2008).  
Cyclosporins are a group of cyclic peptides isolated from Tolypocladium inflatum, with 
cyclosporin A being a major compound (Fig. 1.3). This group contains unusual amino acids; 
however, amino residues such as L-leucine and L-valine are also present as their N-methyl 
derivatives. Beauverolides and beauvericin (Fig. 1.3) are cyclic depsipeptides (peptido-
lactones) produced by Beauveria bassiana (Hanson, 2008). Examples of linear non-ribosomal 
peptides are integramide A (Fig. 1.3) and B produced by Dendrodochium sp. (De Zotti et al., 
2010; Singh et al., 2002).  
Penicillins (mainly produced by Penicillium spp.) also belong to the group of non-ribosomal 
peptides and consist of a thiazolidine ring fused to a β-lactam ring and variable substituents 
attached by a peptide bond. For instance, in benzylpenicillin (= penicillin G), this substituent 
is a benzyl group (Fig. 1.3) (Berg et al., 2002). 
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Figure 1.3. Examples of non-ribosomal fungal peptides. 
 
1.2.3.4. Alkaloids 
Alkaloids are mostly referred to as a group of basic organic compounds, containing at least 
one nitrogen atom in a ring structure of the molecule (Mahmood et al., 2010). However, 
neutral or weakly acidic substances can also be distinguished in the group. Due to the great 
structural diversity, the sub-classification of alkaloids is very complex, but yet not uniform.  
More than 20 alkaloid classes can be recognized including indole, tropane, imidazole and 
pyridine derivatives. 
From the medical and toxicological point of view, the most important among indole alkaloids 
are ergot alkaloids produced by Claviceps purpurea, a fungus growing on rye and other 
cereals and grasses (Krska et al., 2008). More specifically, ergot alkaloids are hemiterpenoid 
indole alkaloids related to lysergic acid, which, in turn, is formed through multiple reactions 
involving Trp and dimethylallyldiphosphate (DMAPP). A characteristic feature of ergot 
alkaloids is the tetracyclic ergoline ring system or the tricyclic alkaloids open between N6 
and C7 positions (according to ergoline numbering) (Fig. 1.4a). They can be divided into 
Cyclosporin A 
Beauvericin Integramide A 
Penicillin G 
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several groups, namely, clavine alkaloids, lysergic acid-derivatives, peptide ergot alkaloids 
(ergopeptines and ergopeptams). Ergine and ergonovine (= ergometrine) (Fig. 1.5) are 
among the simpler lysergic acid amides. The most complex indole steroidal, terpenoid 
alkaloids of natural origin, the ergopeptines with a C17-amide substituent, have a tripeptide-
derived cyclol-lactam structure (Fig. 1.4b) (Schardl et al., 2006). 
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Figure 1.4. Generic structure of the ergoline-derivatives (a) and the ergopeptines (b). Colour-
code in (a) represents the substituent origin: DMAPP, dimethylallyldiphosphate (red); 
AdoMet, S-adenosyl-methionine (green), and L-Trp, L-tryptophan (blue) (Schardl et al., 2006). 
 
The most common and pharmacologically active alkaloids produced by Fusarium spp. 
include bostrycoidin, fusaric acid (Fig. 1.5) and lycomarasmine (Mahmood et al., 2010). 
Another alkaloid, roquefortine C (Fig. 1.5), is primarily detected in samples infected by 
Penicillium spp., especially Penicillium roqueforti (Polonsky et al., 1977; Tiwary et al., 2009). 
Along with 12 known metabolites, two new alkaloids, 9-deacetylfumigaclavine C (Fig. 1.5) 
and 9-deacetoxyfumigaclavine C, were recently isolated from the cultures of Aspergillus 
fumigatus (Ge et al., 2009). 
 
 
 
 
(a) (b) 
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Figure 1.5. Examples of fungal alkaloids. 
 
1.2.4. Classification based on bioactivity 
Secondary fungal metabolites possess a vast range of bioactivity. Although a great number 
of drugs and other beneficial substances of fungal origin have been discovered and put into 
use, for many other metabolites, already identified, biological activity is not yet revealed. 
Physico-chemical properties, steric arrangements of the structure and presence of bioactive 
moieties are responsible for biological activity of a compound (Betina, 1989). 
 
1.2.4.1. Anti-microbial activity 
The anti-microbial activity of secondary fungal metabolites involves anti-bacterial, anti-
fungal and/or anti-viral activity (Zhong et al., 2009). 
Penicillins (a group of related compounds produced by Penicillium spp.) discovered in 1928 
by Alexander Fleming, are a classical example of anti-bacterial fungal metabolites (Table 1.1) 
(Bud, 2007). It kills susceptible bacteria by interfering with the cell wall biosynthesis (Zhong 
et al., 2009). The common structural feature of penicillins, a four-membered β-lactam ring, is 
essential for their anti-bacterial activity (Wilke et al., 2005). Other secondary metabolites of 
Penicillium spp., such as funiculosin, also exhibit anti-bacterial activity, whereas fulvic acid, 
Ergometrine Fusaric acid Roquefortine C 9-deacetylfumigaclavine C 
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8-O-methylaverufin and 1,8-O-dimethylaverantin have anti-fungal effects (Ando et al., 1969; 
Kurobane et al., 1981; Maskey et al., 2003). 
A secondary metabolite of Chaetomium spp., chaetochalasin A, exhibited anti-bacterial 
activity against Bacillus subtilis (ATCC 6051) and Staphylococcus aureus (ATCC 25923) (Oh et 
al., 1998). Cytochalasin A was also effective against B. subtilis as well as against Escherichia 
coli, and, as cytochalasin D, demonstrated anti-fungal properties by inducing unusual 
morphological changes in Botrytis cinerea  (Betina, 1989). Such activity can be explained by 
the macrocyclic lactone structure (Betina, 1989). Altomare et al. reported anti-fungal activity 
of two Fusarium metabolites, fusapyrone and deoxyfusapyrone. These compounds showed 
considerable anti-fungal activity against several plant pathogenic and/or mycotoxigenic 
filamentous fungi and good inhibitory activity toward agents of human mycoses (Altomare et 
al., 2000). 
Recently, four novel naphtho-g-pyrones, namely, isochaetochromins B1, B2 and D1 and 
oxychaetochromin B, produced by Fusarium spp., were discovered. Evaluation of their 
bioactivity revealed that they can serve as inhibitors of HIV-1 integrase (Singh et al., 2003). In 
another study, wickerols A and B, diterpene derivatives isolated from Trichoderma sp., 
showed potent anti-viral activity against the A/H1N1 flu virus (Yamamoto et al., 2012). 
Polyketides from Penicillium sp., purpurquinones B and C, purpuresters A and TAN-931, also 
demonstrated anti-influenza activity (Wang et al., 2011).  
A single compound can possess a large spectrum of biological activity. An outstanding case 
of miscellaneous bioactivity is patulin and mycophenolic acid, produced mainly by 
Penicillium spp., which were first isolated as anti-microbial agents. However, in the following 
years, it was discovered that, in addition to its anti-bacterial and anti-viral activity, patulin 
and mycophenolic acid were toxic to both plants and animals, and were later reclassified as 
mycotoxins (Table 1.1) (Bennet and Klich, 2003; Betina, 1989; Ciegler et al., 1971). 
 
1.2.4.2. Mycotoxins  
Fungi can produce a wide assortment of toxic chemicals, which can pose (even at low 
concentrations) health risk to humans and animals leading to mycotoxicoses. These 
compounds were combined into a group called mycotoxins [μύκης (mykes, mukos) - 
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“fungus”; toxicum - “poison”] (Bennett and Klich, 2003). Mycotoxins are known to occur in 
mycelium of filamentous fungi as well as in spores (D’Mello and Macdonald, 1997; Fox and 
Howlett, 2008). Since the introduction of the “mycotoxin” term in the 1960’s when the 
turkey “X” disease was linked to a peanut meal contaminated with secondary metabolites of 
Aspergillus flavus (Blount, 1961), great scientific attention has been paid to collect data on 
toxic secondary metabolites produced by different fungi. At present, more than 400 
compounds are referred to the group of  mycotoxins (Bennett and Klich, 2003).  
Mycotoxicoses are categorized as acute or chronic. Acute toxicity manifests within a 
relatively short time period (few hours to several days) and has obvious toxic response, 
while chronic toxicity is characterized by low-dose exposure over a long time period (greater 
than 3 months), resulting in cancers and other generally irreversible effects (Bennett and 
Klich, 2003; Williams et al., 2003). Chronic exposure (e.g., cancer, kidney toxicity, immune 
suppression) is considered as the main human and veterinary health problem related to 
mycotoxins. However, acute effects (e.g., turkey “X” disease, ergotism, 
stachybotryotoxicosis) are the most noticeable cases of mycotoxin exposure (Bennett and 
Klich, 2003). 
Aflatoxins (“A. flavus toxin”) are acutely toxic, immunosuppressive, mutagenic, teratogenic 
and carcinogenic compounds (Table 1.1) (Blount, 1961; Kensler et al., 2011; Peraica et al., 
1999). Aflatoxins mainly affect liver, and several studies have shown that the development 
of liver cancer can be induced by aflatoxins in the diet, particularly in individuals already 
exposed to hepatitis B (Li et al., 2001; Peers and Linsell, 1973; Van Rensburg et al., 1985). 
This group of toxins was classified by the International Agency for Research on Cancer (IARC) 
as Group 1 carcinogens, except for aflatoxin M1, which is possibly carcinogenic to humans 
(Group 2B) (IARC, 1987). It has been demonstrated that epoxidation of the unsaturated 
bonds at the position 8, 9 of the terminal furan ring is critical for the carcinogenic potency of 
aflatoxin B1 (Fig. 1.2) (Groopman and Kensler, 2005;  Kensler et al., 2011).  
Adverse effects of ergot alkaloids (produced by Claviceps purpurea) (Table 1.1) have been 
known since centuries; in the Middle Ages, outbreaks of ergotism (also known as St. 
Anthony’s Fire)  became epidemic and led to death of thousands of people in Europe. It was 
caused by eating rye bread contaminated with C. purpurea (Van Dongen and De Groot, 
1995). Toxic effects of ergot alkaloids are due to their structural similarity to several 
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neurotransmitters (Mulac and Humpf, 2011; Schiff, 2006). Two forms of ergotism have been 
identified, namely, gangrenous ergotism, which lately occurred in Ethiopia in 1977-78 (King, 
1979), and convulsive ergotism characterized by gastrointestinal symptoms (nausea, 
vomiting and giddiness) and effects on the central nervous system (drowsiness, prolonged 
sleepiness, twitching, convulsions, blindness and paralysis), last seen in India in 1975 (Peraica 
et al., 1999). In addition to the above-mentioned symptoms, hallucinogenic properties were 
recorded for lysergic acid diethylamide, known as LSD (Van Dongen and De Groot, 1995). 
Owing to improved grain cleaning and milling processes, ergotism is extremely rare in 
present days (Peraica et al., 1999). 
The most frequently-occurring ochratoxin from Aspergillus and Penicillium strains, 
ochratoxin A, has shown to be nephrotoxic, immunosuppressive, carcinogenic and 
teratogenic in experimental animals (Peraica et al., 1999) and was proposed as a causative 
agent of endemic nephropathy (Table 1.1) (Goliński et al., 1984; Peraica et al., 1999). IARC 
classified ochratoxin A as a substance possibly carcinogenic to humans (Group 2B) (IARC, 
1987). The toxic activity of ochratoxin A (Fig. 1.6) has been attributed to its isocoumarin 
moiety, the lactone carbonyl group and presence of the chlorine atom (Betina, 1989; Xiao et 
al., 1996). 
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Figure 1.6. Structure of ochratoxin A. 
 
The first recognized trichothecene mycotoxicosis was recorded in the USSR in 1932. 
Common manifestations of trichothecene toxicity are depression of immune responses and 
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nausea, rarely vomiting (Table 1.1) (Peraica et al., 1999). In experimental animals, 
trichothecenes showed higher toxicity when inhaled compared to oral intake (Smoragiewicz 
et al., 1993). Furthermore, trichothecenes were associated with the Sick Building Syndrome 
(Croft et al., 1986; Smoragiewicz et al., 1993); the symptoms of airborne toxicosis 
disappeared when the buildings and ventilation systems were thoroughly cleaned (Croft et 
al., 1986). There is some evidence that trichothecenes have been used as chemical warfare 
agents in South-East Asia (Mirocha et al., 1983; Wannemacher and Wiener, 1997). A 
sesquiterpenoid ring structure is responsible for the toxicological activity of the 
trichothecenes (Lattanzio et al., 2009). 
Zearalenone is a non-steroidal oestrogenic mycotoxin resembling 17-estradiol, the principal 
hormone produced by the human ovary (Kuiper-Goodman et al., 1987). Zearalenone and its 
derivatives showed estrogenic effects in various animal species (infertility, vulval oedema, 
vaginal prolapse and mammary hypertrophy in females and feminization of males) (Kuiper-
Goodman et al., 1987; Peraica, 1999). IARC has categorized zearalenone as a class 3 
carcinogen (IARC, 1993). Interestingly, a derivative of zearalenone, α-zearalanol, is used as a 
growth promotor in cattle in the USA and other countries (Metzler, 2011). 
The group of fumonisins comprises of several structure-related metabolites, of which 
fumonisin B1 and  fumonisin B2 are of toxicological importance, while the others (fumonisins 
B3, B4, A1 and A2) are less toxic (Table 1.1) (Peraica et al., 1999). The toxic effect of 
fumonisins (as 1-deoxy-analogs of sphinganine) is due to their structural analogy to 
sphingoid bases (Humpf et al., 1998). Symptoms caused by consumption of fumonisin B1 
(from food) include transient abdominal pain, borborygmus and diarrhoea (Bhat et al., 1997). 
A high incidence of oesophageal cancer was attributed to the presence of fumonisin B1 in 
food (in particular, maize) (Peraica et al., 1999). IARC classified fumonisins as possibly 
carcinogenic to humans (Group 2B) (IARC, 1987).  
Other mycotoxins can also cause severe health problems, including nephropathy, human 
tremor, liver damage, vomiting, nausea (Bennet and Klich, 2003; D’Mello and Macdonald, 
1997). 
 
 
 
47 
Introduction to secondary fungal metabolites  
1.3. Occurrence 
Exposure to secondary fungal metabolites occurs through ingestion of mouldy food or feed 
as well as through the dermal and inhalation routes (Zain, 2011). 
 
1.3.1. Feed 
Feed contamination with fungi and, as a consequence, with their secondary metabolites, is 
of great concern in feed safety. This issue of contamination has a considerable impact not 
only on animal welfare, but can potentially lead to toxin transfer into animal products (eggs, 
meat and milk) for human consumption. As the majority of mycotoxins are very stable 
compounds, once formed in a feed ingredient, they can contaminate mixed feeds 
manufactured from it. 
A global survey on the incidence of mycotoxins (aflatoxin B1, deoxynivalenol, fumonisins B1, 
B2 and B3, ochratoxin A, T-2 toxin and zearalenone) was conducted in animal feedstuffs 
(Binder et al., 2007; Monbaliu et al., 2010a; Streit et al., 2012). Low contamination levels 
were found throughout the world, however, significant differences were noted on a regional 
scale (tropical, temperate areas). Deoxynivalenol, T-2 toxin and zearalenone were the major 
contaminants in European feeds, whereas aflatoxins, deoxynivalenol, fumonisins and 
zearalenone were dominant in samples from Asia and the Pacific (Binder et al., 2007). 
Although aflatoxin production was found to occur primarily in tropical or subtropical 
climates, from a European prospect, imported feed (peanut cake, palm kernel, copra, corn 
gluten meal) is considered as the most common source of feed contamination (EFSA, 2004). 
Despite this, the European Food Safety Authority (EFSA) reported incidence of aflatoxin B1 
contamination in European feed. This toxin was recently detected in maize originating from 
Italy where the growth period was characterized by high temperatures, drought and strong 
insect damage (EFSA, 2004). The Rapid Alert System for Food and Feed (RASFF) of the 
European Commission has reported 10 notifications on aflatoxin B1 in maize of European 
origin since autumn 2012. In 2013, feed originating from Serbia and imported in the 
Netherlands and Germany was found to be contaminated with aflatoxins 
(RASFF, http://ec.europa.eu). It was stated that the mycotoxin pattern in Europe might 
change due to a general global rising of average temperatures (Miraglia et al., 2009). 
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Southern Europe, where the importance of deoxynivalenol diminishes and, at the same time, 
Aspergillus flavus infection and aflatoxin contamination become more common, can be a 
good example of this phenomenon. Regarding trichothecene mycotoxins, T-2 toxin and HT-2 
toxin, EFSA estimated exposure to these particular contaminants as low (EFSA, 2011).  
Co-contamination of feed with several mycotoxins is frequently reported. A UK study of 
maize feed products revealed that all 67 samples were co-contaminated with up to 12 
Fusarium mycotoxins (Scudamore et al., 1998; Streit et al., 2012). In 75 % of samples, 
fumonisins occurred together with deoxynivalenol; and 15-acetyldeoxynivalenol, 
moniliformin and zearalenone were also frequent co-contaminants. Co-occurrence of 
deoxynivalenol and zearalenone was reported in 44 % of feed (including silage and 
compound feed) for dairy cattle in the Netherlands (Driehuis et al., 2008). 
Ergot alkaloids were reported in 91 % of the grain and mixed feed samples in Germany. A 
maximum of 4,883 μg/kg was observed for mixed feed for pigs and the largest observation 
for rye feed was 1,236 μg/kg (Ruhland and Tischer, 2008). About half of Dutch feed samples 
contained ergot alkaloids (Mulder et al., 2012). Unexpectedly, compound feeds, containing 
grains as only one of the ingredients, had a relatively higher average ergot alkaloid content 
compared to cereal feeds. A maximum level of 1,000 mg/kg of rye ergot (Claviceps purpurea) 
has been established for feed containing unground cereals in the European Union (Directive 
2002/32/EC, 2002). Many countries have set limits for ergot in grains, but only a few have 
regulation for the individual and total ergot alkaloid content; for instance, the current limit 
for the total ergot alkaloid content in animal feed in Uruguay is 450 µg/kg (EFSA, 2005). 
In recent times, the problem of masked mycotoxins has begun to emerge. These compounds 
can be formed from their parent forms as a result of plant metabolism (Berthiller et al., 
2007), but are not detected with analytical methods, targeted only to parent compounds. It 
has been shown that the conjugated mycotoxins zearalenone-4-glucoside and 
deoxynivalenol-3-glucoside can constitute up to 46 % of the total content of the precursor 
mycotoxin in feedstuffs (De Boevre et al., 2012; Berthiller et al., 2005b, Berthiller et al., 
2006). Reports on conjugated forms of ochratoxin A, fumonisins, T-2 toxin and HT-2 toxin are 
also available (Humpf and Voss, 2004; Lattanzio et al., 2012; Ruhland et al., 1996; Seefelder 
et al., 2003). It is believed that these conjugates can increase exposure to (the parent) 
mycotoxins (Gareis et al., 1990).  
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1.3.2. Food 
Food safety is a complex issue that has an impact on all segments of society. Fungi are 
extremely common, being able to grow on a variety of substrates under a wide range of 
environmental conditions. Secondary fungal metabolites have been detected in agricultural 
products all around the world. These compounds can enter the food chain at different stages, 
e.g., in the field, during storage (Fig. 1.7). Detection, removal and diversion are considered to 
be preventive approaches against the entry of fungal metabolites into the food chains. The 
severity of the contamination problem is more apparent considering that about 25 % of the 
world’s crops are contaminated to some extent with mycotoxins (Fink-Gremmels, 1999). 
 
 
 
Figure 1.7. Factors influencing secondary fungal metabolite occurrence in the food chain 
(adapted from Paterson and Lima, 2010). 
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The toxigenic fungi involved in the food chains belong mainly to five genera: Aspergillus, 
Fusarium, Claviceps, Alternaria and Penicillium (Lasztity, 2009; Sweeney and Dobson, 1998). 
Secondary fungal metabolites can enter the human food chain directly (food consumption) 
and indirectly (consumption of animal-derived food). 
Cereal crops worldwide including corn, wheat, barley, oats and rice were found to be 
contaminated with one or more fungal metabolites. Zearalenone was recently detected in 
corn and corn products in the USA (Hewitt et al., 2012), Spain (Cano-Sancho, 2012) and 
Mexico (Briones-Roeys, 2007). Assessment of the natural occurrence of trichothecenes and 
zearalenone in Argentina was carried out in six different crops during harvest (Quiroga, 1995) 
revealing contamination of about 50 % of collected samples. All the contaminated samples 
contained deoxynivalenol. Zearalenone, 3-acetyldeoxynivalenol, T-2 toxin, HT-2 toxin, 
neosolaniol and diacetoxyscirpenol were present as well. 
Ergot alkaloids are frequent contaminants of cereals. About 90 % of rye-based cereal 
products were contaminated to some extent with ergot alkaloids (Crews et al., 2009). 
Ergotamine, ergocristine and ergosine were the predominant ergot alkaloids in terms of 
level and frequency of occurrence.  
Fumonisins are a frequently occurring group of mycotoxins in maize. Ediage et al. (Ediage et 
al., 2011) detected fumonisins at a maximum concentration of 836 μg/kg accompanied by 
beauvericin in maize samples from Benin. Maximum levels of fumonisins in maize from 
Burkina Faso reached 16,040 µg/kg which exceeded the tolerable daily intake by five times 
(Nikièma et al., 2004). As maize is one of the widely grown staple foods in tropical countries, 
consumption of this commodity can pose risks to public health related to chronic exposure. 
Additionally, a study in Germany revealed the presence of type A and B trichothecenes in 
maize with up to twelve metabolites co-occurring in a single sample (Schollenberger et al., 
2012). 
Moroccan 68 cereal products were found to contain fumonisins (B1, B2 and B3); frequency 
of contamination was 29 % of total samples. The highest value was found in breakfast 
cereals with 228 μg/kg of total fumonisins (Mahnine et al., 2012). 
Different spices (including pepper, chilli, curry powder, cayenne, paprika, cinnamon, 
coriander, turmeric and cumin) were contaminated with aflatoxins. Aflatoxin B1 had the 
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highest incidence of contamination in spice preparations and was found in 20 of 130 samples. 
In five samples (4 %), consisting of chilli, cayenne pepper and turmeric pepper, aflatoxin B1 
was above the regulatory limits of the European Union (i.e., level of 5 µg/kg) (O’Riordan and 
Wilkinson, 2008). Aflatoxins can be found in other commodities such as cereals, nuts, 
peanuts, fruits, oilseeds, olives, dried fruits, cocoa, beer (Cavaliere et al., 2007; Copetti et al., 
2011; Daradimos et al., 2000; Fernández-Cruz et al., 2010; Ghitakou et al., 2006; Leszczynska 
et al., 2000; Tam et al., 2006; Ventura et al., 2004; Ventura et al., 2006). These metabolites 
were even detected in smoked-dried fishes in Nigeria, however, the food was still acceptable 
for consumption (aflatoxin levels were lower than the FDA prescribed maximum 
concentration of 20 µg/kg) (Adetayo, 2011).  
Alternariol, alternariol monomethyl ether and tenuazonic acid were frequently detected in 
apples, apple products, apple juice concentrates, mandarins, olives, pepper, red pepper, 
tomatoes, tomato products, oilseed rape meal, sunflower seeds, sorghum, wheat and edible 
oils (olive oil, rapeseed oil, sesame oil, sunflower oil) (Ostry, 2008; Scott, 2001). Moreover, 
alternariol and its derivative, alternariol monomethyl ether, were found in raspberries, red 
currant, barley, oats and carrots (Scott, 2001; Solfrizzo et al., 2004a).   
The use of mouldy raw materials (e.g., grapes, coffee beans) in beverage production can lead 
to contamination of the final product with fungal metabolites, since the majority of these 
substances are heat-resistant. Natural occurrence of alternariol has been reported in apple 
juice, cranberry juice, grape juice, prune nectar, raspberry juice, red wine (Lau et al., 2003; 
Scott, 2001; Scott et al., 2006). The highest level of this toxin in apples was up to 58,800 
µg/kg. Chaetoglobosins, communesins and patulin were detected in juices as well (Andersen 
et al., 2004; Cho et al., 2010). A survey on ochratoxin A in wine originating from European 
(e.g., Greece, Italy, France, Portugal) and other countries (e.g., Morocco) revealed maximum 
concentrations of ochratoxin A up to 7.6 µg/L (Magan and Olsen, 2004). High concentrations 
of ochratoxin A (max. 2,340 µg/L), aflatoxins (max. 400 µg/L) and zearalenone (max. 426 
µg/L) were detected in home-made South African beers, for which maize and barley were 
used in brewing. The mycotoxin levels were much higher than the recommended values for 
safe consumption (Odhav and Naicker, 2002). Several surveys on tea and herbal infusions 
revealed presence of fumonisin B1 at concentrations up to 1,487 µg/kg (Martins et al., 2001; 
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Monbaliu et al., 2010b; Omurtag and Yazicioglu, 2004). Ochratoxin A and aflatoxin B1 were 
natural contaminants of coffee (Bokhari, 2007).  
To determine transmission of fungal metabolites from mouldy feed to animal tissue, carry-
over studies in livestock have been conducted, however, only for major mycotoxins. 
Ochratoxin A in pig feed can accumulate in porcine tissues (Milićević et al., 2009), while 
some amounts of aflatoxins, citrinin and deoxynivalenol can be carried over into eggs (Völkel 
et al., 2011). Aflatoxin B1 in feed can be metabolized to a hydroxylated derivative, aflatoxin 
M1, by cows which is then secreted in milk. This metabolite could be therefore detected in 
dairy products (cheese) (Anfossi et al., 2012; Yaroglu et al., 2005). 
To prevent formation of secondary fungal metabolites (specifically mycotoxins), the food 
industry has established internal monitoring methods. Furthermore, government regulatory 
agencies constantly initiate surveys on occurrence of mycotoxins in foods and feeds and 
establish regulatory limits.  
 
1.3.3.    Indoor environment 
Secondary fungal metabolites can also be associated with mouldy indoor environments 
(damp buildings). Building-associated fungi, such as Stachybotrys chartarum, Aspergillus 
versicolor, A. sydowii, Penicillium spp., Chaetomium spp., comprise a limited group of species 
that can grow on nutrients available from building materials and adapt to particular amount 
of available water (Jarvis and Miller, 2005).  
In the 1980s the term Sick Building Syndrome (SBS) was introduced describing a group of 
symptoms of unclear aetiology comprised of mucous membrane symptoms related to eyes, 
nose, and throat, dry skin, and general symptoms of headache and lethargy. The symptoms 
were temporally and related to leaving or working in a particular building (Burge, 2004; 
Murphy, 2006). Mould growth and production of secondary metabolites are considered as 
one of the causes of the syndrome (Bennett and Klich, 2003). As mycotoxins are not volatile, 
respiratory exposure is related to inhalation of mould spores, hyphal fragments and 
contaminated dust (Bennett and Klich, 2003). 
A proof of natural fungal metabolite presence indoor was provided by Bloom et al. by 
analyzing more than 100 building samples (settled dust, gypsum board, wallpaper and other) 
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(Bloom et al., 2007; Bloom et al., 2009). Several mycotoxins, namely sterigmatocystin, 
gliotoxin, satratoxins G and H, verrucarol and trichodermol, could be detected in water-
damaged buildings. Interestingly, in most cases the natural producer of a certain metabolite 
was identified in the sample. Polizzi et al. were able to detect roquefortine C, chaetoglobosin 
A, sterigmatocystin, roridin E, ochratoxin A, aflatoxins B1 and B2 in 69 % of building 
materials, and dust and air samples (Polizzi et al., 2009). As in the study of Bloom et al., 
there was a good concordance between identified fungi and detected metabolites. Mouldy 
interiors of Finnish damp buildings also contained sterigmatocystin, satratoxins G and H as 
well as diacetoxyscirpenol, deoxynivalenol, 3-acetyldeoxynivalenol, verrucarol, T-2-tetraol 
and citrinin. Aspergillus versicolor was identified in most sterigmatocystin-containing 
samples, and, similarly, Stachybotrys spp. were present in the samples with satratoxins. 
However, in many other cases, the presence of fungi was not in accordance with the found 
metabolites (Tuomi et al., 2000).  
An extensive study of secondary fungal metabolites in moisture-damaged indoor 
environments was performed by Täubel et al. (Täubel et al., 2011). 186 fungal metabolites 
were included in the LC-MS-based method which revealed presence of 28 compounds with 
emodin, enniatin B and beauvericin being the most prevalent analytes and frequently 
detected in dust.  
 
1.3.4. Biological material 
The link between the observed toxic effect (or disease) and a certain dietary contaminant is 
represented by biomarkers. Biomarkers are divided into two categories, namely direct 
(biomarkers of exposure) and indirect (biomarkers of effect). A biomarker of exposure refers 
to the quantification of a specific compound, its metabolite(s) or interaction products in a 
body compartment or fluid. These biomarkers can give an indication of the presence and 
magnitude of exposure to the contaminant. A biomarker of effect indicates the presence and 
magnitude of a certain biological response following exposure to the contaminant (Dragusel, 
2011; Kensler et al., 2011). The most common parameters in quantifying exposure or effect 
are available from urine, serum and milk, but also feces and hair (Dragusel, 2011).  
As aflatoxin B1 is among the most harmful mycotoxins and can be detected in numerous 
commodities, it was one of the first included in biomarker studies to human exposure. 
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Serum aflatoxin B1-albumin adducts, pointing to chronic exposure, and urinary aflatoxin B1-
N7-guanine adduct, revealing actual genetic damage, are validated biomarkers of aflatoxin 
exposure (Wild et al., 1990; Groopman et al., 1992; Jarvis and Miller, 2005). Metabolic 
products of aflatoxin B1, namely aflatoxin M1 and aflatoxin B1-mercapturic acid, in urine can 
be good indicators of recent exposure (Jarvis and Miller, 2005). Assessment of fumonisin B1 
exposure to animals can be estimated through changes in ratio of sphinganine to 
sphingosine in urine and blood (Cai et al., 2007; Kim et al., 2006; Tran et al., 2006). However, 
the use of these biomarkers to human exposure was less promising (Abnet et al., 2001; Jarvis 
and Miller, 2005; Nikiema et al., 2008; Solfrizzo et al., 2004b). A strong correlation was found 
between the sum of deoxynivalenol and its urinary metabolite deoxynivalenol-3-glucuronide 
and cereal intake of the population (Turner et al., 2008). Therefore, the sum of these two 
metabolites in human urine has been recommended for monitoring of deoxynivalenol 
exposure (Ediage et al., 2012). Presence of ochratoxin A and its metabolites ochratoxin α and 
the hydroxylated form, 4-hydroxyochratoxin A, was reported in urine samples (Jonsyn-Ellis, 
2000; Muñoz et al., 2010). Zearalenone can be metabolized through hydroxylation, 
producing the metabolites α-zearalenol and β-zearalenol, and subsequent conjugation with 
glucuronic acid (Zinedine et al., 2007). To date, presence of α-zearalenol-glucuronide and β-
zearalenol-glucuronide in human urine has not been reported. 
Secondary fungal metabolites (specifically mycotoxins) can also adversely affect human and 
animal health through a dermal route. Two methodologies (in vivo and in vitro) to study 
mycotoxin absorption via skin have been described (Kemppainen, 1988-1989). The skin 
permeation studies of mycotoxins were generally focused on a few compounds. It was 
shown that aflatoxin B1 and trichothecenes were able to penetrate skin (Kemppainen, 1988-
1989). Aflatoxins applied to the skin of rabbits in an in vivo experiment penetrated the 
stratum corneum and caused changes in epidermis and dermis (Joffe and Ungar, 1969). An in 
vitro study, intended to simulate the conditions which occur when agricultural workers are 
exposed to corn dust contaminated with T-2 toxin, demonstrated that T-2 toxin can 
penetrate through the skin (Kemppainen, 1984).  
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2.1. General information 
Investigation of secondary fungal metabolites is a complicated task which involves dedicated 
analysts and specialized equipment. From the analytical point of view, samples (e.g., mouldy 
feed, mouldy building materials) used for analysis of fungal metabolites are considered as 
complex matrices. They can contain not only the analytes of interest, but also an unlimited 
number of matrix components which can disturb the analysis; therefore, sensitive and 
selective analytical methods are vital. 
Separation methods for secondary fungal metabolite analysis include thin-layer 
chromatography (TLC), capillary electrophoresis, high-performance liquid chromatography 
(HPLC) and gas chromatography (GC) (Cigić and Prosen, 2009). For the detection of the 
metabolite response, UV, fluorescence detector and mass spectrometer (MS) are frequently 
used. Each technique has its limitations. For instance, the disadvantage of GC technique 
compared to LC is the necessity of prior derivatization of the analyte which limits the use of 
this method in non-targeted analysis (Villas-Bôas et al., 2005). UV detection has lesser 
sensitivity and specificity in the analysis of complex matrices as compared to MS. Matrix 
components can interfere with the targeted analyte and exhibit similar UV spectra. 
Additionally, it has been observed that, depending on the compound, metabolized 
molecules may have the same retention time and UV spectral characteristic as the parent 
molecule (Anonymous, 2012).  
Nowadays, LC-MS is the most frequently employed hyphenated technique in qualitative and 
quantitative analysis of secondary fungal metabolites owing to its high sensitivity, high-
throughput and possibility to confirm the identity of the components present in complex 
samples (Songsermsakul and Razzazi-Fazeli, 2008; Villas-Bôas et al., 2005).  
LC is a separation technique that is based on distributing the components of a mixture 
between two phases, a stationary phase and a mobile phase, depending on the relative 
affinity of the molecules to the phases (Scott, 2012). Due to differences in physico-chemical 
properties, each compound has a characteristic affinity to the phases. The separation of 
analytes in multi-analyte methods is achieved with HPLC and the more recently emerged 
technique, ultra high performance liquid chromatography (UHPLC or UPLC). By using smaller 
particles of packing material and higher flow rates, UPLC becomes more popular in 
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secondary fungal metabolite analysis due to the increased speed of analysis, higher 
separation efficiency and resolution as compared to HPLC (Kokkonen and Jestoi, 2010; 
Swartz, 2005). The two main types of LC are normal-phase (NP) and reversed-phase (RP) LC. 
Of these two types, RP-LC is most widely used in the separation of fungal metabolites due to 
the essentially inert stationary phase allowing exploitation of a diverse range of solvent 
mixtures (addition of salts, pH alteration) (Fallon et al., 1987; Lattanzio et al., 2007; Spanjer 
et al., 2008; Wilson and Walker, 2010; Zhang et al., 2013). Recently, a new particle 
technology called Fused-Core has been introduced in separation science. Such particles are 
manufactured by “fusing” a porous silica layer onto a solid silica particle. Due to shorter 
diffusion path, columns based on this technology can be used at higher flow rates still 
providing good peak resolution (DeStefano et al., 2008; HALO Brochure, http://www.gc-
lc.com/HALO_Brochure(2).pdf). 
An alternative LC mode for separation of polar compounds, namely hydrophilic interaction 
LC (HILIC), has also been used for the analysis of secondary fungal metabolites (Fæste et al., 
2012; Sørensen et al., 2007). HILIC is a variant of NP-LC, and it employs polar stationary 
phases such as silica or amino; however, the mobile phase used is similar to those employed 
in the RP-LC mode (Buszewski and Noga, 2012). 
The principle of MS is based on ionization of molecules or atoms in a sample and their 
separation according to mass-to-charge (m/z) ratio and further detection by the respective 
m/z and abundance (Barker and Ando, 1999; Gross, 2011). A variety of ionization modes and 
types of mass analyzers is currently available making MS useful in routinely control of 
targeted analytes as well as in the identification of less studied or unknown secondary fungal 
metabolites. 
In the atmospheric pressure ionization (API) LC-MS techniques, ions are formed at 
atmospheric pressure and transferred into the vacuum of the mass analyzer (Bruins, 1994; 
Nielsen et al., 2004). The API includes electrospray ionization (ESI), atmospheric pressure 
chemical ionization (APCI) and atmospheric pressure photoionization (APPI) (De Hoffmann 
and Stroobant, 2007).  
In ESI, ionization occurs in the liquid phase (Kokkonen, 2011). The eluent from the column is  
sprayed through a narrow bore capillary to which a high voltage is applied; and a spray of 
highly charged droplets is produced (Fig. 2.1a).  
 
74 
 Chapter 2 
 
 
Figure 2.1. ESI (a), APCI (b) and APPI (c) ionization process (adapted from Downard, 2004; 
Nieckarz, 2010). 
(c) 
(b) 
(a) 
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The solvent is evaporated from the droplets by a heated gas, leading to shrinkage and 
disintegration to charged species through a complex process. The ions are formed either in 
the solvent before spraying or during the spray droplet shrinkage. The charged species are 
then sampled into the vacuum of the mass analyzer (Nielsen et al., 2004). In APCI the eluent 
from the HPLC column is sprayed through a co-axial capillary with a heated gas to evaporate 
the solvent (Fig. 2.1b). Evaporated solvent molecules are ionized by a corona discharge from 
a needle that is usually placed across the sampling orifice. Analyte molecules are ionized by 
chemical reaction in the gas phase at atmospheric pressure (Nielsen et al., 2004). 
Unlike ESI, APCI does not produce multiply charged ions, therefore, it cannot be applied in 
the analysis of compounds with high molecular mass (Ashcroft, 1997). In APPI the liquid 
eluent is vaporized in a heated nebulizer to form a cloud of gas-phase analytes (Fig. 2.1c). 
Ionization is initiated by a beam of photons emitted from a gas discharge lamp (UV lamp; 
potential 10 eV). There are two ways of APPI, namely direct and dopant-assisted APPI (DA-
APPI). In the first format, an analyte molecule absorbs the photon directly. It occurs when 
the ionization energy of the analyte molecule is lower than the photon energy. In the DA-
APPI, a dopant (e.g., toluene, acetone, phenol) is infused into the ionization region. The 
dopant absorbs photons and ionizes either the sample molecules by charge exchange or the 
solvent molecules which, in turn, ionize sample molecules. APPI is used to ionize non-polar 
and polar low-mass compounds (Dass, 2007; Wanner and Höfner, 2007). 
Though ESI is the dominating ionization method in LC-MS analysis of secondary fungal 
metabolites (Åberg et al., 2013; Diana Di Mavungu et al., 2012; Ediage et al., 2011; Krska et 
al., 2008; Şenyuva et al., 2008), APCI and APPI are also utilized (Biselli et al., 2005; Razzazi-
Fazeli et al., 2002; Takino et al., 2003).  
A wealth of mass analyzers is currently available for the analyst. Mass analyzers use electric 
and magnetic fields (combined or alone) to separate the ions according to m/z; and the main 
difference  between them is the way in which these fields are used to achieve the separation 
(De Hoffmann and Stroobant, 2007). The most common mass analyzers used for a variety of 
analytes including secondary fungal metabolites, are quadrupole, ion trap, time-of-flight 
(TOF), Orbitrap and Fourier transform ion cyclotron resonance (FT-ICR) (Bartók et al., 2006; 
Diana Di Mavungu et al., 2012; Şenyuva et al., 2008; Siegel et al., 2009; Zachariášová et al., 
2011). Hybrid combinations and variants of these analyzers are also employed for structural 
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characterization (Herebian et al., 2009). In triple quadrupole, ions are separated based on 
the stability of their trajectories in the oscillating electric fields that are applied to the rods 
(Barker and Ando, 1999; De Hoffmann and Stroobant, 2007). In ion trap, ions are trapped 
and stored within the trap using an oscillating electric or magnetic field where collisionally-
induced dissociation (CID) can be performed to produce MS/MS or multiple stage MS data. 
Traps that make use of magnetic fields are called ICR. TOF MS separates the ions and 
measures m/z based on the time they take to pass (‘fly’) from the ion source to the detector 
(Downard, 2004).  
Mass resolution and accuracy are the two most important factors for the identification of 
compounds whereas scan speed is of most chromatographic importance (Nielsen et al., 
2004). The performance of common mass analyzers is shown in Table 2.1.  
 
Table 2.1. Performance of common mass analyzers (summarized from De Hoffmann and 
Stroobant, 2007; Holčapek et al., 2010; Hu et al., 2005; Kazakevich and LoBrutto, 2007; Lu et 
al., 2008; Nielsen et al., 2004). 
Mass analyzer 
Resolving power 
(FWHM)a 
Mass accuracy 
(ppm) 
Scan speedb Dynamic rangec 
Quadrupole 1000-2000 100-300 high >104 
Ion trap 1000 100-300 high >103 
Time-of-flight >10,000 2-5 very high >103 
Orbitrap >100,000 <1-5 high >103 
Fourier transform ion 
cyclotron resonance 
>500,000 0.05-0.1 very high >104 
a FWHM: full width at half-maximum 
b scan speed defined as the rate at which analyte measures over a particular mass range 
c dynamic range is defined as the range of ion counts over which a linear response is obtained 
 
Mass resolution usually refers to the ability of separating two narrow mass spectral peaks 
(Metabolomics Fiehn Lab, http://fiehnlab.ucdavis.edu/). The group of low resolution mass 
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analyzers typically includes quadrupole and ion trap analyzers with resolving power in the 
range of few thousands using the full width at half-maximum (FWHM) definition and without 
the possibility of accurate determination of m/z values (Holčapek et al., 2010). High 
resolution (resolving power in the range of tens of thousands; TOF) and ultra-high resolution 
(>100,000 FWHM; Orbitrap, ICR) analyzers give the highest confidence in the spectra 
interpretation and analyte identification (Holčapek et al., 2010). 
Simply stated, mass accuracy is the ability to measure or calibrate the instrument response 
against a known entity. Commonly expressed in parts per million (ppm), the mass accuracy 
indicates the deviation of the instrument response from a known monoisotopic calculated 
mass (Balogh, 2004). High mass accuracy (<5 ppm; TOF) or even better ultra-high mass 
accuracy (<1-5 ppm; Orbitrap, ICR) significantly reduces the number of possible elemental 
compositions for the ion within a given mass tolerance (Holčapek et al., 2010).  
As a conclusion, quadrupole and ion trap mass analyzers possess sufficient features to serve 
in targeted metabolite analysis, whereas TOF, Orbitrap and FT-ICR MS have a great potential 
for untargeted full MS screening of secondary fungal metabolites due to superior full-scan 
sensitivity, mass accuracy and resolution. Owing to the ability of consequential 
fragmentation, the ion trap MS can also be helpful in the establishment of fragmentation 
pathways of an analyte and its structure elucidation. Having outstanding accuracy and 
resolution, the FT-ICR analyzer is however rarely used for the LC-MS analysis of secondary 
fungal metabolites which is likely to be attributed to its high costs. 
 
2.2. Targeted LC-MS analysis: strategy and methods 
Targeted LC-MS analysis comprises of detection of a pre-selected metabolite in a sample and 
determination of its concentration (if reference standard is available). To unambiguously 
confirm the targeted analyte, a mass spectrometer capable of fragmentation is used. 
Tandem mass spectrometry, abbreviated as MS/MS, is commonly accomplished with triple 
quadrupole. In this two-stage mass analysis, a combination of a specific precursor mass and 
(a) unique product ion(s) is used to selectively monitor and unambiguously confirm the 
analyte to be quantified (De Hoffmann and Stroobant, 2007; Songsermsakul and Razzazi-
Fazeli, 2008).  
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For increased sensitivity and selectivity, data acquisition is performed in the selected 
reaction monitoring (SRM) mode. Generally, two SRM transitions are selected for each of 
the analytes. As stated in Commission Decision 2002/657/EC (Commission Decision, 2002), 
for positive identification of an analyte in a sample, three criteria should be met:  
1) A peak with a signal-to-noise (S/N) ratio of at least 3 should be identified for each of SRM 
transitions;  
2) The deviations of relative ion intensities for the SRM transitions should not be greater 
than the maximum permitted tolerances according to the Commission Decision. The relative 
ion intensities expressed as a percentage of the intensity of the most abundant ion should 
correspond to those of the ions in the solutions of standards, with a maximum permitted 
deviation of 20 % (relative ion intensity > 50 %), 25 % (relative ion intensity: 21-50 %), 30 % 
(relative ion intensity: 11-20 %), 50 % (relative ion intensity < 10 %);  
3) The relative retention times with regard to the internal standard should be below the 
maximum permitted deviation of 2.5 %.  
Thus, LC-MS/MS methods can discriminate different analytes by a combination of 
chromatographic, precursor ion and product ion(s) data. However, it is not always possible 
to obtain two specific product ions. A good example is moniliformin which exhibited only 
one abundant product ion (Sulyok et al., 2006). The MS spectra of type B trichothecenes 
showed [M+CH3COO]- adducts as the main precursor ion, which produced either the acetate 
ion (m/z 59) or the [M-H]- ion as the most abundant product ions. Despite being non-specific, 
these product ions were used for quantification, while a third transition (less abundant) was 
added for identification (Sulyok et al., 2006).  
If required, the number of fragmentation steps can be increased; this is referred to as 
multistage MS and labelled as MSn. For this purpose, ion trap is used allowing a maximum 
number of fragmentation steps of seven to eight (De Hoffmann and Stroobant, 2007).  
A number of single- or multi-analyte LC-MS/MS methods has been developed in recent 
years; the majority of them focuses on quantification of mycotoxins (Ediage et al., 2011; 
Freitas-Silva et al., 2011, Kataoka et al., 2009; Kokkonen and Jestoi, 2009; Krska et al., 2008; 
Lattanzio et al., 2007; Lau et al., 2003; Reinsch et al., 2007). Only few studies reported LC-MS 
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methods which included secondary fungal metabolites other than mycotoxins (Abia et al., 
2012; Lehner et al., 2011; Vishwanath et al., 2009). 
Separation of the targeted analytes prior to MS analysis is mostly done utilizing HPLC 
(Berthiller et al., 2005; Diana Di Mavungu et al., 2012; Ediage et al., 2011; Lattanzio et al., 
2011; Sewram et al., 2000; Sulyok et al., 2006); however, in the last years, the popularity of 
UPLC in secondary fungal metabolite analysis is rising (Beltrán et al., 2006; Kokkonen and 
Jestoi, 2010; Monbaliu et al., 2010; Romero-González et al., 2009; Ventura et al., 2006). As 
an example, UPLC-MS/MS analysis of 10 ergot alkaloids could be finished in only 6 minutes 
(Kokkonen and Jestoi, 2010). In another study, although the advantages of a fast UPLC were 
not fully exploited, it was possible to separate the isomers 3-acetyldeoxynivalenol and 15-
acetyldeoxynivalenol, and fumonisin B2 and fumonisin B3 (Monbaliu et al., 2010). Only a few 
studies reported a base-line separation of these compounds (Kotal and Radová, 2002), 
others relied on the difference of characteristic product ions under the SRM mode (Ren et 
al., 2007).   
Regarding the MS part of analysis, an important factor which can influence the sensitivity of 
a targeted LC-MS method is the production of different types of ions in the ionization 
processes of the API techniques. Rundberget and Wilkins (Rundberget and Wilkins, 2002) 
compared the spectra of some mycotoxins in APCI and ESI ionization modes using a mixture 
of methanol and water containing ammonium acetate as mobile phase. APCI (positive) as 
well as ESI (positive and negative) inlets resulted in mainly (de)protonated molecules, 
however, some analytes demonstrated loss of water or formation of adducts, such as 
[M+NH4]+, [M+Na]+. Mycophenolic acid and chaetoglobosin A also formed higher mass 
addition ions ([2M+H]+, [2M+Na]+) which reduced the ion current of the protonated 
molecule by 50-60 % of the total ion current. In negative ESI, [M+HCOO]- and [M+CH3COO]- 
ions were often observed along with deprotonated molecule. Adduct formation was also 
experienced by other researchers (Beltrán et al., 2009; Rasmussen et al., 2010; Sulyok et al., 
2006). Careful selection of mobile phase composition and ion source parameters can help to 
reduce/eliminate undesirable adducts (Nielsen and Smedsgaard, 2003; Rundberget and 
Wilkins, 2002). 
The most common mass analyzer for quantitative analysis of secondary fungal metabolites 
(especially, mycotoxins) is triple quadrupole MS (Ediage et al., 2011; Martos et al., 2010; 
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Monbaliu et al., 2009; Sulyok et al., 2006; Rasmussen et al., 2010). It is cost-effective and 
easy to operate. The triple quadrupole mass analyzer has adequately high data acquisition 
rates for quantitative multi-analyte analysis to provide enough data points across the 
chromatographic peak, even if co-elution of some compounds is unavoidable (Kokkonen, 
2011). 
Besides triple quadrupole, other mass analyzers or hybrid mass spectrometers are utilized in 
targeted secondary fungal metabolite analysis. A hybrid triple quadrupole/linear ion trap 
mass spectrometer was used for quantification of 159 fungal metabolites in indoor matrices 
(Vishwanath et al., 2009) and 340 fungal metabolites in cereals, nuts and their products 
(Abia et al., 2012). The data acquisition was done in positive and negative polarities in two 
separate chromatographic runs. In the analysis of such a wide range of compounds, the main 
challenge is the time available for data acquisition of each of the transitions. To ensure 
enough time for acquisition, a scheduled multiple reaction monitoring (sMRM) mode was 
used. In this mode a separate retention time window is defined for each analyte, thus, each 
MRM transition is monitored only around the expected retention time (Schreiber and Pace, 
2010). 
Takino et al. (Takino et al., 2008) performed analysis of selected toxic macrocyclic 
trichothecenes using LC-MS/MS and LC-TOF-MS. Detection of two product ions and a mass 
error for the precursor ion of less than 2 ppm enabled confirmation and quantification of 
roridin L2, satratoxin G, satratoxin H and iso-satratoxin F in the spores of Stachybotrys 
chartarum. Although it is claimed that less noise is observed using high-resolution 
instruments due to high mass resolving power and therefore narrow mass windows (Lehner 
et al., 2011), limits if detection (LODs) of the LC-TOF-MS method were 6 to 60 times higher 
than those of the LC-MS/MS (Takino et al., 2008).  
Lehner et al. established a sensitive LC-Orbitrap-MS method for quantification of 20 relevant 
mycotoxins in food (Lehner et al., 2011). Simultaneously, a suspects screening of 200 other 
fungal metabolites was performed. Suspects screening can be defined as a kind of targeted 
analysis where full-scan data are examined for a list of analytes of interest (Krauss et al., 
2010). Working in such a way allowed the detection of 13 additional metabolites. Orbitrap-
MS used for quantitative analysis of regulated mycotoxins in cereal grains and grain foods 
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showed similar performance in terms of detection limit, recovery, repeatability and matrix 
effect as well-established triple quadrupole-based approaches (Lattanzio et al., 2011).  
 
2.3. Untargeted LC-MS analysis: strategy and methods 
Detection of less studied or novel compounds promotes further developments in science 
and, as a consequence, gives rise to new targeted methods. In case of secondary fungal 
metabolite analysis, discovery of such compounds is crucial since they might represent a 
danger for human or animal health.  
Strictly defining, untargeted analysis presumes no a priori information on the compounds to 
be detected. However, some studies are designed in such a way that an unknown peak can 
correspond to a structure having a close relationship with the parent (known) compound 
and an adequate control sample is available (Cary et al., 2006; Cirlini et al., 2012). 
Independently on the approach, identification of untargeted analytes is challenging and 
requires sophisticated instrumentation and several data processing steps (Krauss et al., 
2010). The initial step in the workflow of identification of untargeted compounds (Fig. 2.2) is 
full-scan data acquisition followed by (automated) peak detection.  
 
 
Figure 2.2. General workflow for identification of untargeted compounds. 
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The advantage of accurate mass instruments at this step is that they can provide high 
selectivity by performing the exact mass chromatograms with a narrow mass window. An 
example illustrating such potentiality is shown in Fig. 2.3. A peak of roquefortine C was 
extracted from the total ion chromatogram using the nominal mass (Fig. 2.3a) and the exact 
mass of the metabolite (Fig. 2.3b). The obtained S/N ratios of these peaks differ considerably. 
It is clear that a narrow mass window helps to reduce interferences in the chromatogram. 
This is of great importance especially for low-intensity metabolites. Due to the complexity of 
the spectral data, the step of peak detection is often performed automatically by a software 
using different peak detection algorithms (e.g., SIEVE™, MarkerLynx™, MZmine™) 
(Katajamaa, 2006; Krauss et al., 2010; Stumpf and Goshawk, 2004; Sutton et al., unknown; 
Vilas-Bôas et al., 2005).  
 
 
 
Figure 2.3. Signal-to-noise ratio (S/N) of a peak of roquefortine C (extracted from Penicillium 
sp. grown on wallpaper) in the nominal mass chromatogram (a) and the exact mass 
chromatogram (b). 
 
Statistical analysis can be applied to a data matrix produced from raw data to allow 
identification of variables (metabolites) that explain most of variation between datasets. 
Multivariate classification methods, such as, Principal Component Analysis (PCA), Partial 
(b) 
(а) 
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Least Squares Analysis (PLS) or cluster analysis, are widely-used statistical tools for this 
purpose (Sugimoto et al., 2012). PCA converts high dimensional data into fewer dimensions, 
by projecting the data into a reduced dimensional sub-space, while maintaining as much 
variance from the original data as possible. The procedure is repeated until the datasets can 
be presented usually within two or three dimensions (Nyamundanda et al., 2010; Sugimoto 
et al., 2012). Clustering analysis divides observed datasets into several sub-classes or clusters 
based on a selected statistical distance function; in this way datasets with similar 
metabolomic profiles are placed in each sub-group (Blekherman et al., 2010). PLS, a 
regression-based method, builds a low-dimensional sub-space based on linear combinations 
of the original X variables. It makes use of additional Y information by adjusting the model to 
capture the (Y)-related variation into the original X variables. The goal of PLS regression is to 
predict Y from X and to describe their common structure (Abdi, 2003; Sugimoto et al., 2012). 
For the exact mass of interest, an elemental formula is assigned within a set mass tolerance 
(Fig. 2.2). It is unnecessary to set up high element limits for formula generation. For instance, 
it has been shown that for 47 carbon atoms the maximum hydrogen number does not 
exceed 150 using the most common six elements (C, H, N, S, O, P and Si) (Kind and Fiehn, 
2007). Software (e.g., XCalibur™) generates a list of formulas corresponding to the given 
exact mass and disregards the physical existence of chemical structures. Thus, some 
formulas can be either wrong or contain an unlikely high or low number of elements. These 
unreasonable elemental compositions can mislead the analyst and should be manually or 
automatically (Kind and Fiehn, 2007) filtered. Analyzing a large set of molecular formulas 
available from mass spectral databases, it has been observed that the hydrogen/carbon ratio 
(H/C) does not exceed 3 with a few exceptions (e.g., methylhydrazine CH6N2). For the 
majority of formulas this parameter was in the range from 2.0 to 0.5 (Kind and Fiehn, 2007). 
However, this rule has to be handled with caution as there are different chemical classes 
which can fall out of this range. 
For a successful compound elucidation, information on the isotopic pattern should also be 
taken into consideration. The abundance of the isotope ions (M+1, M+2, M+3) is dependent 
on the actual elemental composition and can therefore serve as a powerful filter in 
calculating unique elemental compositions. It has been shown that applying an isotopic 
abundance pattern can remove most of the false candidates from the list of elemental 
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compositions (Kind and Fiehn, 2006). Modern mass spectrometers such as TOF-MS, report 
isotopic abundance patterns with a low relative error of around 5 % (Anonymous, 2009). The 
isotopic pattern is especially useful for detecting the presence of bromine or chlorine-
containing compounds as these atoms have highly characteristic isotopic distributions (Ipsen 
et al., 2010). However, for monoisotopic elements (F, Na, P, I) this feature is of no value 
(Kind and Fiehn, 2007). 
To calculate the elemental composition, the nitrogen rule can be applied (Thermo XCalibur 
User Guide, 2009). The rule states that if the molecular mass of an unknown compound to 
the nearest integer value is an odd number, the compound contains an odd number of 
nitrogens in its molecular formula. If the mass is even, the number of nitrogens in the 
molecule is also even (including 0). However, the nitrogen rule is only reliable in a mass 
range not higher than 500 Da (Kind and Fiehn, 2007). 
An important consideration in the examination of spectral data is formation of adducts 
(Table 2.2). In contrast to the targeted analysis (see section 2.2.), adducts and/or fragments 
can represent a diagnostic value and are used to validate the identity of the (de)protonated 
molecule (Nielsen and Smedsgaard, 2003). 
Once elemental compositions are known, a database annotation can be performed (Fig. 2.2) 
to find out whether the unknown was ever patented, studied or commercialized. Searching 
in large compound databases (e.g., Pubchem, ChemSpider) for plausible structures might 
result in numerous propositions which need to be further ranked by MS/MS (or MSn) data. A 
helpful tool is an in silico fragment simulation (e.g., Mass Frontier, Mass Fragment). However, 
a prediction of product mass spectra yields a large number of possible fragments, of which a 
small number are actually observed (Hill et al., 2008). It has to be also considered that 
multiple structures can be constructed for the same monoisotopic molecular weight (Hill et 
al., 2008). If the ‘unknown’ compound is not reported in databases, a thorough 
fragmentation study combined with a history of the sample (extraction, typical metabolites 
observed for the type of sample investigated) is essential; however, in most complicated 
cases, metabolite isolation and use of Nuclear Magnetic Resonance (NMR) are inevitable for 
structure elucidation (Holčapek et al., 2010). 
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Table 2.2. Common adducts and fragments in ESI and APCI ionization modes (summarized 
from Boyd et al., 2008; Holčapek et al., 2010; Nielsen and Smedsgaard, 2003). 
 
Adduct/fragment Formula m/z shifta Ionization mode Cause of adduct formation 
Alkali metal ions [M+Me]+ 
+ 22 (Na) 
+ 38 (K) 
positive Alkali metal salts 
Ammonia [M+NH4]+ +17 positive 
Ammonium salts               
and/or ammonia 
Water [M±H+H2O]± +18 positive/negative 
Aqueous solvent                       
or water impurity 
Chloride [M+Cl]- +34 negative 
Chlorinated solvents;     
chloride salts 
Methanol [M±H+CH3OH]± +32 positive/negative Methanol in solvent 
Acetonitrile [M±H+CH3CN]± +41 positive/negative Acetonitrile in solvent 
Formate [M+HCOO]- +46 negative Formic acid and/or formates 
Acetate [M+CH3COO]- +60 negative Acetic acid and/or acetates 
Trifluoroacetate [M+CF3COO]- +114 negative Trifluoroacetic acid 
Water loss [M±H-H2O]± -18 positive/negative NA 
CO loss [M±H-CO]± -28 positive/negative NA 
CO2 loss [M±H-CO2]± -42 positive/negative NA 
a the m/z shift is calculated with regards to [M+H]+ (positive) or [M-H]- (negative); M – molecular 
monoisotopic mass; NA – not applicable 
 
LC-MS for untargeted analysis has become a well-established technique in the investigation 
of secondary fungal metabolites. The beneficial properties of untargeted metabolite 
screening by LC-MS include classification of fungal types based on their metabolic profiles 
and additional knowledge on a wider range of metabolites (Şenyuva et al., 2008). Şenyuva et 
al. (Şenyuva et al., 2008) performed a metabolite profiling in fungi grown on different media 
and on figs by means of LC-TOF-MS.  The minimum identification criteria were fixed, namely, 
a mass tolerance of 5 ppm for the protonated molecule and predicted adducts and a 
minimum peak height of 1,000 counts (or S/N of 10). In addition to the known metabolites 
expected to be produced by the fungi (Aspergillus flavus and A. parasiticus), roquefortine A, 
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fumagillin, fumigaclavine B, malformins, aspergillic acid, nigragillin, terrein, terrestric acid 
and penicillic acid were also identified.  
High-resolution MS is an excellent tool for revealing new or less studied masked mycotoxins. 
A new Fusarium masked mycotoxin, fusarenon X-glucoside, was reported for the first time in 
wheat grain together with previously detected nivalenol-glucoside. The new glucoside was 
identified using LC-Orbitrap MS on the basis of accurate mass measurement of characteristic 
ions and MS/MS fragmentation patterns. However, structural isomers of the same elemental 
composition are difficult to identify or distinguish without their chemical standards. 
Therefore, the absolute structure, such as the position of glucosylated OH residue in 
nivalenol and fusarenon X molecules, remained to be clarified. Considering the fragment 
profile, 3-OH glucosylation seemed to be the most probable structure (Nakagawa et al., 
2011). Another study provided data on oligoglycosylated deoxynivalenols which were 
present in cereal products along with the known parent metabolite, deoxynivalenol, and 
deoxynivalenol-3-glucoside. The structure elucidation was supported by two complementary 
approaches, namely, UHPLC-Orbitrap MS with monitoring of specific fragments formed upon 
in-source fragmentation and specific enzymatic hydrolysis reactions. Moreover, literature 
information on MS fragmentation patterns of various deoxynivalenol glycosides was helpful 
in the generic interpretation of obtained mass spectra (Zachariasova et al., 2012). Presence 
of glucoside derivatives of T-2 and HT-2 toxins (type A trichothecene mycotoxins) was also 
identified with a mass accuracy lower than 2.8 ppm and characterized using high-resolution 
mass spectrometry based on Orbitrap technology (Lattanzio et al., 2012). 
Overall, though the instrumentation has advanced, the number of untargeted LC-MS 
methods for secondary fungal metabolite detection and characterization is scarce possibly 
due to time-consuming data interpretation.  
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 Chapter 3 
3.1. Introduction 
In recent years, the indoor environment has gained increasing attention due to health 
complaints of inhabitants. A term called SBS (see Chapter 1) was introduced to describe a set 
of health problems associated with poor indoor air quality. Indoor-air problems include 
insufficient ventilation, excess temperature and dry air, emission of chemicals from 
construction materials, mites and fungal growth caused by water damage in a building 
(Husman, 1996). Serious consideration has been given to indoor moulds and their 
metabolites (mycotoxins), as one of the causative agents of SBS (Abbott, 2002). As a result, 
numerous studies were dedicated to the investigation of selected mycotoxins in mouldy 
buildings. Several LC-MS/MS methods for mycotoxin detection in samples from mouldy 
indoor environments confirmed the presence of satratoxins and other trichothecenes, and 
sterigmatocystin (Bloom et al., 2007; Bloom et al., 2009; Delmulle et al., 2006; Hintikka et al., 
2009; Polizzi et al., 2009; Tuomi et al., 2000). But, when working only in MS/MS mode, the 
instrument is tuned to detect a limited set of the most relevant targeted compounds; other 
compounds, which can be present in complex matrices, are not detected. Those metabolites 
should be taken in consideration since they may also represent a danger for human health. 
Therefore, there is a need for untargeted screening. 
Nowadays, LC-TOF-MS is one of the most common techniques for untargeted analysis. 
Quadrupole TOF (QTOF) mass analyzers are characterized by high accuracy and sensitivity in 
full scan mode compared to tandem quadrupole instruments. A number of TOF-MS-based 
methods have been applied for secondary fungal metabolite analysis. An LC-TOF-MS method 
for fungal metabolite profiling in dried figs was established by Senyuva et al. (Senyuva et al., 
2008). Metabolites of Aspergillus flavus and A. parasiticus (e.g., aflatoxins, kojic acid, 5-
methoxysterigmatocystin, roquefortine A, penicillic acid, aspergillic acid) could be identified 
by automated database searching. This fast and simple method was also used to daily 
monitor levels of aflatoxins, kojic acid and 5-methoxysterigmatocystin over a period of 14 
days. Tanaka et al. (Tanaka et al., 2006) developed an LC-TOF-MS method for the screening 
of 13 Fusarium and Aspergillus mycotoxins (including trichothecenes and aflatoxins) in 
foodstuffs. Larsen et al. (Larsen et al., 2007) investigated six species in Aspergillus section 
Fumigati for secondary metabolite production by direct infusion mass spectrometry on a 
QTOF mass spectrometer. Twenty five secondary metabolites were identified, of which 14 
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(e.g., gliotoxin, cyclopiazonic acid, trypacidin, helvolic acid) were additionally confirmed by 
comparison with available standards. Takino et al. (Takino et al., 2008) developed a method 
for the determination of four macrocyclic trichothecenes in water-damaged houses by LC-
TOF-MS and LC-MS/MS. Both instruments were operated in ESI+. Satratoxins G and H, iso-
satratoxin F and roridine E were found in Stachybotrys chartarum which was isolated from a 
mouldy house. The accuracy of mass measurement ranged from 0.2 to 2.1 ppm. 
In the present work, to establish an untargeted LC-QTOF-MS method and identification 
strategy, fungi, namely, Penicillium brevicompactum and Chaetomium murorum, isolated 
from water-damaged buildings, were grown on malt extract agar (MEA) and wallpaper for 7-
21 days. Inoculated samples were extracted and analyzed by LC-QTOF-MS. As the recorded 
spectra of untargeted analysis are complex, containing metabolite fragment and isotope ions, 
matrix-associated ions and instrument noise, a statistical approach represented by PCA was 
applied to extract potential markers from the LC-MS data. Furthermore, untargeted 
metabolite screening was carried out in samples from mouldy buildings with the intention to 
gather more information on secondary fungal metabolite occurrence in indoor environments. 
This can help to better understand the relationship between SBS and fungal metabolites. 
 
3.2. Experimental 
3.2.1. Chemicals and material 
Methanol (MeOH) of LC-MS grade was obtained from Biosolve (Valkenswaard, The 
Netherlands), whereas HPLC-grade MeOH was from VWR International (Zaventem, Belgium). 
Ethyl acetate (EtOAc) and dichloromethane (DCM) were purchased from Acros Organics 
(Geel, Belgium). Formic acid (HCOOH), acetic acid (CH3COOH), ammonium acetate 
(CH3COONH4) and orthophosphoric acid (H3PO4) (85 %) from Merck (Darmstadt, Germany) 
were used. Ultrapure water (H2O) was produced by a Milli-Q Gradient System (Millipore, 
Brussels, Belgium). Sodium chloride (NaCl) and sodium acetate (CH3COONa) were purchased 
from VWR International. Sigma-Aldrich (Bornem, Belgium) was the supplier of Tween 80. 
Ultrafree®-MC centrifugal filter units (0.22 µm) from Millipore (Bedford, MA, USA) were used.  
Standards of ochratoxin A, aflatoxins B1, B2, G1 and G2, T-2 toxin, zearalenone, neosolaniol, 
diacetoxyscirpenol, sterigmatocystin, nivalenol, deoxynivalenol, verrucarin A, verrucarol, 
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roridin A, deepoxy-deoxynivalenol, reserpine and leucine-enkephalin were purchased from 
Sigma-Aldrich. Standards of chaetoglobosin A and roquefortine C were delivered from Enzo 
Life Sciences (Antwerpen, Belgium). Fermentek (Jerusalem, Israel) was the supplier of 
mycophenolic acid. Ready-made solid portions of commercial standards were dissolved in 
MeOH to reach a concentration of 1 mg/mL, while deepoxy-deoxynivalenol was supplied as 
a 50 µg/mL solution in acetonitrile (ACN). Stock solutions were stored at - 20 °C.  
MEA was prepared as follows: 2 % malt extract (Oxoid, Basingstoke, UK), 0.1 % 
bacteriological peptone (Oxoid), 2 % bacteriological agar (Oxoid) and 2 % α-D-(+)-glucose 
anhydrous 99 % (Acros Organics) were dissolved in water. Sterile Petri dishes, spreaders and 
disposable pipettes (1 mL, 10 mL) were purchased from VWR International. For sterilisation, 
a pressure cooker canner (Presto, USA) was used (121 °C, 1.2 bar, 20 min). 
Wallpaper (WP) was bought in a local retail shop and cut into pieces of 5 x 5 cm. 
 
3.2.2. Samples from mouldy buildings 
Seven samples from two water-damaged buildings in Belgium were collected. Surface 
sampling was done by scraping the spots of fungal growth and/or by gently pressing a 
contact plate containing growth medium. Subsequently, the contact plates were kept at 
25 °C for 10 days to allow development of fungal growth.  
A non-extensive mould distribution was noticed in House #1. Contact plate sampling was 
performed in the living room under the window (1 sample) and in the cellar (1 sample), 
while mould scraping could only be done in the cellar (1 sample). Inhabitants of this building 
complained of allergy. In House #2, high humidity, low temperature and extensive mould 
growth were observed. Most of mould accumulation was found under the window. Contact 
plate sampling (1 sample) and wall scraping (3 samples) was done in the building. The 
inhabitants of House #2 also experienced allergic responses.  
 
3.2.3. Inoculation 
The fungal species (from a home-made collection of fungi sampled in water-damaged 
buildings) were cultivated in sterile Petri dishes filled with 10 mL MEA and on WP in sterile 
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glass containers filled with some amount of water. A spore suspension of each investigated 
fungal species was prepared in physiological solution (aqueous solution of 0.85 % NaCl and 
0.5 % Tween 80) to a concentration of 106 colony forming units/mL. 0.5 mL of the spore 
suspension was put on a solid MEA (in Petri dishes) and WP (in a glass container). Prior to 
inoculation, all materials and solutions were sterilized. To homogenously distribute the 
spores over the media, a sterile spreader was used. The samples were incubated at 25 °C for 
7-21 days. Non-inoculated samples were also prepared to provide a reference. A content of 
the whole plate (containing medium) and pieces of WP were extracted and analyzed by LC-
QTOF-MS. 
 
3.2.4. Sample preparation 
Before extraction the samples were spiked with two internal standards – deepoxy-
deoxynivalenol (m/z 281.1389) and reserpine (m/z 609.2812).  
Sample preparation was based on the procedure described by Delmulle et al. (Delmulle et al., 
2006; Polizzi et al., 2009) which was initially developed by our research group for the multi-
mycotoxin LC-MS/MS analysis of samples from indoor mouldy environments. Extraction of 
the fungi inoculated on MEA was performed by adding 1.5 mL EtOAc to the samples and 
shaking for 15 min on a horizontal shaker (J. Toulemonde & Cie, Paris, France). The EtOAc 
layer was removed and kept separate. The next step was the addition of 1.5 mL DCM to the 
samples followed by shaking for 15 min. EtOAc and DCM layers were then combined. The 
extract was filtered through a folded paper filter (grade 3 hw, 65 g/m2; Egilabo NV, Kontich, 
Belgium). The filtrate was evaporated to dryness at 40 °C under a stream of nitrogen. The 
dry residue was redissolved in 200 μL MeOH:H2O (30:70, v/v) and injected into the LC-QTOF-
MS system. The same sample preparation procedure was applied to the inoculated 
wallpaper, but the extraction solvent was 15 mL of MeOH:H2O (90:10, v/v) which was added 
twice. 
 
3.2.5. LC-MS conditions 
An Alliance 2595 LC system (Waters, Milford, MA, USA) was used for the liquid 
chromatography part. The column used was a SunFire C18 column 3.0 x 150 mm, 3.5 µm 
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(Waters). The mobile phase consisted of (A) H2O containing 0.1 % (v/v) HCOOH and (B) 
MeOH containing 0.1 % (v/v) HCOOH pumping at a flow rate of 0.2 mL/min. The gradient 
elution program was as follows: 0-11 min: 30-60 % B; 11-19 min: 60-85 % B; 19-30 min: 85 % 
B; 30-35 min: 85-30 % B; 35-45 min: 30 % B. The injection volume was 20 µL. 
MS experiments were performed using an orthogonal acceleration QTOF micro MS (Waters) 
equipped with a dual sprayer orthogonal electrospray source (Z-spray, LockSpray). The 
instrument was operated in ESI+ mode. Desolvation gas was set at 450 L/h, cone gas 60 L/h, 
desolvation temperature 300 °C and source temperature 120 °С. ESI capillary was set at 2500 
V and cone voltage at 30 V. TOF flight tube voltage was set at 5630 V, reflectron voltage 
1780 V, pusher voltage 798 V, MCP (micro-channel plate) detector 2200 V. Full scan spectra 
were acquired over a m/z 100-950 range at a resolving power of 5000 FWHM with a scan 
accumulation time of 1.0 sec and interscan delay of 0.1 sec. Leucine-enkephalin was used as 
a lock mass compound (m/z 556.2771; 200 ng/mL in MeOH:H2O (50:50, v/v)) and infused at 
a constant flow rate of 0.1 mL/min using a Kontron pump IRIS 325 (Kontron Instruments, 
Milan, Italy). Real-time mass correction was used. With this technique leucine-enkephalin is 
introduced into the source at the same time as the samples and the instrument software 
constantly corrects the measured mass of the unknown compounds using the know mass of 
the reference compound. The reference compound was sampled every 8 s and data were 
averaged over 5 spectra/min. Daily calibration of the instrument was carried out infusing  
0.1 % H3PO4 in ACN:H2O (50:50, v/v) at a flow rate of 5 µL/min.  
For optimization of MS conditions, selected mycotoxin standards were infused into the 
QTOF-MS at a flow rate of 10 µL/min using a syringe pump. 
The MS/MS experiments were performed using variable collision energies in the range from 
10 to 60 eV to provide the most informative spectra. The LC-MS system was controlled by 
MassLynx software 4.0 (Waters). 
 
3.2.6. Data treatment 
Raw LC-MS data were processed using MarkerLynx 4.1 (Waters). The track peak parameters 
were set as follows: peak width at 5 % height 20 s, automatic peak-to-peak baseline noise, 
intensity threshold 10, mass window 0.05, retention time window 0.2 min, noise elimination 
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level 4.0 and mass tolerance 0.05 Da. All acquired raw data were subjected to mean-
centering and pareto scaling before multivariate analysis. Data from MarkerLynx were 
imported into SIMCA-P 11.0 software (Umetrics, Umeå, Sweden) for multivariate analysis 
(PCA). 
 
3.3. Results and discussion 
3.3.1. Mobile phase selection and optimization of MS parameters 
Mobile phase composition affects not only the chromatographic separation of compounds, 
but also their ionization in MS. Mixtures of H2O and organic solvent (MeOH or ACN) are 
commonly used for secondary fungal metabolite analysis and can be additionally modified to 
enhance separation and/or ionization. In general, the effect of eluent has been considered 
as a more decisive factor for the MS response compared to separation efficiency (Kokkonen, 
2011). 
Mobile phases consisting of H2O, MeOH, HCOOH, CH3COOH or CH3COONH4 were previously 
used for the LC-MS/MS analysis of a wide range of mycotoxins achieving good separation 
(Diana Di Mavungu et al., 2009; Ediage et al., 2011; Martos et al., 2010; Sulyok et al., 2006). 
Therefore, a set of mobile phases containing different modifiers, such as HCOOH, CH3COOH, 
CH3COONH4 and CH3COONa, was prepared for the MS ionization study. MeOH was 
preferred to ACN, because ionization was significantly reduced when ACN was used as 
mobile phase component in previous studies (Frenich et al., 2009; Ren et al., 2007). A 
number of mycotoxin standards, selected as model compounds, were redissolved in mobile 
phase and infused into QTOF-MS. 
All mobile phase combinations could be used for the analysis showing better results for 
some mycotoxins while being less suitable for the others (Fig. 3.1).  
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a Percentage was calculated for signal intensity in each mobile phase relative to the signal intensity recorded for mobile phase containing 0.1 % HCOOH 
Figure 3.1. Comparison of different mobile phase modifiers. Mobile phase composition consisted of H2O:MeOH (70:30, v/v) containing modifiers 
mentioned in the figure legend. 
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For example, aflatoxins demonstrated much higher signal intensity in H2O:MeOH (30:70, v/v) 
containing 0.1 % CH3COOH and 10 mM CH3COONH4, whereas ochratoxin A and 
chaetoglobosin A provided a higher MS signal in H2O:MeOH (30:70, v/v) containing 10 mM 
CH3COONH4 and 20 µM CH3COONa. Along with the protonated ions, sodium adducts were 
formed. This was not considered as a drawback, since adducts can be used for additional 
confirmation of compound identification in untargeted analysis. Finally, as a compromise, 
the mobile phase containing 0.1 % HCOOH was chosen. 
A further step included the optimization of the MS parameters, such as desolvation and cone 
gas flow, source and desolvation temperature, capillary and cone voltage, and MCP detector 
voltage. Most of the parameters were set at common values used in QTOF-MS analysis, as 
their effect on the analyte MS signal was less pronounced. A change in MCP detector 
settings had a significant impact on the MS signal (Fig. 3.2). A dramatic increase of signal 
magnitude was noted for ochratoxin A when the MCP detector voltage was set at 2200 V 
instead of 2100 V. Similar observations were made for the other model analytes. The cone 
gas flow rate was also optimized. Although a lower cone gas flow rate provided a higher MS 
signal for all analytes, by increasing the cone gas, adduct formation was slightly reduced. 
Eventually, the MCP detector voltage and cone gas flow were set at 2200 V and 60 L/h, 
respectively. 
 
 
Figure 3.2. Optimization of MCP detector voltage by direct infusion (example of ochratoxin A). 
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3.3.2. Evaluation of experimental mass error in QTOF-MS analysis 
Effectiveness and validity of establishing an elemental composition for a compound from its 
measured mass depend on correct determination of the mass error limits used for the 
composition generation. Setting a very narrow mass error limit might lead to elimination of a 
possibly correct elemental composition, and oppositely, setting a very wide limit results in 
many formulas and makes the identification procedure complicated (Blom, 2001). Therefore, 
the experimental mass error was established performing multiple injections of mycotoxin 
standard solutions, namely tenuazonic acid (m/z 198.1130), roquefortine C (m/z 390.1930) 
and fumonisin B1 (m/z 722.3963) (Fig. 3.3). 
 
 
Figure 3.3. Experimental mass error of QTOF-MS. The dashed lines represent the typical mass 
error of 5 ppm. 
 
Although the common mass error of QTOF-MS is declared to be 5 ppm (Want et al., 2007; 
Werner et al., 2008), deviations up to 20 ppm were noted. Several other reports also 
mentioned similar deviations in mass accuracy (Blom, 2001; Bristow and Webb, 2003). 
Significant changes in mass error over time (equal to 35 injections or about 26 hours of 
operation) were not observed. 
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Furthermore, two internal standards, namely deepoxy-deoxynivalenol and reserpine, were 
added to the samples and used to monitor the experimental mass errors during each 
analysis on QTOF-MS. 
 
3.3.3. Screening of fungal cultures 
The untargeted screening strategy, suggested in Chapter 2, was first evaluated analyzing 
known fungal cultures inoculated on MEA and WP. 
At the first stage, fungal cultures, namely P. brevicompactum and C. murorum, isolated from 
mouldy houses were inoculated on MEA and WP and grown for 1-3 weeks at 25 °C. The 
cultures were solvent-extracted and analysed by LC-QTOF-MS. The steps of identification are 
presented in detail for Penicillium sp. as an example.  
In order to identify specific metabolites produced by fungal species and to consider the 
matrix impact, a comparison between blank matrix and culture extracts should be made. In 
this case PCA can be a helpful statistical tool. In PCA the data matrix is examined to find 
markers that best describe the maximum variance in the data. Prior to PCA, a mean 
centering and pareto scaling were applied to the data. In mean centering the average value 
of each variable is calculated and subtracted from the data set (Cloarec et al., 2005). The 
mean of the transformed data equals zero. In scaling methods each variable is divided by a 
factor which is different for each variable (van den Berg et al., 2006). Pareto scaling uses the 
square root of variable’s standard deviation as a factor. The advantage of this scaling is that 
it enhances the contribution of lower concentration metabolites without amplifying the 
noise (Cloarec et al., 2005). After data processing, a list of intensities of the peaks detected 
was generated for the samples using retention time and m/z data pairs as identifier of each 
peak. The score plot displays the sample relationships in a multi-dimentional space, with 
similar samples clustered together and dissimilar samples separated. The score plot 
obtained after PCA showed separate clustering of cases (inoculated MEA or WP) and blanks 
(non-inoculated MEA or WP) meaning that some characteristic markers for cases can be 
expected (Fig. 3.4a). To find out precisely what markers significantly contribute to the 
variance observed within the dataset, the loadings plot was constructed (Fig. 3.4b). The 
loadings plot describes the relationship between the variables. Variables contributing most 
to the variance are positioned further from the origin of the plot. Finally, markers with m/z 
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321, 343, 366, 388 and 390 were selected for assignment (Fig. 3.4b). These markers were 
positioned further from the plot origin and were present only in inoculated matrix. 
 
 
Figure 3.4. PCA score plot (a) and loadings plot (b) of Penicillium brevicompactum. m/z 
values of the metabolites of interest are presented in (b). 
 
The spectrum of a peak eluted at 27.5 min was characterized by an abundant ion at m/z 
343.1166 (Fig 3.5). An ion at m/z 321.1328, which appeared on the loadings plot, was also 
present in the spectrum. Owing to the mass difference of 22 Da, it was speculated that m/z 
343 could be a sodium adduct of the protonated ion at m/z 321.  
 
Figure 3.5. Full MS spectrum of mycophenolic acid produced by Penicillium brevicompactum. 
321.1328
Ion Measur. m/z Calcul. m/z Mass error (ppm)
[M+H]+ 321.1328 321.1338 -3.1
[M+Na]+ 343.1166 343.1158 2.3
O
O
O
OH
O
OH
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The exact masses were transferred into the Molecular Formula Generator, incorporated into 
MassLynx software, which simulated possible elemental compositions (Fig 3.6). Within a 15 
ppm mass tolerance, 17 elemental compositions were generated for m/z 321.1328 and 25 
compositions for m/z 343.1166. A subsequent database search assisted in the tentative 
identification of the compound as mycophenolic acid (formula: C17H20O6; molecular weight 
(MW): 320 Da) with a mass error of -3.1 ppm for the protonated ion and 2.3 ppm for its 
sodium adduct. A trend plot, showing marker levels across the samples, confirmed presence 
of mycophenolic acid only in MEA and WP inoculated with P. brevicompactum (Fig. 3.7). 
Non-inoculated matrix did not contain this marker. 
 
 
Figure 3.6. Elemental compositions generated for m/z 343.1166 and 321.1328. 
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BL: refers to as blank and represents non-inoculated matrix, S: refers to as sample and represents inoculated 
matrix. 
Figure 3.7. Trend plot for marker at m/z 321.1328.  
 
To confirm the authenticity of the compound, MS/MS spectra were recorded (Fig. 3.8). The 
accurate mass of the observed fragment ions matched well with the calculated m/z values. 
Remarkably, the fragment ions did not provide the same mass accuracy as the protonated 
ions recorded in MS mode. In some cases, the mass error reached 24 ppm. This could be 
explained by energy differences between ions coming from the second quadrupole. It 
becomes more difficult to focus the kinetic energy of all the ions before each pulse in the 
TOF; also there are no calibration ions for continuous, on-line, accurate mass measurement 
corrections (García-Reyes et al., 2007). 
In the same way, two other metabolites of Penicillium sp. grown on MEA and WP were 
identified, namely brevianamide A and roquefortine C; chaetoglobosin A was produced by C. 
murorum grown on MEA and WP (Table 3.1). Structures of detected metabolites are 
presented in Fig. 3.9, except for roquefortine C which structure was given in Chapter 1. 
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Figure 3.8. MS/MS spectrum of mycophenolic acid produced by Penicillium brevicompactum 
and assignment of some fragment ions. 
 
 
Table 3.1. Metabolites produced by fungi inoculated on MEA and WP.  
Metabolite Fungi RT (min) Ion Measur. m/z Calcul. m/z Mass error (ppm) 
Mycophenolic acid 
Penicillium 
brevicompactum 
27.5 
[M+H]+ 
[M+Na]+ 
321.1328 
343.1166 
321.1338 
343.1158 
-3.1 
2.3 
Roquefortine C 
Penicillium 
brevicompactum 
16.3 [M+H]+ 390.1920 390.1930 -2.6 
Brevianamide A 
Penicillium 
brevicompactum 
17.7 
[M+H]+ 
[M+Na]+ 
366.1806 
388.1637 
366.1818 
388.1634 
-3.3 
-0.8 
Chaetoglobosin A 
Chaetomium 
murorum 
26.1 
[M+H]+ 
[M+Na]+ 
529.2720 
551.2551 
529.2702 
551.2522 
3.4 
5.3 
 
CE=25 eV
Fragment ion Calcul. m/z Measur. m/z Mass error (ppm)
C17H19O5+ 303.1232 303.1286 17.8
C17H17O4+ 285.1127 285.1145 6.3
C16H19O4+ 275.1283 275.1289 2.2
C15H17O4+ 261.1127 261.1140 5.0
C14H15O4+ 247.0970 247.0999 11.7
C13H13O4+ 233.0814 233.0869 23.6
C12H13O4+ 221.0814 221.0807 -3.2
C11H11O4+ 207.0657 207.0672 7.2
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Brevianamide A and mycophenolic acid have been earlier reported as dominant metabolites 
of P. brevicompactum (Frisvad et al., 2004; Nielsen, 2003). Moreover, mycophenolic acid was 
previously found in P. brevicompactum inoculated on building materials (Nielsen et al., 1999). 
The alkaloid, roquefortine C, was detected in several other Penicillium species (Frisvad et al., 
2004; Nielsen, 2003). As for chaetoglobosin A, it was produced as main metabolite by several 
Chaetomium species (De Vries et al, 2002; Nielsen et al., 1999; Oh et al., 1998). However, it 
was not reported being specifically produced by C. murorum. 
The three metabolites detected in cultures of Penicillium sp. have been reported to cause 
inflammatory responses (Rand et al., 2005), while chaetoglobosin A from Chaetomium sp. 
has been found to be cytotoxic (Ohtsubo et al., 1978). 
 
3.3.4. Screening of samples from mouldy environments 
The developed LC-QTOF-MS method was applied for secondary fungal metabolite screening 
in mouldy buildings, where inhabitants experienced some health problems. In three contact 
plate samples (Houses #1 and #2) and in a wall scraping sample (House #2) a peak at 10.9 
min was observed. The abundant ions in the MS spectrum were m/z 434.1830 and m/z 
403.1628. Using generated elemental compositions, a database search revealed a compound 
meleagrin (formula: C23H23N5O4; MW: 433 Da). The observed ions at m/z 434.1830 and m/z 
403.1628 correspond to [M+H]+ (mass error 1.6 ppm) and [M-CH3O+H]+ (-2.7 ppm) ions of 
meleagrin, respectively. The structure of meleagrin is shown in Fig. 3.9. A number of peaks 
could not be identified, some of which might not necessarily belong to secondary fungal 
metabolites, since a good control sample was not always available.   
It has been reported that meleagrin was mostly produced by Penicillium spp. (Frisvad et al., 
2004; García-Estrada et al., 2011). As Penicillium spp. were identified in the sampled 
buildings, the meleagrin detection was in good agreement with the abundant presence of 
these fungi. Previous studies in water-damaged buildings disclosed occurrence of meleagrin 
in naturally-infested wallpaper (Nielsen et al., 1999) and other building materials from 
mouldy indoor environment (Täubel et al., 2011). 
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Figure 3.9. Structures of secondary fungal metabolites detected in fungal cultures and 
mouldy houses. 
 
Meleagrin is defined as non-toxic, although it has to be considered that another common 
Penicillium metabolite, neurotoxic roquefortine C, is a precursor of meleagrin (Nielsen et al., 
1999); however, roquefortine C was not detected in the mouldy houses under investigation. 
Although meleagrin was yielded by fungi collected from the mouldy environments and  
grown at laboratory conditions, that does not necessarily mean its production in the indoor 
environment, as the metabolite production is dependent on the substrate, temperature and 
water content (Polizzi et al., 2011; Van Lancker et al., 2008). 
 
3.4. Conclusions 
The present study was focused on the untargeted screening of secondary fungal metabolites 
in cultures isolated from water-damaged buildings and naturally-infested samples from 
mouldy environments. As a detection technique, QTOF-MS was preferred since it provides 
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enhanced sensitivity in full scan mode compared to triple quadrupole MS, and accurate mass 
measurement which is beneficial for structure elucidation. Post-acquisition data treatment 
was conferred to appropriate statistical tools, in particular PCA. The markers (metabolites), 
best describing variation in the LC-MS dataset, were extracted and identified by searching in 
freely available databases.  
However, some limitations could be experienced with respect to the application of the 
method to the samples from mouldy houses. In the ‘real-sample’ analysis, a number of 
metabolites could not be identified manifesting the need for libraries of secondary fungal 
metabolites. Regarding the existing public libraries, spectral information is often missing or 
unstandardized. In addition, some metabolites, which were isolated and identified many 
years ago, have not been included in the databases. 
Another obstacle lies in the availability of control samples which are used as reference in 
defining suspect metabolites in infected samples. Generally, the indoor environment profile 
(e.g., type of building material) differs from one building or room to another making it 
difficult to characterize the matrix with appropriate non-infected control samples.  
Although a wide range of MS detectors is available, none of them on its own can totally 
characterize the infected sample. A combination of several MS techniques can be more 
efficient for metabolite identification. When database search shows no result, the 
metabolite is considered as unknown and the study requires additional techniques for 
structure elucidation such as NMR. Still, in the case of samples from mouldy buildings it is 
not possible to isolate the metabolite of interest for further NMR analysis due to the limited 
amount of sample. 
To conclude, a ‘real-sample’ analysis of fungal metabolites remains a complicated and time-
consuming task, though the instrumentation and software for data processing have greatly 
advanced. If one intends to perform an untargeted screening, the restrictions mentioned 
above, should be taken into consideration. Apparently, more fundamental research is 
needed for the characterization of secondary fungal metabolites. 
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 Chapter 4 
4.1. Introduction 
Secondary fungal metabolites have long been used as drugs and still serve as structural 
inspiration for new compounds. To date, the genomes of several filamentous fungi have 
been sequenced which led to extensive investigation of biosynthetic metabolic pathways 
and identification of a number of secondary metabolites.  
Members of the genus Aspergillus produce beneficial secondary metabolites such as the 
antibiotic penicillin (Brakhage et al., 2004) and the cholesterol-lowering drug, lovastatin 
(Bizukojc and Ledakowicz, 2007); however, they also yield secondary metabolites that are 
toxic to humans and animals (Bennett and Klich, 2003). Aspergillus flavus is one of the most 
important species in the Aspergillus genus and is distributed world-wide infecting food and 
feed (Bennett and Klich, 2003; Gourama and Bullerman, 1995; Mehl et al., 2012). A. flavus is 
known to produce the toxic and carcinogenic polyketide-derived secondary metabolites, 
aflatoxins, during growth on crops such as cereals, nuts and oilseeds (Bennett and Klich, 
2003; Duran et al., 2007; Schroerder and Boller, 1973), and is the second (after A. fumigatus) 
leading cause of invasive aspergillosis (Hedayati et al., 2007). In addition to the health risks 
associated with aflatoxins, there are also significant adverse economic impacts to producers 
due to market rejections of contaminated crops and livestock losses as well as costs 
associated with monitoring for aflatoxin contamination (Wu, 2006). Besides aflatoxins, A. 
flavus produces a number of other toxic secondary metabolites, such as sterigmatocystin, 
aflatrem, cyclopiazonic acid and gliotoxin (Bennett and Klich, 2003; Duran et al., 2007; Lewis 
et al., 2005; Schroeder and Kelton, 1975).  
The development of software programs for the systematic analyses of genome sequences 
has allowed investigators to identify putative secondary metabolic gene clusters based on 
sequence similarity to established genes such as PKSs, non-ribosomal peptide synthetases 
(NRPSs), hybrid PKS-NRPS and prenyltransferases (PTRs). One of these web-based programs, 
the Secondary Metabolite Unknown Regions Finder (SMURF; www.jcvi.org/smurf), designed 
specifically for analysis of fungal genomes, predicted the presence of 55 gene clusters 
associated with secondary metabolism in A. flavus (Georgianna et al., 2010; Khaldi et al., 
2010). To date, many of these clusters remain uncharacterized with metabolites being 
assigned to only six clusters (Forseth et al., 2012).    
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Studies have shown that production of a number of secondary metabolites in A. flavus and 
other filamentous fungi are controlled by the global regulator, VeA (Calvo et al., 2004; Calvo, 
2008; Chettri et al., 2012; Dhingra et al., 2012; Kato et al., 2003; Merhej et al., 2012). Whole 
genome microarray transcript profiling of A. flavus wild-type and a ∆veA mutant 
demonstrated significant differential expression of a number of genes associated with 
putative secondary metabolic gene clusters (personal communication, Dr. Cary JC). One of 
the genes significantly downregulated in the ∆veA mutant was identified as the cluster 27 
pks as designated by Georgianna et al. (Georgianna et al., 2010).   
In this study, a comparative metabolomics approach, based on UHPLC-HRMS, was applied to 
identify the metabolites associated with A. flavus cluster 27 pks gene. Inactivation of the 
cluster 27 pks gene resulted in production of greyish-yellow sclerotia compared to the dark 
pigment normally observed for A. flavus sclerotia. The sclerotial metabolites of the wild-type 
strain and ∆pks27 mutant were compared using differential statistical analysis to disclose 
metabolites that were only present in the wild-type strain. Identification of the metabolites 
was based on accurate mass and supported by multiple stage fragmentation experiments. 
 
4.2. Experimental 
4.2.1. Chemicals and material 
MeOH and ACN both of LC-MS grade were obtained from Biosolve (Valkenswaard, The 
Netherlands), whereas HPLC-grade MeOH and ACN were from VWR International 
(Zaventem, Belgium). EtOAc, DCM and acetone (dimethyl ketone (DMK)) were purchased 
from Acros Organics (Geel, Belgium). Sigma-Aldrich (Bornem, Belgium) was the supplier of 
ammonium formate (HCOONH4). HCOOH from Merck (Darmstadt, Germany) was used. 
Ultrapure H2O was produced by a Milli-Q Gradient System (Millipore, Brussels, Belgium). 
Ultrafree®-MC centrifugal filter units (0.22 µm) from Millipore (Bedford, MA, USA) were 
used. Sigma-Aldrich was the supplier of agar, uracil, corn steep solids, dextrose, peptone, 
sucrose, yeast extract, glucose, ammonium tartrate, dipotassium hydrogen phosphate 
trihydrate (K2HPO4*3H2O), magnesium sulfate heptahydrate (MgSO4*7H2O), iron(II) sulfate 
heptahydrate (FeSO4*7H2O). Ammonium sulphate (NH4)2SO4, potassium chloride (KCl), 
sodium nitrate (NaNO3) and sorbitol were from Merck. 
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Standards of aflatoxins B1, B2, G1 and G2 and cyclopiazonic acid were purchased from 
Sigma-Aldrich. Ready-made solid portions of commercial standards were dissolved in MeOH 
to reach the concentration of 1 mg/mL. Stock solutions were stored at -20 °C. Standard of 
asparasone was kindly supplied by Dr. Victor Sobolev (U.S. Department of Agriculture, 
Agricultural Research Service, National Peanut Research Laboratory, Dawson, Georgia). 
 
4.2.2. Strains and growth conditions 
An Aspergillus flavus 70 niaD−, pyrG− parental strain (referred to as AF70) was used as host 
for transformation. Three ∆pks27 (Af70 niaD−, ∆pks27) mutants were obtained following 
transformation of the parental strain with the pks27 knockout vector pks27-pyrG. An AF70 
pyrG-1 (niaD−, pyrG+) strain transformed with the pPG2.8 vector expressing the A. 
parasiticus pyrG gene (Skory et al., 1990) was used as a transformation control.  
Vector construction and fungal transformation were carried out at the USDA Southern 
Regional Research Center (New Orleans, LA, USA). A PCR-based method was used to 
construct the A. flavus 70 ∆pks27 in which a 770 bp region within the pks27 coding region 
was replaced by the A. parasiticus pyrG selectable marker gene.  Briefly, 5’ and 3’ regions of 
the pks27 gene were amplified using oligonucleotide primers. Following PCR amplification of 
A. flavus genomic DNA with ExTaq HS polymerase (Takara, Pittsburg, PA, USA), PCR products 
of the expected size of 1218 bp for the 5’ pks27 amplification and 1042 bp for the 3’ pks27 
amplification were obtained. PCR products were subcloned into TOPO pCR2.1 (Invitrogen, 
Carlsbad, CA, USA) and verified by DNA sequencing. The 5’ and 3’ pks27 PCR products were 
released from their TOPO vectors using EcoRI-BamHI and SalI-HindIII digestion respectively 
and subcloned in a stepwise manner into the analogous restriction digested pPG2.8 vector 
harboring the A. parasiticus pyrG selectable marker gene. The resulting knockout vector was 
designated PKS27-pyrG. Transformation was performed as described in Cary et al. (Cary et 
al., 2006) using A. flavus 70 (AF70) as the host.  
For the investigation of cluster 27 metabolites, conidia were grown for 10 days at 30 °C in 
the dark onto GMM agar supplemented with 2 % sorbitol (GMMS; per liter: glucose, 10 g; 
ammonium tartrate, 2.0 g; sorbitol, 2.0 g; Cove’s salts, 20 mL; pH 6.5).  For LC-Orbitrap-MS 
method evaluation, the wild-type AF70 was grown on Wickerham medium supplemented 
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with uracil and ammonium sulphate (WATM-US). The medium contained 2.0 g yeast extract, 
3.0 g peptone, 5.0 g corn steep solids, 2.0 g dextrose, 30.0 g sucrose, 2.0 g NaNO3, 1.0 g 
K2HPO4*3H2O, 0.5 g MgSO4*7H2O, 0.2 g KCl, 0.1 g FeSO4*7H2O and 15.0 g agar per liter (pH 
5.5) and was supplemented with 1 mg/mL uracil and 10 mM (NH4)2SO4. 
The strains used in the investigation of asparasone A production by other Aspergillus spp. 
were obtained from the USDA Southern Regional Research Center (New Orleans, LA, USA). 
These strains were grown on WATM medium as described above. 
 
4.2.3. LC-Orbitrap MS conditions 
An AccelaTM High Speed LC (UHPLC) (Thermo Fisher Scientific, San José, USA) was used for 
separation. The column was ZORBAX RRHD Eclipse Plus C18 (1.8 µm, 2.1 x 100 mm) from 
Agilent Technologies (Diegem, Belgium). The mobile phase consisted of H2O:MeOH (95:5, 
v/v) containing 0.1 % HCOOH and 10 mM HCOONH4 [solvent A] and MeOH:H2O (95:5, v/v) 
containing 0.1 % HCOOH and 10 mM HCOONH4  [solvent B]. The gradient elution program 
was applied as follows: 0-0.5 min: 0 % B, 0.5-20 min: 0-99 % B, 20-21 min: 99 % B, 21-24 min: 
99-0 % B, 24-28 min: 0 % B. The flow rate was 0.4 mL/min. The column temperature was set 
at 30 °C and temperature of the autosampler was 10 °C. Five µL of the sample were injected. 
Accurate mass measurements of the precursor and fragment ions were carried out on an 
Orbitrap ExactiveTM mass analyzer (Thermo Fisher Scientific) equipped with ESI and APCI 
interface. The final MS parameters in the ESI- were the following: spray voltage 4.5 kV, 
capillary temperature 250 °C, heater temperature 250 °C, sheath gas flow rate 45 arbitrary 
units (a.u.), auxiliary gas flow rate 10 a.u. The data were processed using the XcaliburTM 2.1 
and Exactive Tune software (Thermo Fisher Scientific). The instrument was operated in full 
scan mode with a resolution of 100,000 FWHM. The maximum injection time was 200 ms 
and the number of microscans per scan was 1. Each full scan was followed by a same-
polarity “all ion fragmentation” higher energy collisional dissociation (HCD) scan.  
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4.2.4. LC-ion trap MS conditions 
A Surveyor Plus HPLC System (Thermo Fisher Scientific) was used for separation. The column 
was an XBridge MS C18 column (3.5 µm, 150 x 2.1 mm) with an XBridge Sentry guard column 
(3.5 µm, 10 x 2.1 mm i.d.) both supplied by Waters (Milford, MA, USA). The mobile phase 
was as described in section 4.2.3. The gradient elution program was the following: 0-1 min: 0 
% B, 1-24 min: 0-99 % B, 24-25 min: 99 % B, 25-28 min: 99-0 % B, 28-35 min: 0 % B. The flow 
rate was 0.25 mL/min. The column temperature was set at 40 °C and temperature of the 
autosampler was 10 °C. Five µL of the sample were injected. 
An LTQ linear ion trap mass spectrometer (Thermo Fisher Scientific) equipped with an ESI 
source was used for the investigation of fragmentation behaviour. The set MS parameters 
were: source voltage 5 kV, capillary temperature 250 °C, heater temperature 175 °C, sheath 
gas flow rate 40 a.u., auxiliary gas flow rate 10 a.u. The maximum inject time was 200 ms 
and the number of microscans per scan was 3. When performing MSn experiments, the 
precursor ion was isolated in the ion trap with an isolation width of 3 Da and activated at 
different collision energy levels (CELs) to find the optimal conditions for distinct 
fragmentation. XcaliburTM 2.0.7 software (Thermo Fisher Scientific) was used for instrument 
control, data acquisition and processing. 
 
4.2.5. Sample preparation 
Sclerotia were collected from the Petri dish by adding 10 mL of sterile deionized H2O to the 
agar surface and gently scraping colonies with a cell scraper. The collected sclerotia were 
washed two times by addition of 40 mL H2O to remove residual conidia and mycelia. After 
centrifugation and removal of water, metabolites were extracted with 30 mL 
MeOH:DCM:EtAOc (10:20:30, v/v/v) containing 1 % (v/v) HCOOH. The samples were shaken 
during 60 min on an Agitelec overhead shaker (J. Toulemonde & Cie, Paris, France). Four mL 
of extract was transferred into a glass tube and evaporated till dryness under a stream of 
nitrogen. The residue was reconstituted with 200 µL MeOH:ACN:H2O (30:30:40, v/v/v), 
centrifuged in a Ultrafree®-MC centrifugal device for 5 min at 14,000 g and injected into the 
MS. 
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4.2.6. Statistical data treatment 
SIEVE 1.3 software (Thermo Fisher Scientific) was used for LC-MS data mining. SIEVE aligns 
the MS spectra over time for different experimental conditions and determines features in 
the dataset. Parameters for the SIEVE analysis were set as follows: frame time width 0.05 
min, frame m/z width 0.020, peak intensity threshold 10,000, maximum number of frames 
5000, alignment bypass: False, m/z min: 100, m/z max: 1,000, retention time start: 0.01 min, 
retention time stop: 28 min, PCA V1.0. Statistical significance of a frame was calculated 
within the SIEVE package using a t-test. 
To identify the extracted frames, initial database searching was performed using the 
MZLookup function in SIEVE where a home-made database was uploaded. The database was 
constructed based on literature data and consisted of secondary metabolites produced by 
Aspergillus spp.  
 
4.3. Results and discussion 
4.3.1. Development and evaluation of the LC-Orbitrap-MS method 
A common practice in the evaluation of targeted LC-MS method parameters (e.g., extraction 
recovery) is the use of spiked samples (Abia et al., 2013; Commission Decision 2002/657/EC, 
2002; De Boevre et al., 2012; Varga et al., 2013). This approach is difficult to apply to 
untargeted methods, since the number of analytes is unlimited. Moreover, spiking 
experiments have a disadvantage of not being able to fully mimic analyte interactions with a 
matrix. In this study, evaluation of some method parameters was performed using cultures 
of A. flavus AF70. The species was inoculated on WATM-US and grown for 10 days at 30 °C. 
Under these conditions, it produced a number of known metabolites which were identified 
following the strategy described in Chapter 2. Aflatoxins B1, B2, G1 and G2, and 
cyclopiazonic acid were confirmed with authentic standards, while aflatrem and 
ditryptophenaline were identified based on their retention time profile, which was in good 
agreement with the results of Rank et al. (Rank et al., 2012), and fragmentation pattern. Fig. 
4.1 and Table 4.1 summarize data on the detected metabolites. It is worth to mention that 
the dimeric character of ditryptophenaline was revealed in the MS spectra; an ion at m/z 
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346.1550 (C21H20N3O2; -2.0 ppm), corresponding to a monomeric fragment, accompanied 
the protonated ion at m/z 693.3178 (C42H40N6O4; -0.9 ppm). 
 
 
                                        
 
 
                                                        
 
 
 
 
Figure 4.1. Structures of A. flavus AF70 metabolites identified in the study and used in 
method evaluation. Structures of aflatoxins B1 and G1 were shown in Chapter 1, Fig. 1.2. 
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Table 4.1. Secondary metabolites identified in cultures of A. flavus AF70 and used for method 
evaluation. 
Metabolite 
Ionization 
mode 
Formula 
RT 
(min) 
Calcul. m/z Measur. m/z 
Mass error 
(ppm) 
Aflatoxin B1 ESI+ C17H12O6 11.6 313.0707 313.0703 -1.2 
Aflatoxin B2 ESI+ C17H14O6 11.1 315.0863 315.0860 -0.9 
Aflatoxin G1 ESI+ C17H12O7 10.1 329.0656 329.0652 -1.2 
Aflatoxin G2 ESI+ C17H14O7 9.9 331.0812 331.0808 -1.3 
Cyclopiazonic acid ESI+ C20H20N2O3 16.3 337.1547 337.1542 -1.4 
Aflatrem ESI+ C32H39NO4 20.4 502.2952 502.2944 -1.5 
Ditryptophenaline ESI+ C42H40N6O4 15.1 693.3184 693.3178 -0.9 
 
4.3.1.1. Optimization of chromatographic conditions 
As only volatile mobile phase additives are compatible with MS, the number of mobile 
phases for LC-MS analysis is limited. Different mobile phase compositions have already been 
tested for untargeted analysis of secondary fungal metabolites (see Chapter 3) and choice 
was made towards a H2O-MeOH-based mobile phase containing HCOOH. However, along 
with abundant protonated ions, sodium adducts were produced under this condition. In 
untargeted analysis adduct formation can be considered beneficial for reliable compound 
identification. Keeping in mind that the aim of untargeted analysis remains detection of as 
many metabolites as possible in a given sample, efforts were made to increase the signal of 
(de)protonated ions. Additional literature data revealed that HCOONH4 in combination with 
HCOOH can be used in mobile phase mixture to enhance signal of (de)protonated ions and 
reduce formation of sodium adducts (Ediage et al., 2012; Hedgepeth and Dahl, 2011; Lacina 
et al., 2012). Compared to CH3COOH and CH3COONH4 as additives in mobile phase, HCOOH 
and HCOONH4 provided 2-10 times higher MS signal (especially for aflatoxins). At the same 
time, a drop of HT-2 toxin signal intensity was observed in acidified HCOONH4 (Lacina et al., 
2012). Since it is not possible to find a universal mobile phase suitable for all compounds, a 
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mobile phase containing 0.1 % HCOOH and 10 mM HCOONH4 as modifiers was employed in 
the new LC-MS method. 
For increased sensitivity, peak resolution and speed of analysis, UPLC was preferred over 
HPLC. Structural diversity of secondary fungal metabolites leads to outstanding polarity 
differences, therefore selection of a suitable stationary phase was of great importance. It 
was opted for a ZORBAX C18 column which previously demonstrated good separation, 
improved retention of polar compounds such as glucosinolates and masked metabolites of 
deoxynivalenol, and excellent reproducibility (De Boevre et al., 2012; Ediage et al., 2011; 
Varga et al., 2013). In the current study, repeatability (in terms of RSD) of RT on the column 
for model mycotoxins was calculated for injections on the same day and on different days 
and generally did not exceed 0.6 %. 
 
4.3.1.2. Evaluation of experimental mass error in Orbitrap-MS analysis 
Mass accuracy is one of the crucial parameters of mass spectrometric performance and 
determines selectivity of database search in a metabolite identification procedure. A typical 
mass error of 2 ppm was reported for the Orbitrap MS (Hu et al., 2005; Muenster et al., 
2009; Wieghaus et al., 2011).  
In the study, evaluation of the experimental mass error of the MS was done using repetitive 
injections of standard solutions of selected mycotoxins as well as extracts of A. flavus (Fig. 
4.2). The mass accuracy was overall within the typical range for Orbitrap MS, except for a 
few injections for which the mass error reached a value of -2.5 ppm. This indicates that for 
positive identification, a mass error slightly higher than 2 ppm is to be expected; but errors 
above 5 ppm are unlikely to occur. The mass error variation over an LC peak was negligible.  
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Figure 4.2. Experimental mass error of Orbitrap-MS. The dashed lines represent a typical 
mass error of 2 ppm. 
 
4.3.1.3. Optimization of extraction procedure 
Different extraction methods have been applied in the analysis of secondary fungal 
metabolites. A majority of the methods involved multiple clean-up steps to produce ‘clean’ 
extracts (Diana Di Mavungu et al., 2009; Ip and Che, 2006; Lattanzio et al., 2007;  Monbaliu 
et al., 2010), having laboriousness and specificity only towards a selected group of 
compounds as their main drawbacks. From the other hand, a simple ‘dilute-and-shoot’ 
approach ensured extraction and detection of a wide range of analytes, however, yielding 
‘dirty’ extracts (Al-Taher et al., 2013; Mol et al., 2008; Monbaliu et al., 2010; Sulyok et al., 
2007).  
In the current study, a set of commonly used solvents was investigated to develop a fast and 
generic extraction protocol for the purpose of untargeted secondary fungal metabolite 
profiling. The tested solvent compositions were the following: I) MeOH:DCM:EtOAc 
(10:20:30, v/v/v) containing 1 % HCOOH (adapted from Smegsgaard, 1997); II) MeOH:DCM 
(50:50, v/v) followed by EtOAc:DMK (50:50, v/v) containing 1 % HCOOH (adapted from 
Frisvad and Thrane, 1987); III) ACN:H2O (84:16, v/v) (adapted from Berthiller et al., 2005; 
Ren et al., 2007); IV) ACN:H2O:HCOOH (79:20:1, v/v/v) (adapted from Mol et al., 2008; 
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Sulyok et al., 2007; Varga et al., 2013); V) DMK; VI) DMK followed by DCM and H2O. To 
estimate the suitability of the extraction solvent, peak area (n=4) was measured and 
compared for each condition. Overall good results were obtained for all investigated 
solvents (Fig. 4.3). Lower areas were noted for aflatoxin G1 and cyclopiazonic acid using 
solvent VI, while aflatoxin G2 was better extracted using solvent I. This dramatic decrease in 
the area of cyclopiazonic acid can be possibly attributed to a partitioning step in the 
procedure VI, where organic phase was used for the analysis (aqueous phase was discarded). 
Therefore, a partitioning step should be avoided in a generic extraction protocol. Moreover, 
acidification of extraction solvent can be useful, especially with the prospect of applying the 
method to different samples (media, food, feed, etc.). At neutral conditions, acidic and basic 
compounds are prone to interact with matrix (its protonated groups). At acidic conditions, 
acidic compounds are protonated and in their neutral state, and analytes with basic groups 
are ionized (positively charged), and, therefore, bind less to matrix components and remain 
dissolved in extraction solvent (Krska et al., 2008; Mol et al., 2008). 
Based on these observations and keeping in mind that the method can be broadened to 
matrices other than media, solvent I was finally chosen for sample preparation. 
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Figure 4.3. Optimization of extraction solvent. I: MeOH:DCM:EtAOc (10:20:30, v/v) containing 1 % HCOOH; II: MeOH:DCM (50:50, v/v) followed 
by EtOAc:DMK (50:50, v/v) containing 1 % HCOOH; III: ACN:H2O (84:16, v/v); IV: ACN:H2O:HCOOH (79:20:1, v/v/v); V: DMK; VI: DMK followed 
by DCM and H2O. 
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4.3.2. Metabolic profiling and preliminary metabolite assignment 
Recombinational inactivation of the pks27 resulted in A. flavus transformants that no longer 
produced characteristic dark brown sclerotia but instead produced sclerotia that were 
greyish-yellow. Metabolite screening of wild-type A. flavus AF70 and mutant A. flavus AF70 
was performed on an LC-Orbitrap-MS in ESI and APCI, both in positive and negative mode. 
The total ion chromatogram (TIC) for the wild-type and mutant are presented in Fig. 4.4.  
 
 
 
Figure 4.4. Total ion chromatogram of wild-type A. flavus AF70 (a) and mutant A. flavus 
AF70 (b) obtained in ESI-. 1 corresponds to m/z 373; 2: m/z 357; 3: m/z 315; 4: m/z 339. 
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Visual inspection of the TIC of the wild-type revealed presence of four clear peaks, which 
were seen only in the TIC of the parental strain. As low-abundance compounds might not be 
apparent, a statistical differential analysis of the LC-MS data was performed using SIEVE 
software. SIEVE included PCA to highlight differences between the two groups. To compare 
chromatograms of the groups on the basis of peak intensities, peak alignment was done 
using wild-type as reference sample. Significant differences in the metabolite profile were 
observed between the sample groups. On PCA score plot, the wild-type group was clearly 
separated from the other samples, which included the blank media and replicates of the 
mutant (Fig. 4.5). On PCA loadings plot (Fig. 4.5), variables relevant for the clustering pattern 
are shown. A set of four markers, corresponding to 373.0561 (13.4 min) (1), m/z 357.0612 
(15.4 min) (2), m/z 315.0510 (16.6 min) (3), m/z 339.0504 (17.7 min) (4) could be 
distinguished for the wild-type. The reconstructed ion chromatograms confirmed absence of 
these ions in the mutant.  
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Figure 4.5. PCA score plot (a) and loadings plot (b). 
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4.3.3. Fragmentation pathway and metabolite identification  
To identify the detected markers, firstly, accurate mass was used to generate elemental 
compositions leading to tentative metabolite identification by searching a home-made and 
public databases. At this stage, a match was found only for m/z 357.0612 corresponding to 
asparasone A (1,3,6,8-tetrahydroxy-2-(1'-hydroxy-3'-oxobutyl)-anthraquinone) with 
molecular formula C18H14O8, an anthraquinone pigment previously detected in A. 
parasiticus cultures (Sobolev et al., 1997). Identification of m/z 357.0612 as asparasone A (2) 
was confirmed by comparison with an authentic standard. A complete correspondence of 
RT, MS and MSn spectra for the identified metabolite and the standard was observed. MS2 
spectra (Fig. 4.6) were characterized by abundant product ions at m/z 339, and m/z 299 
corresponding to loss of H2O (-18 Da) and C3H6O (-58 Da) from the precursor ion at m/z 357, 
respectively. Subsequent fragmentation of the ion at m/z 339 yielded a product ion at m/z 
297 corresponding to a loss of 42 Da (C2H2O), whereas a fragment at m/z 271, 
corresponding to a loss of CO (-28 Da), was formed through fragmentation of the ion at m/z 
299. MSn data of the m/z 297 and m/z 271 (Fig. 4.7) indicated consecutive losses of 28 Da 
and 44 Da corresponding to CO and CO2, respectively. The fragmentation mechanism for 
these losses of CO and CO2 moieties from the anthraquinone structure was similar to that 
described by Kang et al. (Kang et al., 2007) for isoflavone derivatives. This involved a 
rearrangement of the molecule leading to the loss of the carbonyl and hydroxyl moieties, 
and closing of ring; however, the order in which CO or CO2 were eliminated from the 
structure could not be established. Combining these fragmentation data and accurate mass 
measurement, a fragmentation pathway of asparasone A in ESI- was proposed (Fig. 4.8). The 
above described consecutive losses of CO and CO2 led to the fragments at m/z 141 and 157, 
and m/z 155 from the ions at m/z 297 and m/z 271, respectively.  
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Figure 4.6. CID spectrum of  the precursor ion at m/z 357 (a) and second-generation spectra 
(b, c) acquired for compound 2. The product ions at m/z 339 (b) and m/z 299 (c) were 
isolated and collisionally activated at 40 % CEL. 
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Figure 4.7. Second- (a) and third- (b) generation spectra acquired for compound 2. The 
product ions at m/z 297 (a) and m/z 271 (b) were isolated and collisionally activated at 40 % 
CEL. 
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Figure 4.8. Proposed fragmentation pathway of asparasone A (2). The pathway involved consecutive 
losses of CO and CO2 moiety, starting from the fragments at m/z 299 (C15H7O7), m/z 339 (C18H11O7) 
and m/z 297 (C16H9O6). The order of these losses could not be established; exemplary structures of 
fragments are shown. 
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It was hypothesized that the four compounds detected in the wild-type A. flavus AF70 might 
be a part of the asparasone A biosynthetic pathway and therefore can be structurally 
related. Owing to mass differences of the abundant ions observed in the MS spectra, it was 
assumed that m/z 339 (4) and m/z 315 (3) could represent a molecule of asparasone A in 
which H2O and C2H2O, respectively, were eliminated from the side chain. A difference of 16 
Da for m/z 373 (1) could possibly account for an additional oxygen atom in the structure of 
asparasone A.  
MS2 spectra of compound 3 (m/z 315) showed initially a loss of 18 Da (corresponding to the 
elimination of a water molecule) yielding m/z 297 (Fig. 4.9a), whose fragmentation was 
identical to that observed for asparasone A. Compound 4 (m/z 339) also gave the same 
fragment at m/z 297 (Fig. 4.9b). MS2 of compound 1 (m/z 373) indicated losses of 18 and 58 
Da (Fig. 4.10a), as was observed with asparasone A (Fig 4.6a). The resulting fragments (m/z 
355 and m/z 315) had 16 mass units higher than the corresponding fragments in asparasone 
A, i.e. m/z 339 and m/z 299, respectively. This 16 Da difference pointed to an extra oxygen 
atom in the molecule, exact position of which in the structure could not be deduced from 
further MSn fragmentation of the product ions at m/z 355 and m/z 315. Nevertheless, these 
fragmentation data indicated that the substitution with a hydroxyl-group in the side chain 
was not likely, as the difference of 16 Da between asparasone A (2) and compound 1 was 
still noted after elimination of the side chain from the molecule. Therefore, the hydroxyl-
group could be at positions 4, 5 or 7, and more likely at positions 4 or 5. However, to 
designate the exact position of the hydroxyl-substituent, isolation of the compound and 
NMR experiments are needed. 
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Figure 4.9. CID spectra of precursor ions at m/z 315 (compound 3) (a) and m/z 339 
(compound 4) (b). 
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Figure 4.10. CID spectrum of  a precursor ion at m/z 373 (a) and second-generation spectra 
(b, c) acquired for compound 1. The product ions at m/z 355 (b) and m/z 315 (c) were 
isolated and collisionally activated at 40 % CEL.  
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Based on data described above, compounds 1, 3 and 4 were assigned respectively as 
1,3,4,6,8-pentahydroxy-2-(1'-hydroxy-3'-oxobutyl)-anthraquinone or 1,3,5,6,8-
pentahydroxy-2-(1'-hydroxy-3'-oxobutyl)-anthraquinone, 1,3,6,8-tetrahydroxy-2-(1'-
hydroxyethyl)-anthraquinone and 1,3,6,8-tetrahydroxy-2-(3'-oxobut-1'-en-1'-yl)-
anthraquinone (Fig. 4.11). The elution order of these compounds under the applied 
chromatographic conditions (reversed-phase chromatography) was consistent with the 
proposed structures. Compounds 4 and 3 eluted later than asparasone A (2), being more 
hydrophobic due to absence of polar hydroxyl- and acetyl-groups, respectively. Compound 3 
having a shorter side chain was eluted earlier than compound 4. Compound 1, bearing an 
additional hydroxyl-group is more polar and was eluted before asparasone A (2). 
 
 
Figure 4.11. Structures of newly identified metabolites of A. flavus AF70. Probable positions 
of the additional hydroxyl-group in the structure of compound 1 are shown with the blue 
arrows. 
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The proposed structures proved to be polyketide products, as was predicted by in silico 
analysis (Georgianna et al., 2010). Taking into consideration the A. flavus cluster 27 
metabolites identified in this study, a biosynthetic pathway was proposed (Fig. 4.12). The 
biosynthesis begins with acetate as the starter unit and then proceeds with addition of 8 
malonyl-CoA units, one more than is incorporated into the aflatoxin pksA (Do et al., 2007; 
Korman et al., 2010). Following Claisen condensation and thioester cleavage, the anthrone is 
produced. The resulting anthrone is then oxidized to the anthraquinone and subsequently 
reduced specifically at the C11 position to produce asparasone A (2). This set of reactions 
requires the presence of an oxidoreductase somewhat similar to that represented by AflD in 
aflatoxin biosynthesis. Although such an enzyme is not in the SMURF-identified gene cluster, 
biosynthesis could take advantage of such enzymes, either in the aflatoxin cluster or the 
enzymes of similar function in the conversion of tetrahydronapthalene to 
dihydronaphthalene (DHN) in the formation of DHN-derived melanins (Bell and Wheeler, 
1986).  
 
Figure 4.12. Proposed biosynthetic steps in the formation of cluster 27 pks metabolites: 
1,3,4,6,8-pentahydroxy-2-(1'-hydroxy-3'-oxobutyl)-anthraquinone or 1,3,5,6,8-pentahydroxy-
2-(1'-hydroxy-3'-oxobutyl)-anthraquinone (1), asparasone A (2), 1,3,6,8-tetrahydroxy-2-(1'-
hydroxyethyl)-anthraquinone (3) and 1,3,6,8-tetrahydroxy-2-(3'-oxobut-1'-en-1'-yl)-
anthraquinone (4). Probable positions of the additional hydroxyl-group in the structure of 
compound 1 are shown with the arrows. 
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4.3.4. Production of asparasone A derivatives in selected fungal cultures 
Asparasone A was first identified in A. parasiticus extracts as a pigment that was structurally 
related to versicolorin intermediates of the aflatoxin biosynthetic pathway (Sobolev et al., 
1997).  In their study asparasone A was obtained from total extract of A. parasiticus culture. 
In the investigation of the cluster 27 metabolites described in this work, a AF70 strain was 
used. Production of asparasone A and its derivatives (compounds 1, 3 and 4) was further 
investigated in extracts of other Aspergillus strains (Table 4.3).    
Asparasone A was detected in all fungal cultures studied and occurred together with its 
dehydrated product. In A. terreus culture, compounds 3 and 1, respectively, were not 
detected simultaneously with asparasone A. Investigation of other known Aspergillus 
metabolites revealed co-occurrence of asparasone A, aflatoxin B1 and cyclopiazonic acid. 
However, a clear correlation between these metabolites could not be established.  
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Table 4.3. Production of asparasone A and its derivatives, and a number of other metabolites by Aspergillus spp.  
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4.4. Conclusions 
The present study was designed to determine the metabolites produced by the A. flavus 
cluster 27 pks gene (pks27). Comparative metabolomics, using UHPLC-HR Orbitrap MS, 
allowed to detect metabolites that were differentially expressed in A. flavus wild-type and  
∆pks27 mutant strains. This was supported by a statistical differential analysis of MS data 
using SIEVE software. Accurate mass data from the Orbitrap MS instrument allowed to 
determine the elemental composition of the compounds of interest and thereby to perform 
a preliminary peak assignment, while ion trap multiple stage MS fragmentation trees (up to 
MS5) were required for structural information and confirmation of metabolites. In this way,   
we found that the major metabolite produced by the A. flavus cluster 27 is asparasone A, an 
anthraquinone pigment previously detected in A. parasiticus cultures (Sobolev et al., 1997). 
The ESI- fragmentation pattern of this compound has been elucidated for the first time. 
Three other compounds, namely the dehydration, deacetyl- and oxy-derivatives of 
asparasone A, were identified for the first time. Asparasone A and its newly identified 
derivatives were detected simultaneously with some known A. flavus metabolites in other 
Aspergillus spp. The hyphenation of UHPLC with Orbitrap MS and ion trap multi-stage MS 
proved to be a suitable approach for identification of new or less studied fungal metabolites. 
The study also showed that asparasone A is a sclerotial pigment. Its function for the fungus 
still remains to be determined. Further NMR studies are necessary to assign the complete 
structure of the oxy-derivative of asparasone A identified in this work. 
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 Chapter 5 
5.1. Introduction 
Patulin (Fig. 1.2, Chapter 1) is a toxic fungal metabolite mainly produced by Penicillium and 
Aspergillus spp. It naturally occurs in food commodities such as fruits and their processed 
products (Drusch and Ragab, 2003), wheat bread (Rychlik, 2005), as well as feed (Sabater-
Vilar et al., 2004). Recently a high content of patulin was found in indoor settled dust 
(Vishwanath et al., 2011). 
It has been proven that patulin causes acute and chronic health problems in humans and 
animals (de Souza Sant’Ana et al., 2008; Drusch and Ragab, 2003). Therefore, patulin levels 
in food are regulated in many countries and an action level in juices is set at 50 µg/kg 
(Commission Regulation, 2003; FDA, 2001).  
Methods for patulin detection include TLC for rapid monitoring of patulin levels (Martins et 
al., 2002; Welke et al., 2009), HPLC coupled to UV (Baert et al., 2007; Barreira et al., 2010; 
Wu et al., 2008) or diode array detection (DAD) (Boonzaaijer et al., 2005) and GC-MS (Cunha 
et al., 2009; Roach et al., 2000). These LC and GC methods demonstrate satisfactory LODs, 
but caution has to be taken in the analysis of fruit juices by LC-UV/DAD where interfering 
peaks are likely to occur (Boonzaaijer et al., 2005), while a derivatization is generally 
required for GC-MS (Kataoka et al., 2009). 
LC-MS/MS, being considered as the most advanced analytical technique for qualitative and 
quantitative mycotoxin analysis, is widely used for determination of patulin. There are 
several methods described allowing reliable detection of this compound in ESI- (Kataoka et 
al., 2009), APCI (Sewram et al., 2000) or APPI (Takino et al., 2003) modes. However, methods 
to simultaneously analyze patulin and other toxins are scarce and require polarity switching 
of the MS (Sulyok et al., 2006). Furthermore, in our group, attempts to achieve a useful ESI-
MS signal for patulin using three different generations of triple quadrupole instruments 
were not successful. Therefore, in line with the approach applied by other authors dealing 
with multi-analyte detection of mycotoxins, patulin was omitted in previous multi-mycotoxin 
LC-ESI-MS/MS methods (Diana Di Mavungu et al., 2009; Ediage et al., 2011; Garon et al., 
2006; Monbaliu et al., 2009).  
Besides the food/feed consumption and inhalation routes, mycotoxins can also adversely 
affect human and animal health through skin penetration (Berthiller et al., 2007; 
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Kemppainen et al., 1988-89). However, dermal exposure to mycotoxins currently remains a 
less studied area of research. Reported studies include mainly in vitro experiments of the 
transdermal penetration of a single mycotoxin using diffusion cells filled with bovine serum 
albumin (BSA) in phosphate buffered saline (PBS) as receptor fluid (Kemppainen et al., 1988-
89; Mills and Cross, 2006). Considering the fact that a single mould species can produce 
several secondary metabolites and that exposure to different moulds is possible, it is 
important to monitor a wider range of mycotoxins. This necessitates suitable multi-analyte 
methods. 
This study is focused on a closer investigation of the electrospray ionization of patulin with 
the goal of inclusion of this toxin in a single run multi-analyte LC-ESI+-MS/MS method. 
Adduct formation of patulin appeared to be the only possibility to achieve the purpose of 
the study. The fragmentation behaviour of patulin (methanol adduct) under the applied 
conditions was thoroughly studied combining the advantageous features of ion trap and 
Orbitrap MS. The usefulness of the findings was demonstrated by the development of an LC-
ESI+-MS/MS method that allows a rapid analysis of patulin together with other mycotoxins. 
With the prospect of assessing exposure to mycotoxins through dermal route, the method 
was validated for fluids from transdermal penetration studies. 
 
5.2. Experimental 
5.2.1. Chemicals and material 
MeOH and ACN both of LC-MS grade were obtained from Biosolve (Valkenswaard, The 
Netherlands), whereas HPLC-grade MeOH and ACN were from VWR International (Zaventem, 
Belgium). EtOAc and DCM were purchased from Acros Organics (Geel, Belgium). Ammonia 
p.a. (25 %) was provided by Vel (Leuven, Belgium). Sigma-Aldrich (Bornem, Belgium) was the 
supplier of ammonium bicarbonate (NH4HCO3), BSA (RIA grade) and PBS. Hydrochloric acid 
(HCl), CH3COOH, HCOOH and CH3COONH4 from Merck (Darmstadt, Germany) were used. 
Ultrapure H2O was produced by a Milli-Q Gradient System (Millipore, Brussels, Belgium). 
OasisTM HLB 6 cc (200 mg) SPE extraction cartridges were purchased from Waters (Milford, 
MA, USA). Ultrafree®-MC centrifugal filter units (0.22 µm) from Millipore (Bedford, MA, USA) 
were used. 
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Standards of patulin, ochratoxins A and B, aflatoxins B1, B2, G1 and G2, citrinin, T-2 and HT-2 
toxins, zearalenone, zearalanone, neosolaniol, diacetoxyscirpenol, sterigmatocystin, 
nivalenol, deoxynivalenol, 3-acetyl-deoxynivalenol, 15-acetyl-deoxynivalenol, fumonisins B1 
and B2, beauvericin, alternariol monomethyl ether were purchased from Sigma-Aldrich. 3-
Acetyl-deoxynivalenol was supplied as a 100 µg/mL solution in ACN. Regarding the other 
compounds, ready-made solid portions of commercial standards were dissolved in MeOH (in 
ACN:H2O 50:50, v/v for fumonisins) to reach the concentration of 1 mg/mL. Stock solutions 
were stored at - 20 °C (at 4 °C for fumonisins). Tuning solutions of the mycotoxins were 
prepared at a concentration of 10 µg/mL. MSn experiments and accurate mass 
measurements were performed on a 50 µg/mL solution of patulin in H2O:0.2 M NH4HCO3 
(pH10):MeOH (30:5:65, v/v/v) utilizing the ion trap and Orbitrap MS, respectively. 
 
5.2.2. MS conditions 
5.2.2.1. Ionization efficiency of patulin and multi-mycotoxin analysis 
A Micromass Quattro LC triple quadrupole mass spectrometer (Waters, Milford, MA, USA) 
equipped with ESI and APCI sources and Z-spray was used during the ionization efficiency 
experiments and subsequent multi-mycotoxin LC-MS/MS method development. In the final 
method ESI was used in the positive mode. The optimized MS parameters were as follows: 
probe nebuliser gas flow 100 L/h, desolvation gas flow 830 L/h, capillary voltage 3.5 kV, 
source block temperature 120 °C, desolvation temperature 320 °C, multiplier 700 V. The 
instrument was controlled by MassLynxTM 3.5 software (Micromass, Manchester, UK).   
To evaluate the effects of mobile phase additives on the ionization efficiency, solutions of 
patulin were introduced into the MS by infusion: the solution of patulin coming from a 
syringe at a flow rate of 10 µL/min was mixed with the mobile phase (0.15 mL/min) through 
a T-shaped connector. The mobile phases (MPs) tested during the ionization efficiency 
experiments are listed in Table 5.1. 
 
 
 
 
159 
Ionization strategy for MS analysis of patulin 
Table 5.1. Mobile phases (MPs) used in the ionization efficiency experiments. 
 Mobile phase composition 
MP1 H2O:MeOH (30:70, v/v) containing 0.1 % HCOOH 
MP2 H2O:ACN (30:70, v/v) containing 0.1 % HCOOH 
MP3 H2O:MeOH (30:70, v/v) containing 1 % CH3COOH and 5 mM CH3COONH4 
MP4 H2O:ACN (30:70, v/v) containing 1 % CH3COOH and 5 mM CH3COONH4 
MP5 H2O:MeOH (30:70, v/v) containing 5 mM CH3COONH4 (pH 6.8) 
MP6 H2O:ACN (30:70, v/v) containing 5 mM CH3COONH4 (pH 6.8) 
MP7 H2O:0.2 M NH4HCO3 (pH 10):MeOH (30:5:65, v/v/v)  
MP8 H2O:0.2 M NH4HCO3 (pH 10):ACN (30:5:65, v/v/v) 
 
For the multi-analyte LC-MS/MS method, the SRM mode of acquisition was chosen. The 
optimized MS parameters and the SRM transitions selected for each of the analytes are 
given in Table 5.2. 
 
5.2.2.2. Fragmentation behaviour  
An LTQ linear ion trap mass spectrometer (Thermo Fisher Scientific, San José, USA) equipped 
with an ESI source was used for the investigation of patulin fragmentation behaviour. The 
solution of patulin was infused into the MS as described in section 5.2.2.1. The set MS 
parameters were: source voltage 2 kV, vaporizer temperature 80 °C, capillary temperature 
100 °C, sheath gas flow rate 10 a.u. Nitrogen was used as sheath gas, while helium was used 
as damping and collision gas in the ion trap. The maximum inject time was 200 ms and the 
number of microscans per scan was 3. When performing MSn experiments, the precursor ion 
was isolated in the ion trap with an isolation width of 3 Da and activated at different collision 
energy levels to find the optimal conditions for distinct fragmentation. XcaliburTM 2.0.7 
software (Thermo Fisher Scientific) was used for instrument control, data acquisition and 
processing.  
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Table 5.2. Optimized MS/MS parameters for the detection of 23 mycotoxins by LC-ESI+-
MS/MS. 
 
a The most abundant product ion 
Precursor ion 
(m/z )
169.1   137.1a 10
[M+MeOH-H2O+H]
+ 81.1 14
 205.2a 12
125.2 12
 249.3a 12
203.3 15
 215.3a 17
185.3 20
 205.1a 22
187.3 36
3-Acetyl-  231.3a 11
deoxynivalenol 203.3 20
15-Acetyl-  321.3a 10
deoxynivalenol 137.2 10
 334.7a 40
352.6 34
 245.1a 30
189.2 40
 243.1a 28
200.2 40
 239.2a 24
358.5 14
 287.3a 26
259.3 31
 241.2a 34
285.3 23
 233.1a 16
205.5 25
 307.3a 12
247.3 14
 336.7a 34
318.6 41
 283.5a 13
301.3 10
 303.5a 16
189.4 21
 263.5a 16
215.4 14
Alternariol  128.2a 48
monomethyl ether 115.1 52
 305.5a 15
215.3 26
 281.1a 40
310.1 23
 244.3a 30
262.3 27
Sterigmatocystin 20.1 325.0 [M+H]+ 39
Beauvericin 25.9 783.9 [M+H]+ 47
17.4 273.1 [M+H]+ 52
T-2 toxin 17.9 484.3 [M+NH4]
+ 19
Zearalanone 15.6 321.4 [M+H]+ 24
HT-2 toxin 16.3 442.4 [M+NH4]
+ 17
Fumonisin B2 14.1 706.4 [M+H]+ 56
Zearalenone 15.3 319.4 [M+H]+ 21
Citrinin 11.6 251.3 [M+H]+ 28
Diacetoxyscirpenol 11.9 384.1 [M+NH4]
+ 20
Aflatoxin B2 9.9 315.4 [M+H]+ 51
Aflatoxin B1 11.1 313.4 [M+H]+ 47
Aflatoxin G1 9.1 328.9 [M+H]+ 50
Ochratoxin A 9.2 404.0 [M+H]+ 28
Fumonisin B1 7.9 722.6 [M+H]+ 50
Aflatoxin G2 8.1 331.0 [M+H]+ 49
6.9 339.1 [M+H]+ 24
6.9 339.0 [M+H]+ 21
Neosolaniol 4.7 400.1 [M+NH4]
+ 30
Ochratoxin B 6.6 370.3 [M+H]+ 32
Nivalenol 3.2 313.0 [M+H]+ 23
Deoxynivalenol 3.8 297.1 [M+H]+ 26
Collision 
energy (eV)
Patulin 2.5 30
Mycotoxin RT (min)
Cone voltage 
(V)
Product ions 
(m/z )
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5.2.2.3. Accurate mass measurement 
Accurate mass measurements of the patulin precursor and fragment ions were carried out 
on an Orbitrap ExactiveTM mass analyzer (Thermo Fisher Scientific) equipped with an ESI 
interface. The MS parameters were the following: spray voltage 4 kV, capillary temperature 
150 °C, heater temperature 100 °C, sheath gas flow rate 30 a.u., auxiliary gas flow rate 5 a.u. 
The data were processed using the XcaliburTM 2.1 and Exactive Tune software (Thermo 
Fisher Scientific). To achieve high mass accuracy, the instrument was calibrated externally 
each 24 hours using a standard calibration mixture (caffeine, peptide MRFA and Ultramark 
1621). The instrument was operated in full scan positive mode with a resolution of 100,000 
FWHM. The maximum injection time was 200 ms and the number of microscans per scan 
was 1.                                                                                                                                                         
Each full scan was followed by a same-polarity “all ion fragmentation” HCD scan. The patulin 
solution was infused into the Orbitrap MS as described in section 5.2.2.1.  
 
5.2.3. LC conditions 
For the introduction of the patulin tuning solution into the ion trap and Orbitrap MS, an 
Accela™ High Speed LC (UHPLC) (Thermo Fisher Scientific) was used.  
For the multi-mycotoxin analysis, the chromatographic separation was achieved on a Waters 
Alliance 2595 XE HPLC (Waters, Milford, MA, USA) using an XBridgeTM C18 column (3.5 µm, 
150 mm x 2.1 mm i.d.) (Waters). The mobile phase consisted of H2O:0.2 M NH4HCO3 (pH 
10):MeOH (85:5:10, v/v/v) [solvent A] and H2O:0.2 M NH4HCO3 (pH 10):MeOH (5:5:90, v/v/v) 
[solvent B]. Two different gradient elution programs were applied for the analyses of either 
a limited (gradient I) or an extended (gradient II) number of analytes. They were as follows: 
gradient I: 0-2 min: 50-75 % B, 2-7 min: 75-85 % B, 7-9.5 min: 85-90 % B, 9.5-10 min: 90-50 % 
B, 10-18 min: 50 % B; and gradient II: 0-4 min: 35-50 % B, 4-7.5 min: 50-60 % B, 7.5-9 min: 
60-75 % B, 9-14 min: 75-85 % B, 14-16 min: 85-100 % B, 16-19 min: 100 % B, 19-20 min: 100-
35 % B, 20-30 min: 35 % B. The flow rate was 0.15 mL/min. The column temperature was set 
at 30 °C and temperature of the autosampler was 4 °C. Twenty µL of the sample were 
injected. 
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5.2.4. Clean-up of transdermal  samples 
The samples (1 % BSA in PBS) were cleaned-up using Oasis HLBTM solid-phase extraction 
(SPE) cartridges. Firstly, the SPE cartridges were conditioned with 10 mL of DCM:MeOH 
(80:20, v/v) containing 50 mM HCOOH, followed by 5 mL MeOH, 20 mL H2O containing 10 
mM HCl and 10 mL H2O. After the conditioning step, 200 µL of the sample was quantitatively 
brought onto the SPE cartridge and washed with 10 mL of H2O. Elution of mycotoxins was 
achieved by passing 5 mL MeOH. The eluate was collected into glass test tubes and 
evaporated under a gentle stream of nitrogen at 40 °C and reconstituted with 100 µL of 
injection solvent H2O:0.2 M NH4HCO3 (pH 8.5):MeOH (69:5:26, v/v/v). The resulting solution 
was transferred into an Ultrafree®-MC centrifugal device and centrifuged for 5 min at 14,000 
g prior to LC-MS/MS analysis. 
 
5.2.5. Optimization of MS parameters by experimental design 
The optimization of MS parameters for patulin was supported by experimental design and 
multivariate analysis, using Modde 5.0 statistical graphic software (Umetrics, Umeå, 
Sweden). The most influencing factors were determined by a screening experiment and 
further optimized by a response surface modeling (RSM) experiment.  
A Plackett-Burman design was applied for the screening. The lower and the upper levels of 
the MS parameters in the design were selected on the basis of preliminary experiments. 
Fourteen variables were included in this study, which resulted in a 16-run design. Applying 
this design with three replicates of the center point, the total number of runs was 19. The 
parameter settings are shown in Table 5.3. 
After selection of the important factors, further RSM optimization was carried out applying a 
central composite face-centered (CCF) design. In particular, the central composite design 
was composed of a two-level full factorial design, axial points and replicated center points, 
with a number of experiments equal to  2k + 2k + n; where k is the number of parameters 
and n is the number of replicates of the center point. Three parameters (cone voltage, 
desolvation temperature and ion energy1) were optimized. With this number of parameters 
and three replications of the center point, the experimental design resulted in a number of 
experiments equal to 17. The settings of the parameters in the design are given in Table 5.4.  
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Table 5.3. Plackett-Burman design for screening experiment.  
 
 
 
Table 5.4. Central composite face-centered  design for oprimization experiment. 
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The other MS parameters were kept constant (see section 5.2.2). Absolute intensity of MS 
signal was recorded for each combination of the parameter settings. 
 
5.2.6. Evaluation of the multi-analyte LC-ESI+-MS/MS method   
For the multi-analyte method development and evaluation, artificially fortified 1 % BSA in 
PBS samples were analyzed. Sensitivity of the method was characterized by LOD and was 
determined in spiked samples as a concentration corresponding to a peak of the analyte 
with a S/N of at least 3. Linearity of the method was evaluated by triplicate analysis of spiked 
samples at eight different concentrations by fitting a linear model. Apparent recovery was 
calculated at three concentration levels as a ratio between the actual and the theoretical 
concentration of analyte in spiked samples. The precision was expressed as relative standard 
deviation (RSD) of replicate measurements.  
 
5.2.7. Linear regression for the evaluation of analyte stability 
A linear regression approach was applied to evaluate analyte stability data using SPSS 
Statistics 20 statistical software (IBM Corporation, New York, The USA). The hypotheses 
were stated as follows: 
 
Null hypothesis (Ho): Slope = 0 (no analyte degradation over time) 
Alternative hypothesis (Ha): Slope < 0 (analyte is degraded over time) 
 
To test the significance of the regression coefficient (or of the slope), t-test (one-tailed) was 
used. The significance level α was equal to 0.05. The Ho was rejected, if p-value ≤ 0.05. If the 
p-value was > 0.05, there was no sufficient evidence to reject the null hypothesis. 
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5.3. Results and discussion 
5.3.1. Optimization of patulin MS signal 
A mobile phase consisting of H2O, MeOH, CH3COOH and CH3COONH4 was previously used 
for the LC-MS/MS analysis of a wide range of mycotoxins (Diana Di Mavungu et al., 2009; 
Ediage et al., 2011). Under these conditions a very poor MS signal was obtained for patulin. 
Furthermore, the signal was not useful in subsequent CID experiments. In this study, the 
ionization efficiency of a broader range of solvents and mobile phase additives was 
thoroughly investigated (Table 5.1).  
In preliminary experiments, ESI and APCI interfaces both in positive and negative modes 
were examined. Comparing the full MS spectra that resulted in the highest precursor ion 
signal for each combination of ionization mode and solvent, ESI+ offered the best prospect 
for further investigation (if MP7 is used) (Fig. 5.1). In some previous studies a better ESI- or 
APCI- signal was reported (Kataoka et al., 2009; Sewram et al., 2000). However, a limited 
number of mobile phases was investigated. Furthermore, the formation of precursor ions 
other than the protonated or the deprotonated molecule was not considered.  
 
 
Figure 5.1. Intensity of patulin MS signal in the tested mobile phases in ESI and APCI modes. 
The monitored precursor ions in ESI+ were at m/z 155 (MP1-MP6 and MP8) and m/z 169 
(MP7), in ESI- - at m/z 153 (MP1-MP8), in APCI+ - at m/z 155 (MP1-MP8), in APCI- - at m/z 
153 (MP1-MP8). 
The mobile phase compositions are as described in Table 5.1. 
For visibility reasons a logarithmic scale was applied. 
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A mobile phase consisting of MeOH, H2O and NH4HCO3 buffer at pH 10 (MP7) resulted in 
the highest signal (Fig. 5.1). The most abundant ions were at m/z 187 and 169 (Fig. 5.2) 
which were attributed to a protonated methanol-adduct and its dehydrated product, 
respectively (these ions were observed only with a MeOH-containing mobile phase).  
 
 
Figure 5.2. A typical full MS spectrum of patulin in ESI+ in H2O:0.2 M NH4HCO3 (pH 10):MeOH 
(30:5:65, v/v/v).  
The spectrum was acquired utilizing the triple quadrupole MS (see section 5.2.2.1).  
 
The prospect of this mobile phase for ESI+-MS/MS was more apparent when MS2 
experiments were executed using the precursor ions that gave the best full MS signal with 
each of the mobile phases investigated (Fig. 5.3). This mobile phase was therefore selected 
for further optimization of the MS signal by experimental design, resulting in the MS 
parameter settings shown in Table 5.3. 
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Figure 5.3. Intensity of patulin MS/MS signal in the tested mobile phases in ESI and APCI 
modes. The monitored product ions in ESI+ were at m/z 127 (MP1), m/z 109 (MP2-MP4 and 
MP8), m/z 137 (MP5 and MP7) and m/z 113 (MP6), in ESI- - at m/z 109 (MP1-MP8), in APCI+ - 
at m/z 99 (MP1 and MP7), m/z 113 (MP2, MP4, MP6 and MP8), m/z 137 (MP3) and m/z 109 
(MP5), in APCI-- at m/z 109 (MP1-MP8). 
The mobile phase compositions are as described in Table 5.1. 
For visibility reasons a logarithmic scale was applied. 
 
5.3.1.1. Optimization of MS parameters by experimental design 
5.3.1.1.1. Screening experiment 
The MS parameters included in the screening were source temperature, desolvation 
temperature, cone voltage, capillary voltage, multiplier voltage, extractor voltage, entrance, 
exit, ion energy1, ion energy2, LM resolution1, LM resolution2, HM resolution1, and HM 
resolution2. The influence of these parameters on the intensity of the ions at m/z 187 and 
169 was assessed by means of a Plackett-Burman experimental design. The individual effects 
of the 14 investigated parameters on the intensity of the signal at m/z 169 and 187 are 
shown in Fig. 5.4.  
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Figure 5.4. Regression coefficient plots for the ions at m/z 169 (a) and 187 (b).  
Cone: cone voltage; Cap: capillary voltage; Des: desolvation temperature; Sou: source temperature; 
Mul: multiplier voltage; Ext: extractor voltage; LM1: LM resolution1; HM1: HM resolution1; IE1: ion 
energy1; Ent: entrance; Exi: exit; LM2: LM resolution2; HM2: HM resolution2; IE2: ion energy2.    
 
The plot consists of bars corresponding to the regression coefficients. The 95 % confidence 
interval is shown by means of an error bar over the coefficient. A coefficient smaller than the 
experimental error, indicates that the change in response caused by changing the parameter 
(from low to high value) is not significant. The magnitude of the effect is proportional to the 
value of the regression coefficient. A positive regression coefficient reveals a positive effect, 
while a negative regression coefficient indicates a negative impact of a specific parameter on 
the MS signal. 
The results indicated that the intensity of the MS signal for both ions (m/z 169 and m/z 187) 
was mostly influenced by three factors: cone voltage, desolvation temperature and ion 
energy1. Increasing the cone voltage lead to a reduction of the signal, whereas increasing 
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the desolvation temperature and ion energy1 had a positive effect on the signal intensity. 
The effects of the other parameters were less significant. 
 
5.3.1.1.2. Response surface modeling 
The parameters that mostly influence the MS signal, namely the cone voltage, desolvation 
temperature and ion energy1, were further optimized by means of a central composite 
design (see section 5.2.5). The design allowed to model the response surface by fitting a 
second-order polynomial model. The statistical analysis of the model gave R2 values of 0.95 
(for ion at m/z 169) and 0.90 (ion at m/z 187) and Q2 values of 0.86 (ion at m/z 169) and 0.85 
(ion at m/z 187). The R2 value corresponds to the fraction of the variation of the response 
which can be explained by the model, while the Q2 value corresponds to the fraction which 
can be predicted by the model. The obtained Q2 values were close to 1, which indicated the 
suitability of the model for predicting the optimal conditions. 
The response surface plots for the intensity of the ions at m/z 169 and 187 as a function of 
cone voltage, desolvation temperature and ion energy1 are depicted in Fig. 5.5. It was 
observed that for both ions at m/z 169 and 187, increasing the ion energy1 slightly improved 
the MS signal. The MS signal for both ions reached a maximum when the desolvation 
temperature was approximately 320 °C. For the cone voltage, a lower value improved the 
signal at m/z 187, while an optimal signal for m/z 169 was obtained with a cone voltage 
around the central value. Based on the observations, a desolvation temperature of 320 °C 
and ion energy1 of 4 were chosen for both ions; while cone voltages of 30 V and 10 V were 
selected for the ions at m/z 169 and 187, respectively. 
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Figure 5.5. Response surface plots for the intensity of ions at m/z 169 (a, b, c) and 187 (d, e, 
f) as a function of cone voltage (CONE), desolvation temperature (DES) and ion energy1 (IE1).  
INT = intensity (x 105)  
 
Using the optimized MS parameters, different collision energies (10-60 eV) were applied in 
further CID experiments in order to find conditions that lead to the best product ion spectra. 
In this way the two patulin SRM transitions shown in Table 5.2 were established. The 
observed signal was stable and the spectra (Fig. 5.6) were overall more useful than those 
obtained with the protonated or the deprotonated molecule of patulin. The most abundant 
product ions of the precursor ion at m/z 187 were the ions at m/z 169, 137 and 109 (Fig. 
5.6a). The product ion at m/z 137 was also intense in the MS2 spectrum of m/z 169 (Fig. 
5.6b). 
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Figure 5.6. MS2 spectra of the precursor ions at m/z 187 (cone voltage = 10 V, collision 
energy = 13 eV) (a) and 169 (cone voltage = 30 V, collision energy = 9 eV) (b). 
The spectra were acquired utilizing the triple quadrupole MS (see section 5.2.2.1.).  
 
5.3.2. Confirmation of the methanol adduct of patulin (m/z 187) 
A study of the fragmentation behaviour of the ion at m/z 187, performed by combining MSn 
experiments (ion trap) (Fig. 5.7) and accurate mass measurements (Orbitrap), resulted in the 
fragmentation pathway shown in Fig. 5.8; thereby confirming the formation of a MeOH-
adduct of patulin. As already mentioned, the full MS spectrum of patulin showed among 
others, an intense ion at m/z 187, pointing to a protonated MeOH-adduct of the molecule.  
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Figure 5.7. MS2 spectrum of the precursor ion at m/z 187 (a) and MS3 spectra of the first 
generation product ions at m/z 159 (b), 169 (c) and 155 (d).  
The spectra were acquired using the ion trap MS (see section 5.2.2.2.). 
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The MS2 spectrum of the precursor ion (m/z 187) showed an intense ion at m/z 169 
corresponding to a loss of H2O (-18 Da) (Fig. 5.7a). An ion corresponding to the protonated 
molecule of patulin (m/z 155) could be seen, resulting from the loss of MeOH (-32 Da). The 
ion at m/z 159 could be attributed to a loss of carbon oxide (CO) (-28 Da); further losses of 
carbon dioxide (CO2) (-44 Da) and CO (-28 Da) accounted for the fragment at m/z 87. 
Likewise, consecutive losses of CO2 and CO from the ion at m/z 155 generated the ions at 
m/z 111 and 83, respectively. The ion at m/z 137 pointed to the consequential losses of H2O 
and MeOH from the precursor ion (m/z 187), while the ions at m/z 127 and 141 pointed to a 
loss of CO (-28 Da) from the ions at m/z 155 and 169, respectively.  
MS3 data indicated that the fragment at m/z 127 and 141 could also be generated from the 
ion at m/z 159 through a loss of MeOH and H2O, respectively (Fig. 5.7b). The MS3 data 
further confirmed that the fragment at m/z 137 was produced, on one hand, through a loss 
of MeOH (-32 Da) from the ions at m/z 169 and, on the other hand, through a loss of H2O (-
18 Da) from the ion at m/z 155 (Fig. 5.7c and 5.7d). These data also confirmed that the 
fragments at m/z 141 and 127 were generated through a loss of MeOH from the ions at m/z 
169 and 155, respectively. Furthermore, the MS3 data revealed that the ion at m/z 139 was 
generated by a loss of formaldehyde (-30 Da) from the ion at m/z 169. A corresponding loss 
(-30 Da) from the ion at m/z 155 accounted for the fragment at m/z 125. 
MS4 investigation of the second generation product ions (m/z 125, 127, 131, 137 and 141) 
indicated that the fragment at m/z 109 was generated by the ions at m/z 141, 137 and 127 
through a loss of MeOH (-32 Da), CO (-28 Da) and H2O (-18 Da), respectively. It was also 
shown that the ion at m/z 113 was generated through a loss of CO (-28 Da) from the ion at 
m/z 141, while a loss of ethylene (C2H4) (-28 Da) from the ion at m/z 127 accounted for the 
ion at m/z 99. This ion could also be generated through a loss of MeOH (-32 Da) from the 
fragment at m/z 131, which in turn produced the ion at m/z 113 through a loss of H2O. The 
fragment at m/z 69 was shown to be generated from the ion at m/z 125 through consecutive 
losses of two CO molecules.  
Further MS5 experiments revealed that the fragment at m/z 81 could be obtained from the 
ion at m/z 113 (through a loss of 32 Da), the ion at m/z 109 (through a loss of 28 Da) or the 
ion at m/z 99 (through loss of 18 Da). Further loss of C2H4 (-28 Da) from the fragment at m/z 
81 produced an ion at m/z 53. It was shown that this ion could also be generated by the 
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fragments at m/z 85 (loss of MeOH) and m/z 71 (loss of H2O), which in turn were generated 
by the ion at m/z 113 (loss of C2H4) and m/z 99 (loss of CO), respectively. The MSn 
experiments also indicated that a loss of 44 Da (corresponding to CO2) from the fragment at 
m/z 99 generated the ion at m/z 55. It was shown that this ion at m/z 55 could also be 
generated, on one hand, from the fragment at m/z 159 through the consecutive losses of 
CO2 (-44 Da), CO (-28 Da) and MeOH (-32 Da), and, on the other hand, from the fragment at 
m/z 155 through successive losses of CO2, CO and C2H4. 
To confirm the assignments proposed above, exact mass measurements were performed 
using Orbitrap MS. Generally this instrument is not capable to isolate the precursor ion for 
fragmentation. However, applying the “all ion fragmentation” HCD scan beside the full scan, 
accurate masses could be recorded for the precursor and product ions. The experimental 
masses were compared to the calculated (generated elemental compositions) and the mass 
error was not higher than 2.1 ppm, enabling unequivocal structure elucidation. Using both 
the MSn (ion trap) and exact mass measurement (Orbitrap) data in combination with the 
automated fragmentation generated by simulation in Mass FrontierTM 6.0 software 
(ThermoFinnigan), a fragmentation pattern was proposed (Fig. 5.8) thereby confirming the 
identity of the precursor ion at m/z 187.  
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Figure 5.8. Proposed fragmentation pathway of patulin starting from its methanol adduct 
(m/z 187).  
The fragment at m/z 159 can alternatively undergo successive losses of CO2 (-44 Da), CO (-28 Da) and 
MeOH (-32 Da) to yield an ion with m/z 55. This ion can also be generated on one hand from the 
fragment at m/z 99 through a loss of CO2 (-44 Da); and on the other hand from the fragment at m/z 
155 through successive losses of CO2 (-44 Da), CO (-28 Da) and C2H4 (-28 Da).  
The ion at m/z 53 can also be generated from the fragment at m/z 99 through a primary loss of CO    
(-28 Da), followed by a loss of H2O (-18 Da). 
The assignment of fragments was supported by the Mass FrontierTM software. 
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5.3.3. Applicability in multi-mycotoxin LC-MS/MS analysis  
The usefulness of the selected ionization approach was demonstrated by the development 
of an LC-MS/MS multi-analyte method for the simultaneous determination of patulin and 
other mycotoxins. XBridge C18 stationary phase was chosen, as it has previously shown 
excellent pH stability (Diana Di Mavungu et al., 2012). The SRM ESI+ chromatograms 
obtained by analyzing a mixture of 23 mycotoxins are shown in Fig. 5.9. It has to be 
mentioned that for the purpose of multi-analyte method the ion at m/z 169 was chosen for 
patulin as it was more abundant than the ion at m/z 187. Although a baseline separation was 
not achieved for all adjacent peaks, this was not considered as a problem due to different 
SRM transitions.  
 
Figure 5.9. Typical SRM ESI+ chromatograms of a mixture of 23 mycotoxins, including patulin 
(1), nivalenol (2), deoxynivalenol (3), neosolaniol (4), ochratoxin B (5), 3-acetyl-
deoxynivalenol (6), 15-acetyl-deoxynivalenol (7), fumonisin B1 (8), aflatoxin G2 (9), aflatoxin 
G1 (10), ochratoxin A (11), aflatoxin B2 (12), aflatoxin B1 (13), citrinin (14), 
diacetoxyscirpenol (15), fumonisin B2 (16), zearalenone (17), zearalanone (18), HT-2 toxin 
(19), alternariol monomethyl ether (20), T-2 toxin (21), sterigmatocystin (22), beauvericin 
(23). The LC-MS conditions are as described in sections 5.2.2.1 and 5.2.3. 
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5.3.4. Mycotoxin stability and injection solvent selection 
The use of a high pH buffer in the mobile phase raised the question of analyte stability 
during the LC-MS/MS analysis. Therefore, the effect of the injection solvent on analyte 
stability and MS signal was investigated. The study was perfomed for a selection of 
mycotoxins. Five injection solvents were included in the study, namely (I) H2O:MeOH (80:20, 
v/v), (II) H2O:0.2 M NH4HCO3 (pH 10):MeOH (69:5:26, v/v/v), (III) H2O:0.2 M NH4HCO3 (pH 
8.5):MeOH (69:5:26, v/v/v), (IV) H2O:MeOH:CH3COOH (57.2:41.8:1, v/v/v) containing 5 mM 
CH3COONH4 and (V) MeOH:ACN:H2O (20:40:40, v/v/v). 
Mycotoxin standard solutions at relevant concentrations were prepared in the above-listed 
injection solvents. The samples were analyzed by LC-MS/MS and the MS signal was 
monitored over time (about 60 hours). The peak areas of mycotoxins were plotted as a 
function of time and linear regression was applied. The results (Table 5.5) indicated that p-
value for the slope was greater than 0.05 in the majority of cases.  
Patulin has been reported to decompose at high pH (Dombrink-Kurtzman and Blackburn, 
2005). Investigation of its stability during analysis, indicated a signal loss only when patulin 
was dissolved in the mobile phase (pH 10) (II) and kept for a long time (appr. 60 hours) 
before analysis. The patulin signal proved to be stable over the same period of time in an 
autosampler maintained at 4 °C, when the buffer of the sample solvent was adjusted to pH 
8.5 (III). As for the other mycotoxins, their signals in basic injection solvent at pH 8.5 (III) 
were also stable. Finally, injection solvent H2O:0.2 M NH4HCO3 (pH 8.5):MeOH (69:5:26, 
v/v/v) (III) was chosen for the LC-MS analysis. 
 
5.3.5. Clean-up procedure and evaluation of the method 
In transdermal experiments using diffusion cells, only a limited amount (about 200 µL) of 
sample is commonly available, which does not allow sample concentration. A direct injection 
of the samples into the LC-MS instrument is also not possible due to presence of BSA and 
PBS. It became clear that a sample clean-up was necessary. 
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Table 5.5. Linear regression of the data obtained during stability study for mycotoxins dissolved in different injection solvents. 
 
Mycotoxin 
Injection solvent a 
(I) (II) (III) (IV) (V) 
r2 t p-value r2 t p-value r2 t p-value r2 t p-value r2 t p-value 
Patulin 0.037 -1.201 0.119 0.806 -12.242 0.000 0.037 -1.205 0.118 0.007 0.501 0.310 0.056 1.460 0.077 
Fumonisin B1 0.006 0.484 0.316 0.129 -2.371 0.012 0.068 -1.662 0.053 0.055 1.463 0.076 0.001 0.196 0.423 
Ochratoxin A 0.272 -3.717 0.001 0.209 -3.125 0.002 0.020 -0.862 0.197 0.010 0.616 0.271 0.005 0.437 0.333 
Aflatoxin B1 0.017 0.789 0.218 0.813 -12.672 0.000 0.003 0.338 0.369 0.118 -2.227 0.016 0.061 1.548 0.065 
Citrinin 0.00001 -0.020 0.492 0.048 1.368 0.090 0.059 1.538 0.066 0.064 1.592 0.060 0.044 1.307 0.100 
Zearalenone 0.019 0.862 0.197 0.050 1.393 0.086 0.0007 0.060 0.477 0.066 1.616 0.058 0.061 1.549 0.065 
T2-toxin 0.001 -0.199 0.422 0.859 -15.232 0.000 0.055 -1.482 0.073 0.020 0.866 0.196 0.060 1.541 0.066 
Fumonisin B2 0.015 -0.761 0.226 0.101 -2.035 0.025 0.070 -1.671 0.052 0.023 -0.943 0.176 0.031 -1.093 0.141 
Ochratoxin B 0.220 -3.272 0.001 0.307 -4.103 0.000 0.068 -1.667 0.052 0.002 0.299 0.383 0.004 -0.370 0.357 
Aflatoxin B2 0.069 1.650 0.054 0.783 -11.567 0.000 0.004 -0.390 0.350 0.044 1.664 0.053 0.069 1.652 0.054 
Zearalanone 0.062 1.563 0.063 0.001 0.234 0.409 0.006 0.490 0.314 0.042 1.274 0.106 0.067 1.626 0.056 
HT2-toxin 0.030 -1.075 0.145 0.069 1.682 0.051 0.0004 -0.116 0.454 0.050 1.388 0.087 0.00004 -0.036 0.486 
a (I) H2O:MeOH (80:20, v/v); (II) H2O:0.2 M NH4HCO3 (pH 10):MeOH (69:5:26, v/v/v); (III) H2O:0.2 M NH4HCO3 (pH 8.5):MeOH (69:5:26, v/v/v); (IV) H2O:MeOH:CH3COOH 
(57.2:41.8:1, v/v/v) containing 5 mM CH3COONH4; (V) MeOH:ACN:H2O (20:40:40, v/v/v) 
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For the study, seven relevant mycotoxins were selected based on their toxicity and co-
occurrence data. In preliminary experiments, both liquid-liquid extraction and SPE using 
Oasis HLBTM cartridges were evaluated. SPE proved to be more suitable and was therefore 
chosen for further development.  
After the conditioning step, 200 µL of the sample was quantitatively brought onto the SPE 
cartridge, which was then washed by passing through 10 mL of H2O. This ensured 
elimination of BSA and PBS from the sample, while the targeted analytes were retained on 
the column.  For elution of the mycotoxins, two commonly used solvents, namely MeOH and 
ACN, were compared. Along with the investigation of elution solvent, elution volume was 
also included. The results indicated that MeOH could be a suitable elution solvent for the 
majority of analytes, while ACN was superior for the elution of aflatoxins. Since sufficient 
recovery of the aflatoxins (> 80 %) was obtained with MeOH, this solvent was selected in the 
final method. Regarding the elution volume, a value of 5 mL could be suggested. Applying 
the optimized conditions, good extraction recoveries were obtained using the SPE procedure. 
These recoveries were in the range from 67 % (citrinin) to 95 % (T-2 toxin). Lower recovery 
values were reported for fumonisins (below 70 % (Sulyok et al., 2006; Van Pamel, 2011); and 
in some cases even below 40 % (Monbaliu et al., 2009)). Fumonisins are better extracted 
using high water content solvent mixtures and are therefore generally poorly recovered 
when multi-mycotoxin analysis is performed, using more generic extraction solvents. In this 
study, no extraction was performed prior to SPE, resulting in better recoveries (fumonisin B1: 
82 %, fumonisin B2: 93 %). With regard to patulin, 80 % was recovered using the proposed 
method, while this toxin could not be detected in other studies (Garon et al., 2006). 
Evaluation of the method (Table 5.6) demonstrated its fit for the detection of the seven 
targeted mycotoxins in a model transdermal penetration study. LODs were in the range from 
1 to 10 ng/mL sample.  
The linearity of the method was supported by the high values of coefficients of 
determination R2 and lack-of-fit p-values above 0.05. The values of the standard error (Syx) 
were all below 5 % of the estimate, even at low concentrations of the analytes. This feature 
of method performance is of a high value since some researchers experienced a non-linear 
signal of patulin and therefore had to omit this mycotoxin from the analysis (Sulyok et al., 
2006).  
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Table 5.6. Evaluation of the LC-ESI+-MS/MS method in support of a transdermal mycotoxin penetration study. 
Mycotoxin 
Concentration  Apparent  Precision 
Linearity 
LOD Concentration  Regression equation R2 Syx p-value nc ni 
level (ng/mL) recovery (%)  (RSD; n=6) (ng/mL) range (ng/mL) 
Patulin 
Low (10) 114 22 
5 10 - 250 y=0.0042x+0.0893 0.920 0.00043 0.945 
8 3 
Medium (50)  111 11 
High (250) 104 7 
Citrinin 
Low (2) 117 10 
1 2 - 50 y=0.0929x+0.0162 0.994 0.00140 0.440 Medium (10)  93 9 
High (50) 101 11 
Fumonisin B1 
Low (20) 98 20 
10 20 - 500 y=0.0031x+0.0380 0.937 0.00016 0.574 Medium (100)  89 16 
High (500) 98 11 
Aflatoxin B1 
Low (2) 110 21 
1 2 - 50 y=0.0384x-0.0018 0.960 0.00155 0.500 Medium (10)  104 13 
High (50) 104 10 
Ochratoxin A 
Low (10) 109 10 
5 10 - 250 y=0.0088x-0.0162 0.980 0.00021 0.998 Medium (50)  103 14 
High (250) 101 9 
Zearalenone 
Low (20) 107 18 
10 20 - 500 y=0.0025x+0.0151 0.992 0.00004 0.987 Medium (100)  108 7 
High (500) 97 11 
T2-toxin 
Low (5) 110 11 
2.5 5 - 125 y=0.0131x+0.0018 0.988 0.00025 0.497 Medium (25)  96 13 
High (125) 106 11 
nc - number of concentration points; ni – number of repetitions per concentration point; RSD – relative standard deviation, R
2 – coefficient of determination, Syx -  standard error of the estimate 
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The trueness, referred to as apparent recovery (Thorburn Burns et al., 2002), was evaluated 
by recovery experiments from spiked samples since material with certified concentrations of 
mycotoxins was not available for intended study. Apparent recoveries for all the analytes 
were from 89 to 117 % and precision at low concentration levels did not exceed 22 %. These 
data were considered as appropriate and in good agreement with the Commission Decision 
2002/657/EC performance criteria for quantitative methods of analysis (Commission 
Decision, 2002).   
The use of a triple quadrupole (two SRM transitions monitored for each analyte) provided 
high selectivity and specificity. The specificity of the method was further confirmed through 
the analysis of blank samples that were passed through the skin obtained from different 
donors. For each of the SRM transitions, no peak with a S/N of at least 3 was detected at the 
expected retention time.  
Further support of the suitability of the method for its intended use resides in the 
application of the method in ‘real-world’ samples from an in vitro skin penetration study 
using diffusion cells conducted in the Laboratory of Drug Quality and Registration (prof. Bart 
De Spiegeleer), Faculty of Pharmaceutical Sciences, Ghent University. The method allowed to 
measure simultaneously and in a relatively short time seven selected model mycotoxins 
(including patulin) not only in the receptor compartment of the diffusion cell, but also in the 
donor chamber and in the skin, thereby enabling to assess the recovery of the mycotoxins in 
the mass balance (Boonen et al., 2012). 
 
5.4. Conclusions 
This study is the first report demonstrating an intense and stable MS signal of patulin in ESI+ 
mode by formation of a protonated MeOH-adduct using a MeOH-containing mobile phase 
under alkaline conditions. The use of high resolution Orbitrap MS in combination with MSn 
experiments unambiguously confirmed the authenticity of this adduct and its fragmentation 
pattern. Under the applied conditions other mycotoxins could also be ionized and gave 
satisfactory MS signals, thereby allowing inclusion of patulin in multi-mycotoxin LC-MS/MS 
methods. The usefulness of these findings was clearly demonstrated by the development of 
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a sensitive, linear and accurate LC-ESI+-MS/MS method in support of transdermal 
penetration experiments for selected mycotoxins with prior SPE on OasisTM HLB cartridges.  
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 Chapter 6 
6.1. Background 
Ergot alkaloids are mycotoxins produced by fungi of the Claviceps genus, mainly by Claviceps 
purpurea (Komarova and Tolkachev, 2001). Infections are mostly prevalent in cereals and 
wild grasses  (Naude et al., 2005). Among the cereal species, rye and triticale that have open 
florets are known to be especially susceptible, but wheat, barley, oats and other cereal 
grains are also potential fungal hosts (Krska and Crews, 2008). After the infection is 
established, the fungus replaces the developing grain or seed with an alkaloid-containing 
hard black tuber-like wintering structure called sclerotium, also known as ergot or ergot 
body. The alkaloid pattern and individual alkaloid contents in sclerotia vary largely, due to 
differences in the maturity of the sclerotia and other factors such as the fungal strain, the 
host plant, the geographical region and the prevailing weather conditions (Lombaert, 2001; 
Storm et al., 2008). Similarly, data from the literature indicate that the total alkaloid content 
in sclerotia can vary between 0.01 and 1 % (w/w) (Burk et al., 2005; Lombaert, 2001; Scott, 
2009).  
The sclerotia are harvested together with the cereals or grass and can thus lead to 
contamination of cereal-based food and feed products with ergot alkaloids, the ingestion of 
which can cause ergotism in humans and animals. Investigations in Germany have indicated 
an increase in the occurrence of Claviceps purpurea infections in the last few years (Krska 
and Crews, 2008). This increase seems to be associated with the more extensive use of 
hybrid varieties of rye and perennial rye cultivars (Krska and Crews, 2008). Although 
nowadays effective cleaning procedures at mills allow to remove up to 82 % of ergots from 
grain (Krska and Crews, 2008), ergot alkaloids have been detected in surveys of Swiss, 
Canadian, Swedish, Danish, British and German cereals and cereal products at total levels up 
to 18,114 µg/kg in German rye flours (Baumann et al., 1985; Dusemund et al., 2006; Krska 
and Crews, 2008; Scott, 2009). In the Middle Ages, consumption of grains that were highly 
contaminated with ergot was found to be the cause of an intoxication described as Holy Fire 
or St. Anthony’s Fire, with respect to the intense pain resulting from vasoconstriction and 
subsequent gangrene with loss of fingers, hands, feet and even entire limbs. Lower doses 
can induce symptoms including abdominal pain, vomiting, burning sensation of the skin, 
insomnia, and hallucinations. Cases of human poisoning from ergot have been reported in 
more recent times in France (Fuller, 1968), India (Krishnamachari and Bhat, 1976), and 
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Ethiopia (Urga et al., 2002). Nowadays ergotism has practically been eliminated as a human 
disease, but it remains an important veterinary problem, particularly in cattle, horses, sheep, 
pigs and chicken.  
More than 40 different ergot alkaloids are known. Their common structural feature is the 
ergoline ring with a nitrogen atom at position 6 (Fig. 6.1). In many toxins, this nitrogen is 
methylated, and the ring is substituted at C8 and possesses a double bond between C8 and 
C9 or C9 and C10. The main ergot alkaloids produced by Claviceps species are ergometrine, 
ergotamine, ergosine, ergocristine, ergokryptine, and ergocornine (Fig. 6.1). Ergot alkaloids 
that have a double bond between C9 and C10 (known as ergolenes) undergo epimerization, 
with respect to the centre of symmetry at C8, resulting in rotating (C8-(S) configuration) 
isomers. The left rotating (C8-(R) configuration) and the right rotating (C8-(S) configuration) 
epimers are named ergopeptines and ergopeptinines, respectively. These epimers differ in 
biological and physicochemical properties. C8-(R)-isomers (-ines) are biologically active, 
whereas the C8-(S)-isomers (-inines) are inactive (Krska and Crews, 2008). Both forms are 
found together in naturally contaminated samples. The conversion of the -ine to the -inine 
isomers occurs rapidly in aqueous solutions (Komarova and Tolkachev, 2001), and can 
reverse in some aqueous and organic solvents (Crews et al., 2009). It is therefore important 
to consider both epimers when the ergot alkaloid contamination level of a cereal or cereal 
product has to be determined. 
This chapter deals with different aspects of the ergot alkaloid issue and includes i) analytical 
method development and validation for determination of selected ergot alkaloids and its 
further application to a European survey of cereals and cereal products, ii) investigation of 
binder efficacy towards ergot alkaloids in feed, as well as iii) untargeted screening of other 
ergot alkaloid derivatives. 
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Figure 6.1. Structures of the most common ergot alkaloids. 
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6.2. LC-MS/MS determination of six major ergot alkaloids and their corresponding epimers 
in cereals and cereal products 
6.2.1. Introduction 
Different methods have been reported for the analysis of ergot alkaloids, including TLC 
(Salvat and Godoy, 2001), capillary electrophoresis (Franch and Blaschke, 1998), enzyme 
linked immunosorbent assay (Hill et al., 2001), GC with electron capture detection (Barrow 
and Quigley, 1975), LC with UV (Veress, 1993), fluorescence (Komarova and Tolkachev, 2001; 
Storm et al., 2008) or MS (Burk et al., 2006; Kokkonen and Jestoi, 2010; Krska et al., 2008; 
Mohamed et al., 2006) detection. In recent years, LC-MS has become the method of choice 
for mycotoxin determination (Shephard et al., 2011; Spanjer, 2010), and has provided an 
unequivocal identification of ergot alkaloids in various matrices (Friedrich et al., 2004; Krska 
et al., 2008; Lehner et al., 2005; Mohamed et al., 2006). However, validated LC-MS methods 
for the simultaneous quantitative determination of the major ergot alkaloids in food and 
feed are scarce. Such methods are required for the monitoring of these toxins, as well as for 
further research and study of the ergot problem. A number of the methods mentioned 
above have been used for biomedical application (Friedrich et al., 2004) and/or for 
identification purposes (Lehner et al., 2005). Some include no or only few -inine isomers 
(Burk et al., 2006; Kokkonen and Jestoi, 2010; Mohamed et al., 2006), possibly because of 
the lack of available standards. Krska et al. (Krska et al., 2008) reported an LC-MS/MS multi-
analyte method including both the -ine as well as the -inine isomers of the six most common 
ergot alkaloids, which was validated for ten different cereal matrices. ACN was used under 
alkaline conditions as extraction solvent and as organic modifier in mobile phase. MeOH, the 
other commonly used organic modifier, was not assessed. On the other hand, although ergot 
alkaloids have been reported in silages and other feed matrices (Blaney et al., 2010; Nagy 
and Kuldau, 2003), no validated LC-MS method has included these matrices until now.  
A maximum level of 1,000 mg/kg of rye ergot (Claviceps purpurea) has been established for 
feed containing unground cereals in the European Union (Directive 2002/32/EC, 2002). 
Many countries have set limits for ergot in grains, but only a few has regulation for the 
individual and total ergot alkaloid content; for instance, the current limit for the total ergot 
alkaloid content in animal feed in Uruguay is 450 µg/kg (EFSA, 2005). However, there are still 
no limits for ergot alkaloids in food. 
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The European Food Safety Authority (EFSA) published an opinion on ergot alkaloids as 
undesirable substance in animal feed in 2005 (EFSA, 2005). In 2012 the Panel on 
Contaminants in the Food Chain recommended that data on the variability of the ergot 
alkaloid patterns in food and feed commodities should be collected in Europe with a special 
attention to processed foods (EFSA, 2012). The available data do not allow yet to identify a 
marker that could be monitored in all food or feed materials as indicator for ergot alkaloid 
contamination. It is necessary to generate more data on the presence of ergot alkaloids, not 
only in unground cereals but also in cereal products and compound feed and food and to 
obtain reliable data on the ergot alkaloid pattern. 
The present study was designed to develop and validate a new LC-MS/MS method that 
allows simultaneous determination of the six ergot alkaloids defined by the EFSA as among 
the most common and physiologically the most active (i.e. ergometrine, ergotamine, 
ergosine, ergocristine, ergokryptine and ergocornine), together with their corresponding -
inine isomers (ergometrinine, ergotaminine, ergosinine, ergocristinine, ergokryptinine and 
ergocorninine) in different food and feed matrices including cereals and cereal-based 
products, as well as grass and corn silages. Furthermore, the method was applied to obtain 
representative data on the occurrence of ergot alkaloids in different European countries in 
rye, wheat, triticale and multigrain samples intended for human consumption and animal 
feeding.  
 
6.2.2. Experimental 
6.2.2.1. Standards 
Fine film dried ergot alkaloid standards ergometrine, ergosine, ergotamine, ergocornine, 
ergokryptine, ergocristine, ergometrinine, ergosinine, ergotaminine, ergocorninine, 
ergokryptinine and ergocristinine were purchased from Coring System Diagnostix GmbH 
(Gernsheim, Germany). The film dried standards were, as indicated by the manufacturer, 
reconstituted in 5 mL of solvent (ACN), to give concentrations of 100.0 µg/mL  (uncertainty: 
± 5.0 µg/mL) and of  25.0 µg/mL (uncertainty: ± 1.5 µg/mL), respectively for the main ergot 
alkaloids and for the -inine isomers. Definite ergot alkaloids in solution readily undergo 
epimerization. Therefore, from the freshly prepared standard solutions, deep frozen 
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standard residues were prepared as follows: defined volumes of individual or mixed 
standard solutions were pipetted into dark brown or aluminium covered glass tubes, 
evaporated to dryness at 40 °C under a stream of nitrogen, and deep frozen at -20 °C. Lauber 
et al. (Lauber et al., 2005) reported that the ergot alkaloids stored under these conditions 
are stable for at least one year. The deep frozen standards were reconstituted in the 
required amount of solvent immediately before use. Methylergometrine (as 
methylergometrine maleate, purity: 98 %) and dihydroergotamine (as dihydroergotamine 
tartrate salt, purity: 99 %), used as internal standards, were purchased from Sigma Aldrich 
(Bornem, Belgium). From the crystalline standards, individual stock solutions were prepared 
respectively in MeOH:ACN (10:90, v/v) (methylergometrine) or in ACN (dihydroergotamine) 
at a concentration of 1 mg/mL.  These fresh solutions were used to prepare deep frozen 
standard residues as described above. The residues were reconstituted in the required 
amount of solvent immediately before use. 
 
6.2.2.2. Chemicals and material 
MeOH and ACN used during sample preparation were HPLC-grade and were both obtained 
from VWR International (Zaventem, Belgium). n-Hexane was also obtained from VWR 
International. For LC-MS analysis, LC-MS grade MeOH and ACN from Biosolve 
(Valkenswaard, the Netherlands) were used. EtOAc and DCM were purchased from Acros 
Organics (Geel, Belgium). A Milli-Q purification system (Millipore, Brussels, Belgium) was 
used to purify demineralized H2O. H3PO4, HCOOH, ammonium carbonate ((NH4)2CO3) and 
(NH4)2SO4 were purchased from Merck (Darmstadt, Germany). NH4HCO3 was supplied by 
Sigma Aldrich (Bornem, Belgium). Concentrated ammonia (NH3) was purchased from Vel 
(Leuven, Belgium). The Bakerbond aminopropyl (NH2) cartridges were from Achrom (Zulte, 
Belgium). Oasis® HLB extraction cartridges were supplied by Waters (Milford, MA, USA). 
Bond Elut AccuCAT cartridges were purchased from Varian Belgium NV/SA (Sint-Katelijne-
Waver, Belgium). Ultrafree®-MC centrifugal filter devices (0.22 µm) from Millipore (Bedford, 
MA, USA) were used. 
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6.2.2.3. Samples 
Method optimization and method validation were performed using sample material (rye) 
that was tested free from ergot alkaloids. The absence of ergot alkaloids was confirmed as 
follows: a portion of sample was analyzed as such and another portion was spiked with the 
target analytes prior to analysis. By comparing with a solution of standards, no peaks 
corresponding to the target analytes were found in the non-spiked sample, whereas they 
were found in the spiked sample. 
For the investigation of ergot alkaloid occurrence, 1065 cereals and cereal-based products 
were collected in different European countries over a 3-year period. This included i) rye food 
(flour – 202 samples; crispbread – 6; bread – 16; grain – 2), ii) wheat food (flour – 151; 
biscuit – 4; bread – 32; bran – 137; germs – 2; grain – 6), iii) multigrain food (flour – 18; 
biscuit – 42; crispbread – 11; bread – 81; flakes – 34), iv) rye feed (grain – 157), v) wheat feed 
(grain – 137) and vi) triticale feed (grain – 27). Conventionally as well as organically grown 
cereal samples were included. The selection of the countries took into consideration the 
geographic location. The number of samples for each country was as follows: Belgium – 243 
samples, the United Kingdom – 43, Poland – 99, Sweden – 62, Switzerland – 25, the 
Netherlands – 82, Germany – 92, Finland – 83, Estonia – 48, France – 80, Denmark – 28, 
Czech Republic – 56, Italy – 12; 112 samples were of unknown origin. 
Rye, wheat and triticale feed grains were sampled at the level of feed manufacturers in 
collaboration with the European Feed Manufacturer’s Federation (FEFAC), while collection of 
wheat and rye flour samples was supported by the European Flour Milling Association. 
Cereal-based products were randomly collected from retail markets in Belgium. 
As a general scheme (Commission Regulation 401/2006/EC, 2006) for cereal (grain and flour) 
sampling, incremental samples were taken from different places in each sample lot. 
Subsequently, an aggregate sample was made by combining all the incremental samples 
taken from the lot. From the aggregate sample, a representative laboratory sample was 
taken for analysis.  
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6.2.2.4. Sample preparation 
6.2.2.4.1. Cereals and cereal products 
Five gram of sample were extracted with 40 mL EtOAc:MeOH:0.2 M NH4HCO3 pH 8.5 
(62.5:25:12.5, v/v/v) [Step 1] during 30 minutes on an Agitelec overhead shaker (J. 
Toulemonde & Cie, Paris, France). The sample extract was centrifuged and a phase 
separation was induced by adding 5 mL of a 0.2 M NH4HCO3 buffer pH 10 and 5 mL of a 
saturated solution of (NH4)2SO4 to 15 mL of the extract [Step 2]. 5 mL of the EtOAc-phase 
was evaporated until dryness, and the residue was reconstituted in 200 µL of 
MeOH:ACN:H2O (20:40:40, v/v/v). Subsequently, 200 µL of n-hexane were added and the 
resulting mixture was vortexed and centrifuged in an Ultrafree®-MC centrifugal device for 10 
min at 14,000 g. The n-hexane was discarded and the aqueous phase was analyzed by LC-
MS/MS. 
 
6.2.2.4.2. Corn and grass silages 
The procedure was as described in 6.1.2.4.1 but the residue from the EtOAc-phase (5 mL) 
was redissolved in 1000 µL DCM and 500 µL of 0.2 M NH4HCO3 buffer pH 10, and 500 µL of 
saturated solution of (NH4)2SO4 were subsequently added. The resulting mixture was 
vortexed and centrifuged for 10 min at 14,000 g. 500 µL of the DCM-phase were evaporated 
to dryness and the residue was redissolved in 200 µL of MeOH:ACN:H2O (20:40:40, v/v/v) 
and treated as above prior to LC-MS/MS analysis.   
 
6.2.2.5. Evaluation of extraction and clean-up recovery 
The evaluation of the extraction and clean-up recovery was carried out by spiking analyte-
free samples before and after the extraction and clean-up step, and subsequent LC-MS/MS 
analysis. Calculations were performed by comparing peak areas for the same compound in 
samples spiked ante and post extraction and clean-up.  
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6.2.2.6. Optimization of method parameters using experimental design 
The optimization of MS parameters was supported by experimental design, using Modde 9.1 
statistical graphic software (Umetrics, Umea, Sweden). The most influencing factors were 
determined by a screening experiment and further optimized by an RSM experiment.  
A Plackett-Burman design was applied for the screening experiment. The lower and the 
upper levels of the MS parameters in the design were selected on the basis of preliminary 
experiments. 15 variables were included in this study, which resulted in a 20-run design. 
Applying this design with three replicates of the center point, the total number of runs was 
23 (Table 6.1). 
After selection of the important factors, further RSM optimization was carried out applying a 
CCF design. Four parameters (desolvation temperature, cone, multiplier and extractor 
voltages) were optimized. With this number of parameters and 3 replications of the center 
point, the experimental design resulted in a number of experiments equal to 27 (Table 6.2).  
A CCF design was also applied during the optimization of the extraction and clean-up 
procedure with four variables: pH of the ammonium bicarbonate solution in the extraction 
solvent, extraction solvent volume, extraction time and solvent evaporation temperature (k 
= 4) and three replications of the center point (n = 3) giving a total of 27 runs (Table 6.3). 
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Table 6.1. Plackett-Burman design applied for the screening experiment. 
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Table 6.2. CCF design applied for the optimization experiment. 
          
Exp. No Multiplier (V) Extractor (V) Cone voltage (V) Desolvation temperature (°C) 
1 600 1 20 150 
2 750 1 20 150 
3 600 5 20 150 
4 750 5 20 150 
5 600 1 55 150 
6 750 1 55 150 
7 600 5 55 150 
8 750 5 55 150 
9 600 1 20 400 
10 750 1 20 400 
11 600 5 20 400 
12 750 5 20 400 
13 600 1 55 400 
14 750 1 55 400 
15 600 5 55 400 
16 750 5 55 400 
17 600 3 37.5 275 
18 750 3 37.5 275 
19 675 1 37.5 275 
20 675 5 37.5 275 
21 675 3 20 275 
22 675 3 55 275 
23 675 3 37.5 150 
24 675 3 37.5 400 
25 675 3 37.5 275 
26 675 3 37.5 275 
27 675 3 37.5 275 
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Table 6.3. CCF design applied in the optimization of the extraction and clean-up procedure. 
          
Exp. No 
Solvent Extraction  Shaking  
pH of 
NH4HCO3   
evaporation 
temperature (°C) volume (mL) time (min) solution 
1 40 20 10 7 
2 60 20 10 7 
3 40 40 10 7 
4 60 40 10 7 
5 40 20 50 7 
6 60 20 50 7 
7 40 40 50 7 
8 60 40 50 7 
9 40 20 10 10 
10 60 20 10 10 
11 40 40 10 10 
12 60 40 10 10 
13 40 20 50 10 
14 60 20 50 10 
15 40 40 50 10 
16 60 40 50 10 
17 40 30 30 8.5 
18 60 30 30 8.5 
19 50 20 30 8.5 
20 50 40 30 8.5 
21 50 30 10 8.5 
22 50 30 50 8.5 
23 50 30 30 7 
24 50 30 30 10 
25 50 30 30 8.5 
26 50 30 30 8.5 
27 50 30 30 8.5 
          
 
6.2.2.7. LC-MS/MS analysis 
The LC-MS/MS analyses were performed on an Alliance HPLC 2695 (Waters, Milford, MA, 
USA) platform coupled to a Micromass Quattro triple quadrupole mass spectrometer 
(Waters) equipped with a Z-spray ESI interface. Chromatographic separation was achieved 
using an XBridge MS C18 column (3.5 µm, 150 x 2.1 mm) with an XBridge Sentry guard 
column (3.5 µm, 10 x 2.1 mm i.d.) both supplied by Waters. The column temperature was set 
at 30 °C. A mobile phase consisting of eluents A [H2O:0.2 M NH4HCO3 pH 10:MeOH (85:5:10, 
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v/v/v)] and B [H2O:0.2 M NH4HCO3 pH 10:MeOH (5:5:90, v/v/v)] was used at a flow rate of 
0.15 mL/min. A gradient elution was applied as follows: 0-3 min: 30-15 % A; 3-7 min: 15 % A; 
7-10 min: 15-0 % A; 10-13 min: 0 % A; 13-14 min: 0-30 % A; 14-23 min: 30 % A. The injection 
volume was  20 µL. The mass spectrometer was operated in the ESI+ mode. During the 
tuning process, the acquisition of the first-order mass spectra as well as the CID experiments 
were performed on 10 μg/mL solutions of individual ergot alkaloid standards brought into 
the MS using a syringe pump. MS parameters for the analysis were as follows: ESI source 
block and desolvation temperatures: 150 °C and 300 °C, respectively; capillary voltage: 3.5 
kV; argon collision gas: 1.2 x 10-3 mbar; probe nebuliser and desolvation gas flows: 100 and 
830 L/h, respectively. After selection of the precursor ions for each analyte, product ions 
were obtained with a combination of cone voltages and collision energies, parameters that 
were previously optimized. For increased sensitivity and selectivity, data acquistion was 
performed working in SRM mode. Two SRM transitions were selected for each of the 
analytes. For positive identification of ergot alkaloids in the samples, the criteria described in 
Chapter 2 (section 2.2) were used:  
MassLynx and QuanLynx software (Micromass, Manchester, UK) were used for data 
acquisition and processing. 
 
6.2.2.8. Method validation 
The developed method was validated according to the Commission Decision 2002/657/EC 
(Commission Decision 2002/657/EC, 2002). Method linearity, LOD and limit of quantification 
(LOQ), decision limit (CCα), detection capability (CCβ), system and method repeatability, 
within-laboratory reproducibility and method trueness in terms of recovery were evaluated 
by spiking experiments using sample material that was tested free from ergot alkaloids. 
Eventually, samples with very low levels of one or more of the analytes were used. The 
specificity of the method was assessed through the analysis of unspiked blank samples. The 
method was initially validated for cereals (rye, wheat, triticale, barley and oats), and was 
further extended to processed foods (bread, crispbread and biscuits) and feeds (composite 
feed, corn and grass silages). 
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The LODs and LOQs were determined as the minimum concentration of analyte in the spiked 
blank samples inducing SRM traces with a S/N of 3 and 10, respectively. To assess the 
linearity of the method, the blank samples were spiked with the different ergot alkaloids 
over a concentration range of 1 – 150 µg/kg. In total, 8 different concentrations were 
included and the analytical procedure was performed in triplicate at each concentration. A 
linear regression was applied.  
The trueness, referred to as apparent recovery (Thorburn Burns et al., 2002), was evaluated 
by recovery experiments. Since cereals with certified concentrations of ergot alkaloids were 
not available at the time this study was done, artificially fortified ergot alkaloid-free samples 
were analyzed and the percent analyte recovery assessed. In detail, samples that were 
spiked with the different ergot alkaloids over a concentration range of 1 – 150 µg/kg, were 
analyzed. The observed signal was plotted against the actual concentration. The measured 
concentration was determined using the obtained calibration curves, and the recovery was 
calculated as follows (Equation 6.1): 
 % 𝑹𝑹𝑹𝑹𝑹𝑹𝑹𝑹𝑹𝑹𝑹𝑹𝑹𝑹𝑹𝑹 = 𝟏𝟏𝟏𝟏𝟏𝟏 × 𝑴𝑴𝑹𝑹𝑴𝑴𝑴𝑴𝑴𝑴𝑹𝑹𝑹𝑹𝑴𝑴 𝑹𝑹𝑹𝑹𝒄𝒄𝑹𝑹𝑹𝑹𝒄𝒄𝒄𝒄𝑹𝑹𝑴𝑴𝒄𝒄𝒄𝒄𝑹𝑹𝒄𝒄 ÷ 𝑨𝑨𝑹𝑹𝒄𝒄𝑴𝑴𝑴𝑴𝑨𝑨 (𝑴𝑴𝑴𝑴𝑴𝑴𝑹𝑹𝑴𝑴) 𝑹𝑹𝑹𝑹𝒄𝒄𝑹𝑹𝑹𝑹𝒄𝒄𝒄𝒄𝑹𝑹𝑴𝑴𝒄𝒄𝒄𝒄𝑹𝑹𝒄𝒄 
(Eq. 6.1) 
 
The precision of the method was studied by repeated analysis of spiked samples. The 
experiments were carried out at different concentrations of the analyte in the sample on the 
same day (repeatability) and on 3 consecutive days by different operators (within-laboratory 
reproducibility). The precision was calculated as RSD of replicate measurements.  
The linearity and precision data were also used to calculate CCα and CCβ. CCα was 
determined as the concentration corresponding to ‘the y-intercept of the calibration curve 
plus 2.33 times the standard deviation of the within-laboratory reproducibility’ (α= 0.01). 
CCβ was calculated as the concentration corresponding to ‘CCα plus 1.64 times the standard 
deviation of the within-laboratory reproducibility’ (α= 0.05). 
An estimate of the relative standard uncertainty (uc, %) associated with the results was 
gained for each alkaloid by combining the within-laboratory reproducibility (SRW) with the 
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uncertainty associated with the purity of standards (U(Cref)) as well as the uncertainty 
associated with the mean recovery (Sbias) as follows (Equation 6.2):  
 
 𝑴𝑴𝑹𝑹  =  �𝑺𝑺𝑹𝑹𝑹𝑹𝟐𝟐 + 𝑼𝑼(𝑪𝑪𝑹𝑹𝑹𝑹𝒓𝒓)𝟐𝟐 + 𝑺𝑺𝒃𝒃𝒄𝒄𝑴𝑴𝑴𝑴𝟐𝟐      (Eq. 6.2) 
 
An estimate of the expanded uncertainty (U, %) corresponding to a confidence interval of 
approximately 95 % was obtained by multiplying the combined uncertainty by a coverage 
factor of  2, i.e (Equation 6.3).  
 
𝑼𝑼 = 𝟐𝟐 ×  𝑴𝑴𝑹𝑹            (Eq. 6.3) 
 
6.2.2.9. Method robustness 
The assessment of method robustness was based on evaluation of extraction recoveries of 
ergot alkaloids varying the following method parameters: pH of the extraction buffers, 
buffer concentration, extraction volume, shaking time and drying temperature. These 
factors were selected as potential sources of variability when performing the analysis. The 
intervals of the factors were set at values which slightly exceed the variations which can be 
expected when a method is transferred from one laboratory to another. The influence of 
these factors on the response was examined by means of 2-level fractional factorial design 
using Modde 9.1 statistical software (Umetrics, Umeå, Sweden). Having three replicates of 
the centre-point and 8 factors, the total number of runs was 19. The experimental design 
set-up is presented in Table 6.4. 
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Table 6.4. Experimental design set-up for evaluation of robustness. 
Exp. No pH of extraction buffer [Step 1] 
Buffer 
concentration 
[Step 1] (mol/L) 
Extraction 
volume        
[Step 1] (mL) 
Shaking 
time (min) 
pH of 
extraction 
buffer [Step 2] 
Buffer 
concentration 
[Step 2] (mol/L) 
Extraction 
volume       
[Step 2] (mL) 
Temperature 
of drying (°C) 
1 8.3 0.18 38 28 9.8 0.18 19 37 
2 8.7 0.18 38 32 9.8 0.22 21 37 
3 8.3 0.18 42 32 10.2 0.18 21 37 
4 8.7 0.18 42 28 10.2 0.22 19 37 
5 8.3 0.22 38 32 10.2 0.22 19 37 
6 8.7 0.22 38 28 10.2 0.18 21 37 
7 8.3 0.22 42 28 9.8 0.22 21 37 
8 8.7 0.22 42 32 9.8 0.18 19 37 
9 8.3 0.18 38 28 10.2 0.22 21 43 
10 8.7 0.18 38 32 10.2 0.18 19 43 
11 8.3 0.18 42 32 9.8 0.22 19 43 
12 8.7 0.18 42 28 9.8 0.18 21 43 
13 8.3 0.22 38 32 9.8 0.18 21 43 
14 8.7 0.22 38 28 9.8 0.22 19 43 
15 8.3 0.22 42 28 10.2 0.18 19 43 
16 8.7 0.22 42 32 10.2 0.22 21 43 
17 8.5 0.20 40 30 10.0 0.20 20 40 
18 8.5 0.20 40 30 10.0 0.20 20 40 
19 8.5 0.20 40 30 10.0 0.20 20 40 
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6.2.3. Results and discussion 
6.2.3.1. Optimization of the analytical method 
6.2.3.1.1. MS/MS detection 
6.2.3.1.1.1. Preliminary experiments 
Determination of the optimal SRM transitions and MS settings (mode, cone voltage, collision 
energy) for the different analytes was performed as described in sections 6.2.2.6 and 6.2.2.7. 
Krska et al. (Krska et al., 2008) reported the suitability of a NH4HCO3-containing mobile 
phase for the LC-ESI+-MS/MS analysis of ergot alkaloids. The authors used ACN as organic 
modifier, but MeOH, the other commonly used organic modifier, was not assessed. In the 
current study, different mobile phases were investigated, including MeOH-containing and 
ACN-containing mobile phases, as well as acidic and basic mobile phases. A mobile phase 
consisting of H2O:0.1 M (NH4)2CO3 pH 8.5:MeOH (30:5:65, v/v/v) was selected as it showed 
enhanced sensitivity. Both ESI and APCI interfaces were investigated, working in the positive 
and in the negative mode of ionization. ESI in the positive mode gave higher sensitivity and 
was therefore selected for further optimization. Full MS scan for the epimers revealed a 
signal at m/z corresponding to [M-H2O+H]+ higher than that of the protonated molecules. 
Therefore, further optimization of the MS signal was carried out on the ion at m/z 
corresponding to [M-H2O+H]+ for the epimers except ergometrinine.  
 
6.2.3.1.1.2. Optimization of MS parameters applying experimental design 
The MS parameters included in this study were source temperature, desolvation 
temperature, cone voltage, capillary voltage, multiplier voltage, extractor voltage, RF lens, 
entrance, exit, ion energy1, ion energy2, LM resolution1, LM resolution2, HM resolution1 
and HM resolution2. The influence of these parameters on the intensity of the ions at m/z 
corresponding to [M+H]+ (for the main compounds and ergometrinine) or [M-H2O+H]+ (for 
the epimers other than ergometrinine) was assessed by means of a Plackett-Burman 
experimental design. The results (Fig. 6.2) indicated that the intensity of the MS signal for 
both ions monitored is mostly influenced by four factors: cone voltage, desolvation 
temperature, extractor voltage and multiplier voltage. Increasing the cone voltage led to a 
 
205 
Ergot alkaloids in cereals  
reduction or increase of the MS signal depending on the analyte. The extractor voltage 
showed a positive effect on the MS signal of the epimers, whereas the desolvation 
temperature and the multiplier voltage demonstrated a positive effect on the signal of all 
analytes. The effects of the other parameters were less significant. 
 
 
   
 
    
 
    
Continue 
 
Figure 6.2. Regression coefficient plots for different MS parameters for ergometrine (a), 
ergometrinine (b), ergosine (c), ergosinine (d), ergotamine (e), ergotaminine (f), ergocornine 
(g), ergocorninine (h), ergokryptine (i), ergokryptinine (j), ergocristine (k), ergocristinine (l), 
methylergometrine (m), dihydroergotamine (n).  
A logarithmic transformation of the responses was done. 
Sou = source temperature; Mul = multiplier voltage; RF = RF lens; Extr = extractor voltage; Cap = 
capillary voltage; Con = cone voltage; Exit = exit; Ent = entrance; IE2 = ion energy2; IE1 = ion energy1; 
DesT = desolvation temperature; LM1 = LM resolution1; LM2 = LM resolution2; HM2 = HM 
resolution2; HM1 = HM resolution1. 
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Figure 6.2 (continued) 
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The parameters that have the most influence on the MS signal, namely the cone voltage, 
desolvation temperature, extractor voltage and multiplier voltage, were further optimized 
by means of a central composite design. The design allowed to model the response surface 
by fitting a second-order polynomial model. The statistical analysis of the model gave R2 
values of 0.97 to 0.99 and Q2 values of 0.79 to 0.91. The obtained Q2 values are close to 1, 
which indicates the suitability of the model for predicting the optimal conditions. 
The response surface plots (Fig. 6.3) for the MS signal intensity of the different analytes 
indicated that cone voltage values around 20 V were optimum for the main ergot alkaloids (-
ine compounds) except for ergometrine (cone voltage of 30 V), while values in the range 30 
– 40 V were necessary for the –inine compounds as well as for the semi-synthetic 
compounds methylergometrine and dihydroergometrine used as internal standards.   
The CID experiments were carried out using the optimized conditions (Table 6.5) and 
applying different collision energies. The product ion spectra revealed for most of analytes, 
an intense signal for the ions at m/z 223 and 208 (Table 6.5). These results confirmed those 
reported by Lehner et al. (Lehner et al., 2005) and Krska et al. (Krska et al., 2008). Lehner et 
al. (Lehner et al., 2005) attributed these fragments at m/z 223 and 208 to the four-ring 
system of the lysergic moiety and its demethylated counterpart, respectively.  
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Figure 6.3. Response surface plots for MS signal intensity of ergometrine (a), ergometrinine (b), ergosine (c), ergosinine (d), ergotamine (e), 
ergotaminine (f), ergocornine (g), ergocorninine (h), ergokryptine (i), ergokryptinine (j), ergocristine (k), ergocristinine (l), methylergometrine 
(m), dihydroergotamine (n) as a function of multiplier voltage and cone voltage, and desolvation temperature and extractor voltage.  
A logarithmic transformation of the responses was done. 
 
(a) (b) 
(c) (d) 
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Figure 6.3 (continued) 
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Figure 6.3 (continued) 
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Figure 6.3 (continued) 
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Table 6.5. Optimized MS/MS parameters for the analysis of ergot alkaloids in the SRM ESI+ 
mode. 
 
6.2.3.1.2. LC-MS/MS analysis 
The ionogenic nature of ergot alkaloid makes the polarity of both the stationary phase and 
the mobile phase an important factor to be considered during the development of the 
chromatographic method. Acidic (Mohamed et al., 2006; Smith et al., 2009) as well as basic 
(Krska et al., 2008; Müller et al., 2009) mobile phases have been used for reverse-phase LC 
of ergot alkaloids. Although better separation of these analytes is achieved in basic mobile 
phases, acidic mobile phases are often preferred because conventional silica-based 
a The most abundant product ion. 
Ergot alkaloid RT (min) Precursor ion (m/z) 
Cone 
voltage (V) 
Product 
ions (m/z) 
Collision 
energy (eV) 
Ergometrine 3.2 326.3 [M+H]+ 30  223.3
a 
208.2 
23 
30 
Methylergometrine 3.5 340.3 [M+H]+ 28  223.3
a 
208.2 
25 
30 
Ergometrinine 4.3 326.2 [M+H]+ 33  208.0
a 
223.0 
25 
25 
Ergosine 7.6 548.3 [M+H]+ 20  208.1
a 
223.3 
40 
33 
Ergotamine 8.5 582.5 [M+H]+ 22  208.2
a 
268.4 
25 
45 
Dihydroergotamine 9.1 584.5 [M+H]+ 20  270.2
a 
225.3 
30 
35 
Ergocornine 10.4 562.5 [M+H]+ 20  268.3
a 
223.3 
40 
25 
Ergokryptine 10.5 576.3 [M+H]+ 21  268.4
a 
208.1 
45 
25 
Ergocristine 10.9 610.4 [M+H]+ 23  208.1
a 
268.4 
25 
45 
Ergosinine 11.4 530.4 [M-H2O+H]
+ 38  223.2
a 
263.2 
28 
23 
Ergotaminine 11.8 564.4 [M-H2O+H]
+ 35  223.2
a 
208.2 
32 
50 
Ergocorninine 12.5 544.4 [M-H2O+H]
+ 39  277.5
a 
223.3 
26 
37 
Ergokryptinine 14.0 558.5 [M-H2O+H]
+ 38  223.3
a 
305.3 
35 
27 
Ergocristinine 14.8 592.4 [M-H2O+H]
+ 35  223.3
a 
305.4 
35 
29 
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stationary phases are degraded at high pH. XTerra C18 and XBridge C18 stationary phases 
have been reported to be stable in the pH range 1 – 12 (Jenkins et al., 2005)  and were 
previously used for the analysis of other basic compounds (Diana Di Mavungu, 2005). In this 
study, the suitability of basic mobile phases in combination with the XTerra or the XBridge 
stationary phase was investigated. A mobile phase consisting of H2O, 0.1 M (NH4)2CO3 pH 
8.5 and MeOH was used as it gave enhanced MS signal. The XBridge column gave an overall 
better chromatographic separation and proved to be stable over a long period of use. 
Therefore, this column was selected for further investigation. A gradient elution was needed 
to elute all analytes within reasonable time. A good separation of the analytes was achieved; 
however, a shift of retention time was observed during analysis. This was overcome by 
replacing (NH4)2CO3 with NH4HCO3 and by further adjusting the buffer pH at 10. The pKa 
values of the ergot alkaloids vary from 4.8 to 6.2 (Krska and Crews, 2008). Therefore, under 
the pH conditions of the mobile phase applied, nearly 100 % of the molecules are neutral, 
leading to a more efficient interaction of the analyte with the stationary phase. As a 
consequence, well-resolved peaks and good peak shape were achieved for almost all 
components within 15 min, the total run time being 23 min (Fig. 6.4). Ergokryptine and 
ergocristine were not baseline separated, but this was of minor importance as they have 
different SRM transitions. Moreover the overall good separation allowed the SRM detection 
of the ergot alkaloids in five different time window functions, thereby leading to an 
enhanced sensitivity. An investigation into the analyte stability under the selected analytical 
conditions revealed that epimerization occurred when samples dissolved in the mobile 
phase were allowed to stand in the autosampler for several hours before the LC-MS/MS 
analysis. Ergosine showed the highest tendency to epimerize while ergometrine proved to 
be the most stable compound among the ergot alkaloids investigated. It has been reported 
that the epimerization of ergot alkaloids is minimal when standard solutions are prepared in 
aprotic solvents such as chloroform or ACN (Hafner et al., 2008). However, the use of a 
sample solvent that is stronger than the mobile phase leads to peak distortion. A careful 
investigation of different solvent mixtures indicated that a sample solvent consisting of 
MeOH:ACN:H2O (20:40:40, v/v/v) delivers a good peak shape while keeping the 
epimerization negligible. Finally, it was shown that by using this sample solvent, maintaining 
the autosampler temperature at 4 °C and limiting the sample sequence to a maximum of 24 
hours, no epimerization occurred during the LC-MS/MS analysis. 
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Figure 6.4. LC-ESI+-MS/MS total ion chromatogram of a blank rye sample spiked with the 
ergot alkaloids at 25 µg/kg (a) and a naturally contaminated sample (b). 
Em: ergometrine; MeEm: methylegometrine; Emn: ergometrinine; Es: ergosine; Et:  ergotamine; DHEt:  
dihydroergotamine; Eco: ergocornine; Ekr: ergokryptine; Ecr: ergocristine; Esn: ergosinine; Etn:  
ergotaminine; Econ:  ergocorninine; Ekrn: ergokryptinine; Ecrn: ergocristinine. 
 
6.2.3.1.3. Extraction and clean-up 
Ergot alkaloids (pKa 4.8-6.2) are positively charged at N6 in acidic solutions and neutral at 
higher pH. They can therefore be extracted either with non-polar organic solvents under 
alkaline conditions or with polar solvents under acidic conditions. In this work, different 
alkaline extraction solvents, namely an ACN:(NH4)2CO3 buffer mixture (Krska et al., 2008) 
and a EtOAc:MeOH:NH4HCO3 buffer mixture (Diana Di Mavungu et al., 2009; Müller et al., 
2009), as well as an acidic solvent i.e. a MeOH:0.25 % H3PO4 mixture were evaluated. Blank 
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rye samples spiked with ergot alkaloids at a concentration of 250 µg/kg were used. To 
adequately compare the different extraction solvents, no clean-up was performed prior to 
LC-MS/MS analysis; the extracts were simply diluted (1:10) and filter-centrifuged in an 
Ultrafree®-MC centrifugal device. The highest SRM responses of the ergot alkaloids were 
obtained after extraction with ACN:3 mM (NH4)2CO3 (84:16, v/v) or EtOAc:MeOH:0.2 M 
NH4HCO3 pH 8.5 (62.5:25:12.5, v/v/v) (Fig. 6.5).  
 
 
Figure 6.5. Extraction recoveries for ergometrine (Em), ergometrinine (Emn), ergosine (Es), 
ergosinine (Esn), ergotamine (Et), ergotaminine (Etn), ergocornine (Eco), ergocorninine 
(Econ), ergokryptine (Ekr), ergokryptinine (Ekrn), ergocristine (Ecr), ergocristinine (Ecrn), 
methylergometrine (MeEm), dihydroergotamine (DHEt) applying different extraction 
solvents: (A) MeOH:0.25 % H3PO4 (40:60, v/v), (B) ACN:3 mM (NH4)2CO3 (84:16, v/v) and (C) 
EtOAc:MeOH:0.2 M NH4HCO3 (62.5:25:12.5, v/v/v). 
 
The suitability of SPE exploiting ion exchange mechanism (Bond Elut AccuCAT and 
Bakerbond aminopropyl cartridges) or hydrophilic-lipophilic interactions (Oasis® HLB 
column) was investigated, using the ACN:(NH4)2CO3 buffer extract. Poor recoveries were 
obtained with these SPE cartridges. Mohamed et al. (Mohamed et al., 2006) also reported 
unsatisfactory results for two different strong cation exchange SPE cartridges. Furthermore, 
the multiple and tedious steps of conditioning and washing led to the epimerization of the 
ergot alkaloids (up to 20 % for ergosine) during sample preparation. In further experiments, 
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the efficiency of a liquid-liquid partition clean-up after extraction with the solvent mixture 
EtOAc:MeOH:0.2 M NH4HCO3 pH 8.5 (62.5:25:12.5, v/v/v) was examined. The components 
of this extraction solvent as well as their ratio were carefully chosen to allow a quick sample 
clean-up by simply altering the solvent ratio. Indeed, after extraction of the ergot alkaloids, a 
phase separation was induced by adding a NH4HCO3 buffer to the extract. In this way, polar 
matrix components were removed with the aqueous phase, leading to partially cleaned 
extract. The addition of a saturated solution of (NH4)2SO4 allowed to improve the transfer of 
ergot alkaloids in the EtOAc-fraction by reducing the availability of water in the aqueous 
phase. As a result, the recovery of the relatively more polar ergot alkaloids (ergometrine, 
ergometrinine, methylergometrine) was improved. Using an EtOAc-containing extraction 
solvent, several apolar interfering substances (e.g., pigments, essential oils, fatty acids) were 
coextracted. Therefore, a defatting step with n-hexane was considered. Since EtOAc is 
miscible with hexane, the extract was first evaporated to dryness and redissolved in the 
solvent mixture MeOH:ACN:H2O (20:40:40, v/v/v) before adding n-hexane.  
The parameters that have an effect on the extraction efficiency and/or on the epimerization 
of the ergot alkaloids, namely the pH of the NH4HCO3 solution in the extraction solvent, the 
extraction solvent volume, the extraction time and the solvent evaporation temperature 
were optimized by means of experimental design. The R2 values obtained by fitting a second 
order polynomial model were above 0.88 and the Q2 values above 0.6 except for ergosine 
(Q2 = 0.49), ergotamine (Q2 = 0.57), ergokryptine (Q2 = 0.53) and ergokryptinine (Q2 = 0.57). 
The results (Appendix I) indicated that, in the range investigated (pH 7 – pH 10), an increase 
of pH the NH4HCO3 solution in the extraction solvent had a positive effect on the extraction 
efficiency of all analytes. However, it was also found that increasing the pH also increased 
the epimerization rate (Appendix II). Therefore, a pH of 8.5 was selected as a compromise. 
The results also showed that 40 mL of extraction solvent and an extraction time of 30 min 
were sufficient. Longer extraction time resulted in higher epimerization rate. Regarding the 
drying temperature (investigated in the range from 40 to 60 °C), less epimerization occurred 
when a temperature of 40 °C was applied; this temperature was therefore selected in the 
optimized procedure. 
The use of liquid-liquid partition and a careful optimization of the extraction and clean-up 
parameters allowed to shorten the overall sample preparation procedure, and thereby to 
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minimize the epimerization process. Other measures to minimize epimerization during the 
sample preparation step included the use of a brown glass tube or aluminium foil, and the 
use of a temperature controlled centrifuge.    
Applying the optimized conditions, the extraction and clean-up recoveries were assessed for 
diverse sample matrices. For the different combinations of matrices and analytes, the 
recoveries were above 50 %, except for ergometrine in biscuits (about 45 %) (Fig. 6.6). In 
general, little variability in recovery was observed between ergot alkaloids. Relatively low 
recoveries were observed for biscuits, while the recoveries were much higher for oats and 
triticale. The low recoveries for biscuits were not considered to be an obstacle for a reliable 
determination, as the other performance data (discussed in section 6.2.3.2) such as 
trueness, precision, linearity and detection limits were good.     
Application of the developed extraction and clean-up procedure to different cereal-based 
products was straightforward. However, simply applying the procedure to corn and grass 
silages resulted in insufficiently cleaned extracts, which could not be directly brought into 
the LC-MS. Therefore, for these matrices, the residue from the EtOAc-phase underwent 
further liquid-liquid partitioning using small volume of DCM (1 mL) and of NH4HCO3 buffer 
(0.5 mL) prior to the defatting step with n-hexane, resulting in a cleaner extract.   
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Figure 6.6. Recovery for individual ergot alkaloids and their corresponding epimers in different matrices. 
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6.2.3.2. Method validation 
The method validation data for rye matrix are summarized in Table 6.6 as an example. Low 
LODs and LOQs were obtained for the different ergot alkaloids and matrices investigated. 
The reported LODs were in the range 0.04 – 0.29 µg/kg, whereas the LOQs were in the range 
0.15 – 0.96 µg/kg. Since estimating the sensitivity of the method through LOD and LOQ lacks 
sufficient statistical significance, the concept of CCα and CCβ was introduced in Commission 
Decision 2002/657/EC (Commission Decision 2002/657/EC, 2002). CCα is defined as the 
lowest concentration level of the analyte that can be detected in a sample with a chance of 1 
% of false positive decision. CCβ is defined as the smallest content of the analyte that can be 
detected in a sample with a chance of 5 % of false negative decision. The CCα and CCβ values 
ranged from 0.57 to 1.13 µg/kg and 1.18 to 2.53 µg/kg, respectively. Although no regulatory 
limits are set for the content of ergot alkaloids in food and feed, results presented in Table 
6.6 indicated that the proposed method is suitable for the detection of ergot alkaloids, even 
at very low µg/kg levels. Comparing these data to those reported in the literature (Krska et 
al., 2008; Mohamed et al., 2006), the method proposed here reaches overall lower LODs and 
LOQs. 
Calibration curves for all the analytes in different matrices were linear over a concentration 
range of 1 – 150 µg/kg. The calibration data obtained in rye are shown as an example (Table 
6.6). The coefficient of determination (R2) for the eight-point calibration curves ranged from 
0.975 (for ergotamine) to 0.996 (for ergometrine). The p-values for the lack of fit test 
(α=0.05) confirmed, for all analytes, the good fit of data with a linear model. Further 
evidence of linearity was provided by the residual plots, which showed no systematic trend 
(residuals randomly distributed around zero). The values for the standard error (Syx) were all 
below 5 % of the estimate, even at low concentrations of analytes. 
The trueness results shown in Table 6.6 were obtained for rye spiked at 2.5, 50 and 150 
µg/kg and were in good agreement with the Commission Decision 2002/657/EC 
performance criteria for quantitative methods of analysis: all trueness values were within 
80-110 %.  
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Table 6.6. Method validation data for ergot alkaloid determination in rye. 
 
 
The precision data were calculated as RSD of replicate measurements. The RSD value under 
repeatability conditions (RSDr) should be between the half or two thirds of the value 
calculated by Horwitz equation (Equation 6.4). For mass fractions of 150 µg/kg, this means 
that the RSDr should be lower than 14 %. Using this equation, mass fractions of 50  µg/kg 
and 2,5 µg/kg will results in RSDr limits of 17 % and 26 %, respectively. With regard to the 
RSD under within-laboratory reproducibility conditions (RSDR), the observed values should 
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not be greater than those calculated using the Horwitz equation. For mass fractions of 150 
µg/kg, this means that the RSDR should be lower than 21 %. However, using this equation, 
mass fractions of 50  µg/kg and 2,5 µg/kg, will results in RSDR limits of 25 % and 39 %, 
respectively. These values are high; therefore, for concentrations below 50 µg/kg, an RSDR 
guidance limit of 25 % was chosen.  
Data presented in Table 6.6 indicated the good precision of the method. 
 
𝑪𝑪𝑪𝑪 = 𝟐𝟐(𝟏𝟏−𝟏𝟏.𝟓𝟓𝑨𝑨𝑹𝑹𝟓𝟓𝑪𝑪)               (Eq. 6.4) 
 
Table 6.6 also gives, for each of the ergot alkaloids, the expanded measurement 
uncertainties calculated at different concentrations, using rye as matrix. The uncertainty was 
not higher than 51 % at a concentration level of 2.5 µg/kg and not higher than 30 % at 
concentration levels of 150 µg/kg. 
The use of a triple quadrupole provides high selectivity and specificity. Two SRM transitions 
were monitored for each analyte, which improves specificity. For identification, the ratios of 
the two SRM transitions were compared with those of the standards. The specificity of the 
method was further confirmed through the analysis of many blank samples (more than 20 
samples for some matrices). For each of the SRM transitions, no peak with a S/N of at least 3 
was detected. 
Data presented above highlight the performance characteristics of the proposed method for 
the analysis of ergot alkaloids. The method can be applied to a wide range of food and feed 
matrices including rye, wheat, triticale, barley, oats, bread, crispbread, biscuits, composite 
feed, corn and grass silages. 
 
6.2.3.3. Robustness study 
Robustness of the method, that plays an important role in ensuring correct quantification, 
was investigated. The influence of small changes of the sample preparation parameters on 
the recovery of ergot alkaloids was evaluated. Parameters such as pH and concentration of 
extraction buffer, shaking time, drying temperature and extraction volumes were included in 
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the investigation (Appendix III). A fractional factorial design was used. The central values 
were those specified in the method and the extreme values (low and high) were computed 
from the nominal ones taking into account possible uncertainty (Table 6.4). It was observed 
that in the range examined, changes in the above-mentioned parameters did not 
significantly affect the recoveries of ergot alkaloids (α = 0.05); the recovery values for all 
compounds were within the 95 % confidence interval. Therefore, the applied LC-MS/MS 
method for determination of ergot alkaloids was considered to be robust and is expected to 
be easily transferred from one operator/laboratory to another.  
 
6.2.4. Application of the developed LC-MS/MS method to a European survey of cereals and 
cereal products 
The developed method was applied to a survey on the occurrence of ergot alkaloids in 
cereals and cereal products in European countries. The results revealed that 59 % of samples 
(a total of 1065 samples were analyzed) were, to some extent, contaminated with ergot 
alkaloids. Overall, the highest frequencies of contamination were noted for the food samples 
as compared to the feed, while the highest levels of total ergot alkaloid content were found 
in the latter (Table 6.7). This observation could be possibly explained by the fact that during 
food processing (the majority of the analyzed food samples were flours) the ground raw 
material is homogenously mixed leading to equal distribution of ergot alkaloids (if present) 
within the sample. It should also be considered that raw materials used for the preparation 
of food samples could include cereal from different fields characterized by varied ergot 
contamination; thereby increasing the rate of positive samples (when homogeneously 
mixed). The number of positive samples was the highest in rye food (84 %), followed by 
wheat food (67 %), rye feed (52 %), multigrain food (48 %) and triticale feed (44 %), while 
only 27 % of wheat feed contained ergot alkaloids. Among the food samples, ergot alkaloids 
were more frequently found in rye in comparison to wheat. The same trend was observed 
for the feed. The concentration of ergot alkaloids in the investigated samples ranged from < 
LOQ to 12,340 µg/kg with an average content of 89 µg/kg. It should be noted that samples 
with an alkaloid content < 1 µg/kg were considered negative, regardless of the actual LOQ 
(see section 6.2). 
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Table 6.7. Descriptive statistics for the total ergot alkaloid content in the different matrix 
groups. 
  
  
Matrix group 
Rye 
food 
Wheat 
food 
Multigrain 
food 
Rye 
feed 
Wheat 
feed 
Triticale 
feed 
Total number of samples 226 332 186 157 137 27 
Mean (µg/kg) 87 62 7 311 19 62 
Median (µg/kg) 28 7 < LOQ 1 < LOQ < LOQ 
Maximum (µg/kg) 1121 591 123 12340 701 1103 
Minimum (µg/kg) < LOQa < LOQ < LOQ < LOQ < LOQ < LOQ 
75th percentile (µg/kg) 87 54 8 54 1 5 
90th percentile (µg/kg) 233 246 23 615 12 154 
95th percentile (µg/kg) 393 375 36 1456 52 787 
       a LOQ = 1 µg/kg 
       
Rye feed was the only sample type where the ergot alkaloid content exceeded 2,000 µg/kg 
(4.5 % of samples); and this matrix actually showed the largest variation in the data, from < 
LOQ to 12,340 µg/kg (Table 6.7). Although the mean total ergot alkaloid concentration in this 
group was 311 µg/kg, the median was 1 µg/kg.  
Fig. 6.7 presents the distribution of the total ergot alkaloid content in different matrix groups 
per country of production/sampling. The highest levels and frequencies of contamination 
were noted for rye feed collected in Switzerland (total ergot alkaloid content ranged from 
833 to 12,340 µg/kg in 6 out of the 7 samples, although the total alkaloid content in the 
other sample was 61 µg/kg). The other countries demonstrated a different pattern: the total 
ergot alkaloid content in the majority of rye feed samples was below 500 µg/kg, with only 
few samples showing higher levels.  
As for the wheat feed, it was observed that in most of these samples ergot alkaloids were 
not present or present at low levels. All wheat feed samples from Belgium, Finland as well as 
the only sample from France were free from ergot alkaloids. In more than half of the 
samples from Germany (64 %), Poland (65 %), Switzerland (75 %) and Czech Republic (85 %) 
ergot alkaloids were not detected.  
More than half of the triticale samples were not contaminated with ergot alkaloids. Most of 
these non-contaminated samples were from Czech Republic and Germany.  
 
224 
 Chapter 6 
Unlike rye feed samples, ergot alkaloids were found in the majority of rye food samples. 
Hence, a great part of French (93 %), Estonian (97 %) and Polish (100 %) samples tested 
positive for the ergot alkaloids. 
For the wheat food, samples from Belgium and France were the most contaminated with 
maximum content of 590 and 544 µg/kg, respectively. The maximum content for other 
countries were below 100 µg/kg.  
For most of multigrain food the country of production was not known. Belgium, Germany 
and France had a similar distribution, however, the highest maximum alkaloid concentration 
was noted for the Belgian multigrain samples and amounted to 123 µg/kg.  
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Figure 6.7. Distribution of the total ergot alkaloid content in different matrix groups per 
country. n: number of samples. It has to be noted that the ‘Country’ refers to the country of 
sampling for the feed and some food (flour from mills) samples, and to the country of 
production for the food samples collected in retail markets in Belgium. 
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Using the full set of data, it was found that all six ergot alkaloids (the main compounds were 
combined with epimers) co-occurred in 35 % of positive samples. Taking into account the 
matrix groups, the food and the feed samples showed clear differences in the ergot alkaloid 
pattern (Fig. 6.8). Presence of all six ergot alkaloids was most common for food samples, 
especially for rye food (44 %) and wheat food (42 %). At the same time, feed samples were 
characterized by the predominant presence of a single ‘pair’ (i.e., a pair ‘main compound-
epimer’). This was observed in 54 % of positive wheat feed samples and 33 % of triticale 
feed. Rye feed had almost equal percentage of co-occurrence of a single ‘pair’ (20 %) and of 
all six toxins (23 %).  
 
 
 
Figure 6.8. Frequency of co-occurrence of ergot alkaloids in different matrix groups (the main 
compound was combined with its corresponding epimer; only positive samples are 
considered). n: number of samples. 
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6.2.5. Conclusions 
A new rapid and sensitive LC-MS/MS method has been developed and validated for the 
simultaneous determination of the six most prominent ergot alkaloids, ergometrine, 
ergosine, ergotamine, ergocornine, ergokryptine and ergocristine, as well as their 
corresponding epimers in food and feed samples. The suitability of a mixture of EtOAc and 
MeOH as extraction solvent under alkaline conditions, as well as the efficiency of liquid-
liquid partitioning as sample clean-up approach were demonstrated. MeOH also proved to 
be a suitable alternative to ACN for its use as organic modifier, as the former gave enhanced 
MS signal. The stability of an XBridge stationary phase allowed the use of an alkaline mobile 
phase, thereby improving the chromatographic separation of the ergot alkaloids. The 
application of a simple sample clean-up protocol and a careful selection of the sample 
solvent allowed minimizing the epimerization of the ergot alkaloids during analysis. A major 
strength of the proposed method is the low limits of detection and of quantification, and its 
applicability to a wide range of food and feed matrices. In addition, the method also has the 
advantages of being rapid, simple, robust and suitable for routinely determination of ergot 
alkaloids in various matrices. The method represents a suitable tool for research of the ergot 
problem.  
Its application was represented by a European survey on ergot alkaloids in cereals and cereal 
products intended for human consumption and animal feeding. The results revealed that, 
though the highest frequencies of contamination were observed for food samples, the feed 
samples, and in particular the Swiss rye feed, accounted for the highest levels of ergot 
alkaloids. The co-occurrence of all six ergot alkaloids was noted in 35 % of positive samples.  
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6.3. A systematic assessment of the variability of matrix effects in LC-MS/MS analysis of 
ergot alkaloids in cereals 
6.3.1. Introduction 
A combination of LC with ESI-MS is preferred for the quantitative analysis of ergot alkaloids 
(Krska and Crews, 2008). However, matrix effects are a major drawback of this technique. 
Matrix effect (or signal suppression/enhancement (SSE)) is a change in MS signal of an 
analyte due to co-eluting matrix. The analyte signal can be enhanced or suppressed resulting 
in inaccurate performance characteristics of the method. Due to possible over- or 
underestimation of the analyte concentration, matrix effect is a parameter of concern during 
method development and/or validation. 
One of the approaches to deal with the occurrence of matrix effects in quantitative LC-MS 
analyses is the use of isotopically labelled standards (Kokkonen, 2011). Since these 
compounds have the same chemical properties and therefore the same retention times as 
the non-labelled substances, exact correction to the signal suppression or enhancement can 
be achieved. However, to date, no isotopically labelled standards of ergot alkaloids are 
commercially available. Hence, in various LC-MS/MS methods, matrix-matched calibration 
(i.e., preparing the standards in a blank extract of the targeted matrix) is applied to 
compensate for matrix effects (Krska et al., 2008; Mohamed et al., 2006). The closeness of 
match between the matrix to be used for the calibration and the samples to be investigated 
is of great importance in achieving reliable and accurate results when this approach is 
applied. Matuszewski et al. (Matuszewski et al., 2003) demonstrated a high variability of 
matrix effect among different lots of plasma and highlighted the need to investigate beside 
the absolute matrix effect, the relative matrix effect which can reveal differences in 
response among various lots of the same matrix. Cereals which are complex matrices might 
also result in variability of matrix effects between and within grain types and grain variety. 
On the other hand, matrix effects can be minimized by a careful selection of sample 
preparation, as well as chromatographic and ionization conditions. Krska et al. (Krska et al., 
 
229 
Ergot alkaloids in cereals  
2008) proposed primary secondary amine (PSA) as a fast and effective technique for the 
analysis of ergot alkaloids in different cereals and cereal-based products. A tendency toward 
underestimation of the analyte concentration was observed for wheat and malted-milk 
biscuits. SSE values in the range of 80-86 % were obtained for seven ergot alkaloids including 
ergometrine, ergosine and ergocornine (Krska et al., 2008). Importance of a clean-up step in 
sample preparation of ergot alkaloids was also shown by Mohamed et al. (Mohamed et al., 
2006). The use of C18 SPE cartridges demonstrated lower matrix effects compared to a 
simple extraction with acetonitrile. Lenain et al. (Lenain et al., 2012) developed a class-
selective molecularly imprinted solid-phase extraction (MISPE) with the prospect of 
improved efficiency in minimizing matrix effects as compared to conventional SPE. 
Kokkonen and Jestoi (Kokkonen and Jestoi, 2010) described the application of MycoSep®150 
Ergot SPE push-through clean-up columns. UPLC was applied in the analysis of ergot 
alkaloids, which provides high separation efficiency and might play a significant role in 
occurrence of matrix effects. However, the influence of this separation technique on matrix 
effects was not investigated.  
The ion interface can also affect matrix effect as physico-chemical processes of ion 
formation vary depending on the ionization technique. ESI, APCI and APPI are widely used in 
mycotoxin LC-MS analysis (Kokkonen, 2011). For the determination of ergot alkaloids in 
particular, ESI was mostly applied in daily analysis. A comparison of matrix effects using 
other modes has not been reported yet, likewise in-depth studies on matrix effects in the 
analysis of ergot alkaloids. 
The aim of this study was therefore a systematic assessment of signal 
suppression/enhancement in LC-MS/MS analysis of ergot alkaloids in grains, including 
different grain types and grain varieties using a previously developed LC-MS/MS method 
(see section 6.2). The effect of the sample preparation procedure, the chromatographic 
separation and the ionization technique on the matrix effect was also investigated. 
 
6.3.2. Experimental 
6.3.2.1. Standards 
The standards of ergot alkaloids used in the study were as described in section 6.2.2.1.  
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6.3.2.2. Chemicals and material 
MeOH and ACN of HPLC-grade were both supplied from VWR International (Zaventem, 
Belgium). n-Hexane, anhydrous disodium hydrogen phosphate (Na2HPO4) and potassium 
dihydrogen phosphate (KH2PO4) were also obtained from VWR International. LC-MS grade 
MeOH and ACN were bought from Biosolve (Valkenswaard, The Netherlands). EtOAc and 
triethylamine (Et3N) were purchased from Acros Organics (Geel, Belgium). For purification of 
demineralized H2O a Milli-Q purification system (Millipore, Brussels, Belgium) was used. HCl, 
sodium hydroxide (NaOH), (NH4)2CO3 and (NH4)2SO4 were bought from Merck (Darmstadt, 
Germany). Sigma-Aldrich was a supplier of NH4HCO3 and citric acid. Concentrated NH3 (25 
%) was purchased from Vel (Leuven, Belgium). Ultrafree®-MC centrifugal filter devices (0.22 
µm) from Millipore (Bedford, MA, USA) were used. MycoSep®150 SPE multifunctional 
columns were provided by Romer Labs® (Tulln, Austria). Discovery® DSC-SCX SPE columns 
(500 mg, vol. 6 mL) were purchased from Sigma-Aldrich. Bondesil PSA bulk sorbent (40 μm) 
from Agilent Technologies (Diegem, Belgium) was used for dispersive solid-phase extraction. 
Paper filters (grade 3 hw, 65 g/m2) were supplied from Egilabo NV (Kontich, Belgium). Bond 
Elut empty SPE cartridges (3 mL) and polypropylene frits (diameter 9.5 mm; 20 µm) were 
provided by Agilent Technologies. 
 
6.3.2.3. Spiking 
For evaluation of matrix effects, the ergot alkaloids were spiked in cleaned-up extracts of 
blank grain samples and in the injection solvent free of matrix at four concentrations 
(ranging between 5 and 100 µg/kg for ESI mode and between 25 and 500 µg/kg for APCI 
mode). The samples were prepared and analyzed in triplicate on two different days. 
For evaluation of extraction recovery, the ergot alkaloids were fortified in blank grain 
samples which were then subjected to the corresponding extraction procedure.  
For evaluation of epimerization, the ergot alkaloids (main compounds and epimers spiked 
separately) were spiked at 100 µg/kg in blank grain samples which were then subjected to 
the corresponding extraction procedure. A mixture of main compounds or epimers prepared 
in injection solvent was also analyzed to provide a reference. 
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6.3.2.4. Sample preparation 
6.3.2.4.1. Liquid – liquid extraction (LLE) 
The LLE procedure exploited in this work was as described in section 6.2.2.4.1. At the last 
step, the n-hexane was discarded and the aqueous phase then used to redissolve the dried 
residues of ergot alkaloid standards. 
 
6.3.2.4.2. SPE using PSA 
The sample preparation procedure using PSA was adapted from (Krska et al., 2008). Five 
gram of fine ground grain sample were extracted with 25 mL of ACN:(NH4)2CO3 (200 mg/L) 
(84:16, v/v) during 30 min on an Agitelec overhead shaker (J. Toulemonde & Cie). The extract 
was filtered through a paper filter (grade 3 hw, 65 g/m2, Egilabo NV). Consequent dispersive 
SPE was done by vortex-mixing 4 mL of the extract in a glass tube containing 200 g PSA for 
45 sec. Then, the mixture was filtered through a paper filter and 2 mL were dried under a 
stream of nitrogen at 40 °C. The residue was redissolved in 200 µL of injection solvent 
MeOH:ACN:H2O (20:40:40, v/v/v), and 100 µL of it was used to redissolve the dried residues 
of ergot alkaloid standards. 
 
6.3.2.4.3. SPE using strong cation exchange (SCX) columns 
Five gram of fine ground grain sample were extracted with 40 mL of ACN:NH4HCO3 (16 g/L) 
pH 8.5 (85:15, v/v) during 30 min on an Agitelec overhead shaker (J. Toulemonde & Cie). The 
extract was centrifuged for 10 min at 4,000 g; 5 mL of supernatant were brought into a test 
tube and evaporated till dryness at 40 °C under a stream of nitrogen. The residue was 
reconstituted with 5 mL of absorption buffer [8 mM citric acid containing 4 mM Na2HPO4 pH 
4, adjusted with NaOH]. Five mL of n-hexane were added to the solution, vortexed and 
centrifuged for 10 min at 4,000 g. The n-hexane phase was discarded and 4 mL of the lower 
phase was brought onto a preconditioned SCX SPE column. The SPE column was conditioned 
with 6 mL of 3.2 mM HCl, followed by 3 mL H2O and 2 x 3 mL absorption buffer. After sample 
loading, the column was washed with 1 mL H2O. The ergot alkaloids were eluted with 3 mL 
MeOH:NH3 (80:20, v/v). The composition of elution solvent was optimized by means of an 
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experimental design using Modde 9.1 statistical software (Umetrics, Umea, Sweden) 
(Appendix IV).  
The eluate was collected into a glass tube and evaporated till dryness at 40 °C under a 
stream of nitrogen. The residue was redissolved in 200 µL of injection solvent 
MeOH:ACN:H2O (20:40:40, v/v/v) and centrifuged in an Ultrafree®-MC centrifugal device for 
10 min at 14,000 g. This solution was then used to redissolve the dried residues of ergot 
alkaloid standards. 
 
6.3.2.4.4. SPE using MycoSep® Ergot multifunctional columns 
The sample preparation procedure using Mycosep®150 Ergot SPE cleanup columns was 
according to the instructions given by the manufacturer (Romer Labs®) with only slight 
adaptations. Five gram of fine ground grain sample were extracted with 25 mL of 
ACN:(NH4)2CO3 (200 mg/L) (84:16, v/v) during 30 minutes on an Agitelec overhead shaker (J. 
Toulemonde & Cie). The extract was centrifuged for 10 min at 4,000 g and 4 mL of 
supernatant were brought into the provided glass tube. The extract was cleaned-up by 
pushing Mycosep® column through the extract till the bottom of the tube. Afterwards, 1 mL 
of the purified extract was evaporated till dryness at 40 °C under a stream of nitrogen. The 
dried down residue was redissolved in 100 µL of injection solvent MeOH:ACN:H2O (20:40:40, 
v/v/v). This solution was then used to redissolve the dried residues of ergot alkaloid 
standards. 
 
6.3.2.4.5. SPE using molecularly imprinted polymers (MIPs) 
Five gram of ground sample was extracted with 40 mL ACN:NH4HCO3 (16 g/L) pH 8.5 (85:15, 
v/v) for 30 min. Afterwards, the extract was centrifuged for 10 min at 4,000 g and 10 mL of 
supernatant was evaporated at 40 °C till dryness under a stream of nitrogen. The residue 
was redissolved with 250 µL ACN:buffer KH2PO4-Na2HPO4 pH = 7 (80:20, v/v) (pH of a 0.1 M 
Na2HPO4 solution was adjusted till 7 using a 0.1 M KH2PO4 solution). A MISPE column was 
prepared by packing 50 mg MIP between two frits in an empty SPE cartridge. The MIP 
preparation and extraction procedure were according to Lenain et al. (Lenain et al., 2012). 
The packed column was firstly conditioned by passing 2 mL ACN. The sample extract (250 µL) 
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was then loaded onto the SPE column. Two mL H2O was used in the following washing step. 
Elution was finally achieved by passing 3 mL MeOH:Et3N (95:5, v/v) through the column. The 
collected fraction was dried under a stream of nitrogen and reconstituted in 500 µL injection 
solvent MeOH:ACN:H2O (20:40:40, v/v/v). This solution was then used to redissolve the 
dried residues of ergot alkaloid standards. 
 
6.3.2.5. HPLC-MS/MS analysis 
The HPLC-MS/MS analyses were performed as described in section 6.2.2.7.  
For this study, the mass spectrometer was operated in ESI and APCI modes, both in positive 
and negative polarities. During tuning experiments a 10 μg/mL solution of individual ergot 
alkaloid standards was infused into the MS using a syringe pump. The MS and MS/MS 
spectra were recorded. A precursor ion was selected for each analyte, then its product ions 
were obtained with an optimized combination of cone voltages and collision energies. For 
increased sensitivity and selectivity, data acquisition was performed in SRM mode. Two SRM 
transitions were selected for each of the analytes.  
MS parameters for the ESI analysis were as follows: ESI source block and desolvation 
temperatures: 120 °C and 300 °C (400 °C in ESI-), respectively; capillary voltage: 3.5 kV in ESI+ 
and 3.8 kV in ESI-; argon collision gas: 1.2 x 10-3 mbar; probe nebuliser and desolvation gas 
flows: 100 and 830 L/h, respectively. The monitored SRM transitions as well as the optimized 
cone voltages and collision energies in ESI+ are described in section 6.2.3.1.1.2., while the 
ESI- parameter settings are presented in Table 6.8. 
MS parameters for the APCI analysis were as follows: APCI source block temperature: 150 °C; 
probe temperature: 550 °C in APCI+ and 500 °C in APCI-; corona voltage: 4 kV in both APCI+ 
and APCI-; argon collision gas: 1.2 x 10-3 mbar; probe nebuliser and desolvation gas flows: 
100 and 830 L/h, respectively. The monitored SRM transitions as well as the optimized cone 
voltages and collision energies are presented in Tables 6.9 and 6.10.  
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Table 6.8. Optimized MS/MS parameters for the analysis of ergot alkaloids in the SRM ESI- 
mode. 
Ergot alkaloid Precursor ion (m/z) 
Cone 
voltage (V) 
Product 
ions (m/z) 
Collision 
energy (eV) 
Ergometrine 324.3 [M-H]- 25   223.1
a 
180.2 
20 
30 
Methylergometrine 338.2 [M-H]- 25   223.2
a 
180.1 
20 
35 
Ergometrinine 324.2 [M-H]- 26   180.2
a 
223.2 
25 
15 
Ergosine 546.3 [M-H]- 14  296.4
a 
181.1 
15 
30 
Ergotamine 580.5 [M-H]- 10   330.4
a 
215.1 
15 
30 
Dihydroergotamine 582.3 [M-H]- 28  467.2
a 
423.3 
20 
25 
Ergocornine 560.4 [M-H]- 14  195.1
a 
310.3 
25 
15 
Ergokryptine 574.3 [M-H]- 10  324.5
a 
209.1 
20 
30 
Ergocristine 608.3 [M-H]- 10   358.3
a 
243.2 
15 
30 
Ergosinine 546.3 [M-H]- 10   181.0
a 
296.3 
25 
20 
Ergotaminine 580.3 [M-H]- 10  215.2
a 
330.2 
30 
15 
Ergocorninine 560.3 [M-H]- 10  195.3
a 
310.4 
25 
20 
Ergokryptinine 574.3 [M-H]- 10   324.3
a 
209.3 
15 
30 
Ergocristinine 608.2 [M-H]- 10  358.0
a 
243.3 
15 
30 
a The most abundant product ion 
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Table 6.9. Optimized MS/MS parameters for the analysis of ergot alkaloids in the SRM APCI+ 
mode. 
a The most abundant product ion 
 
 
Ergot alkaloid Precursor ion (m/z) 
Cone 
voltage (V) 
Product 
ions (m/z) 
Collision 
energy (eV) 
Ergometrine 326.3 [M+H]+ 28   223.1
a 
208.1 
25 
30 
Methylergometrine 340.3 [M+H]+ 28   223.1
a 
208.1 
25 
30 
Ergometrinine 326.2 [M+H]+ 30   208.4
a 
223.3 
25 
25 
Ergosine 548.3 [M+H]+ 10  223.1
a 
208.1 
25 
45 
Ergotamine 582.5 [M+H]+ 10   223.1
a 
208.1 
35 
40 
Dihydroergotamine 584.5 [M+H]+ 26  322.4
a 
253.2 
25 
35 
Ergocornine 562.5 [M+H]+ 10  277.4
a 
223.3 
30 
40 
Ergokryptine 576.3 [M+H]+ 18  223.2
a 
305.4 
40 
30 
Ergocristine 610.4 [M+H]+ 10   325.5
a 
223.1 
30 
30 
Ergosinine 530.3 [M-H2O+H]+ 37 
 223.1a 
263.6 
25 
25 
Ergotaminine 564.4 [M-H2O+H]+ 37 
 223.2a 
297.2 
25 
25 
Ergocorninine 544.4 [M-H2O+H]+ 30 
 348.2a 
223.4 
20 
35 
Ergokryptinine 558.5 [M-H2O+H]+ 34 
  291.7a 
223.2 
25 
25 
Ergocristinine 592.4 [M-H2O+H]+ 34 
 223.3a 
305.3 
30 
30 
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Table 6.10. Optimized MS/MS parameters for the analysis of ergot alkaloids in the SRM APCI- 
mode. 
Ergot alkaloid Precursor ion (m/z) 
Cone 
voltage (V) 
Product 
ions (m/z) 
Collision 
energy (eV) 
Ergometrine 324.2 [M-H]- 32   223.4
a 
180.2 
20 
30 
Methylergometrine 338.3 [M-H]- 33   223.3
a 
208.2 
25 
30 
Ergometrinine 324.2 [M-H]- 35   223.3
a 
180.2 
20 
30 
Ergosine 546.3 [M-H]- 18  296.3
a 
181.5 
20 
25 
Ergotamine 580.5 [M-H]- 19   215.0
a 
330.0 
35 
20 
Dihydroergotamine 582.5 [M-H]- 34  467.6
a 
423.6 
25 
25 
Ergocornine 560.4 [M-H]- 18  195.4
a 
310.3 
30 
20 
Ergokryptine 574.3 [M-H]- 18  324.2
a 
209.0 
15 
30 
Ergocristine 608.3 [M-H]- 33   358.4
a 
243.4 
20 
30 
Ergosinine 546.3 [M-H]- 18   181.5
a 
296.3 
30 
20 
Ergotaminine 580.5 [M-H]- 23  215.3
a 
330.1 
30 
20 
Ergocorninine 560.5 [M-H]- 18  195.4
a 
310.1 
30 
20 
Ergokryptinine 574.4 [M-H]- 18   209.4
a 
324.1 
30 
20 
Ergocristinine 608.4 [M-H]- 18  358.3
a 
243.0 
20 
30 
a The most abundant product ion 
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6.3.2.6. UPLC-MS/MS analysis 
The UPLC-MS/MS analyses were performed on a Waters ACQUITY UPLC system coupled to a 
Micromass Quattro Micro triple quadrupole mass spectrometer (Waters) equipped with a Z-
spray ESI. Chromatographic separation was achieved using an ACQUITY UPLC BEH C18 
column (1.7 µm, 100 x 2.1 mm i.d.) with an ACQUITY BEH C18 VanGuard pre-column (1.7 
µm, 5 x 2.1 mm i.d.), both supplied by Waters, or ZORBAX RRHD Eclipse plus C18 column (1.8 
µm, 100 mm x 2.1 mm i.d.), supplied by Agilent Technologies. The column temperature was 
set at 30 °C. A mobile phase consisting of eluents A [H2O:0.2 M NH4HCO3 pH 10:MeOH 
(85:5:10, v/v/v)] and B [H2O:0.2 M NH4HCO3 pH 10:MeOH (5:5:90, v/v/v)] was used at a flow 
rate of 0.3 mL/min. A gradient elution was applied as follows: 0-1 min: 50-40 % A; 1-2.5 min: 
40-35 % A; 2.5-6.5 min: 35 % A; 6.5-7 min: 35-30 % A; 7-9 min: 30 % A; 9-12 min: 30-10 % A; 
12-13 min: 10 % A; 13-14 min: 10-50 % A; 14-17 min: 50 % A. The injection volume was 5 µL. 
The mass spectrometer was operated in ESI positive mode. MS parameters for the ESI 
analysis were as follows: ESI source block and desolvation temperatures: 120 °C and 300 °C, 
respectively; capillary voltage: 3.5 kV; cone nitrogen and desolvation gas flows: 20 and 500 
L/h, respectively. The monitored SRM transitions as well as the optimized cone voltages and 
collision energies are shown in Table 6.11.  
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Table 6.11. Optimized MS/MS parameters for the UPLC-MS/MS analysis of ergot alkaloids in 
the SRM ESI+ mode. 
 
Ergot alkaloid 
RT UPLC 
ACQUITY  
BEH (min) 
RT UPLC 
ZORBAX 
(min) 
Precursor ion 
(m/z) 
Cone 
voltage 
(V) 
Product 
ions (m/z) 
Collision 
energy 
(eV) 
Ergometrine 1.7 1.7 326.2 [M+H]+ 26   223.1
a 
208.1 
25 
26 
Methylergometrine 1.9 2.0 340.1 [M+H]+ 31   208.1
 a   
223.1 
26 
22 
Ergometrinine 2.4 2.5 326.1 [M+H]+ 35   208.1
a 
223.0 
25 
25 
Ergosine 4.8 6.0 548.4 [M+H]+ 33   208.1
 a 
223.3 
38 
30 
Ergotamine 5.6 7.4 582.3 [M+H]+ 29   223.3
a 
208.3 
31 
43 
Dihydroergotamine 6.3 8.5 584.1 [M+H]+ 40  270.0
a 
297.0 
26 
27 
Ergocornine 6.1 8.0 562.1 [M+H]+ 32  268.1
a 
223.0 
23 
36 
Ergokryptine 7.9 11.0 576.4 [M+H]+ 29  208.1
a 
268.3 
44 
25 
Ergocristine 8.2 11.8 610.4 [M+H]+ 31   208.3
a 
268.3 
46 
24 
Ergosinine 8.4 11.7 530.1 [M-H2O+H]
+ 40  223.2
a 
263.0 
25 
22 
Ergotaminine 9.9 12.6 564.3 [M-H2O+H]
+ 40   297.2
 a 
223.3 
24 
23 
Ergocorninine 10.3 13.0 544.4 [M-H2O+H]
+ 38  277.2
a 
223.2 
24 
24 
Ergokryptinine 10.7 13.4 558.3 [M-H2O+H]
+ 40   305.0
a 
223.0 
25 
28 
Ergocristinine 10.9 13.6 592.3 [M-H2O+H]
+ 37  325.0
a 
305.0 
23 
24 
a The most abundant product ion 
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6.3.2.7. Matrix effects 
For evaluation of matrix effects, the ergot alkaloids were spiked in cleaned-up extracts of 
blank grain samples and in the injection solvent free of matrix at four concentrations, and 
analyzed by LC-MS/MS. A linear function of the calibrants spiked in cleaned-up extract was 
compared to that of calibrants spiked in matrix-free solvent. Matrix effects were expressed 
as SSE and calculated according to Equation 6.5. 
 
𝑺𝑺𝑺𝑺𝑺𝑺 (%) = 𝟏𝟏𝟏𝟏𝟏𝟏 × 𝑺𝑺𝑨𝑨𝑹𝑹𝑺𝑺𝑹𝑹 𝑴𝑴𝑺𝑺𝒄𝒄𝒔𝒔𝑹𝑹𝑴𝑴 𝑹𝑹𝒆𝒆𝒄𝒄𝑹𝑹𝑴𝑴𝑹𝑹𝒄𝒄 ÷ 𝑺𝑺𝑨𝑨𝑹𝑹𝑺𝑺𝑹𝑹 𝑹𝑹𝑴𝑴𝑨𝑨𝒄𝒄𝒃𝒃𝑹𝑹𝑴𝑴𝒄𝒄𝒄𝒄𝑴𝑴 𝒄𝒄𝒄𝒄 𝑺𝑺𝑴𝑴𝑹𝑹𝑹𝑹 𝑴𝑴𝑹𝑹𝑨𝑨𝑹𝑹𝑹𝑹𝒄𝒄𝒄𝒄             
(Eq. 6.5) 
 
An SSE value of 100 % indicates no matrix effect, while a value above 100 % designates signal 
enhancement and an SSE below 100 % points to signal suppression due to presence of 
matrix.  
Epimerisation of ergot alkaloids, which might have considerable impact on SSE results, was 
minimized by maintaining the autosampler at 4 °C and immediate analysis of the samples. 
For the data treatment a statistical software IBM SPSS Statistics 20 (IBM Corporation, New 
York, USA) was used. 
 
6.3.3. Results and discussion 
6.3.3.1. Grain type and grain variety 
As common cereal grains can be infected with Claviceps spp. (Krska and Crews, 2008), it was 
the intention of the study to investigate at first stage matrix effects when analyzing different 
grain types. Five cereals were chosen for the experiment, namely rye, wheat, triticale, oat 
and barley. The samples were subjected to LLE and analyzed by HPLC-MS/MS as described in 
sections 6.3.2.4.1 and 6.3.2.5. The SSE data are visualized in Fig. 6.9. A difference in matrix 
effects between the grain types was observed with up to 80 % and 90 % decrease of signal 
for ergometrine in barley and oat, respectively. The late-eluting ergokryptinine and 
ergocristinine demonstrated nearly no signal suppression/enhancement in rye, wheat and 
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triticale, whereas in oat and barley the SSE were below or equal to 50 %. An ANOVA test 
showed that SSE means for the different grain types were significantly different (p-value < 
0.001). A Tukey multiple comparison test (Table 6.12) revealed that the mean SSE values of 
the different combinations of grain types were significantly different (p-values < 0.001) 
except for the combinations of rye – wheat (p-value = 0.078) and wheat – triticale (p-value = 
0.124). 
 
 
Figure 6.9. SSE (%) for the different grain types. 
 
Considering the fact that different grain varieties are cultivated all over the world, at the 
next stage, an assessment of SSE for different varieties within one grain type was done using 
rye as an example. The difference in matrix effects between the three varieties of rye 
investigated (Askari, Conduct and Evolo) was significant (ANOVA p-value = 0.001). Tukey 
multiple comparison test revealed a significant difference in SSE between Askari and 
Conduct (p-values = 0.001) (Table 6.12 and Fig. 6.10), while no significant difference could be 
demonstrated for the combinations Askari – Evolo (p-value = 0.271) and Conduct – Evolo (p-
value = 0.063). Overall, it can be stated that the differences in matrix effects between grain 
varieties were moderate (Fig. 6.10), as compared to grain types. However, the results of this 
investigation clearly highlight the need for a correct choice of the blank matrix when  matrix-
matched calibration has to be performed. 
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Table 6.12. Tukey multiple comparisons for grain type and grain variety. 
            
Grain type Mean difference p-value 
95 % confidence interval 
Lower 
bound 
Upper 
bound 
Rye Wheat -6.61 0.078 -13.65 0.43 
Rye Triticale -12.71* < 0.001 -19.75 -5.67 
Rye Oat 44.39* < 0.001 35.77 53.01 
Rye Barley 28.67* < 0.001 20.04 37.29 
Wheat Triticale -6.10 0.124 -13.14 0.94 
Wheat Oat 50.99* < 0.001 42.37 59.61 
Wheat Barley 35.27* < 0.001 26.65 43.89 
Triticale Oat 57.10* < 0.001 48.47 65.72 
Triticale Barley 41.37* < 0.001 32.75 50.00 
            
Grain variety Mean difference p-value 
95 % confidence interval 
Lower 
bound 
Upper 
bound 
Askari Evolo -4.68 0.071 -7.07 -2.29 
Askari Conduct -11.53* 0.001 -13.92 -9.15 
Conduct Evolo 6.85 0.063 4.46 9.24 
            
*The mean difference is significant at the confidence level α = 0.05   
            
 
Figure 6.10. SSE (%) for the different varieties of rye. 
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6.3.3.2. Comparison of different ion sources and ionization modes 
The commonly used ionization techniques in the LC-MS/MS analysis of mycotoxins are ESI 
and APCI in either positive or negative mode (Royer et al., 2004; Sulyok et al., 2007). Due to 
their different ionization mechanisms, the efficiency of formation of the targeted ions in the 
presence of the same coeluting compounds can vary depending on the utilized interface. 
Considering this fact, matrix effects in the LC-MS/MS analysis of ergot alkaloids using 
different ion sources (as well as different ionization modes) were studied under identical 
sample preparation and chromatographic conditions. Rye samples were subjected to LLE and 
analyzed by HPLC-MS/MS as described in sections 6.3.2.4.1. and 6.3.2.5. 
It was demonstrated that the type of ion source can have a relevant effect on analyte MS 
signal (Fig. 6.11, Table 6.13). A suppressive matrix effect was observed in the ESI mode for 
almost all analytes with ergometrine being the most susceptible. Less signal suppression 
occurred using the ESI interface in the positive instead of negative ionization mode; the MS 
signal of the ergot alkaloids dissolved in matrix-free solvent was 10 times higher in ESI+ than 
in ESI-. Using ESI+, a great signal suppression for ergometrine in rye and wheat was also 
noticed by Kokkonen and Jestoi (Kokkonen and Jestoi, 2010). The use of APCI instead of ESI 
resulted in a tremendous signal enhancement for most of the ergot alkaloids (SSE around 
200 % for ergometrine) leading to an overestimated ergot alkaloid content in cereal samples.  
 
Figure 6.11. SSE (%) for the different ion sources and ionization modes. 
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Table 6.13. Tukey multiple comparisons for the different ion sources and ionization modes. 
            
Ionization Mean difference p-value 
95 % confidence interval 
Lower bound Upper bound 
ESI+ ESI- 7.55 0.204 -2.38 17.47 
ESI+ APCI+ -71.04* < 0.001 -80.89 -61.19 
ESI+ APCI- -80.50* < 0.001 -90.35 -70.65 
ESI- APCI+ -78.59* < 0.001 -88.51 -68.66 
ESI- APCI- -88.05* < 0.001 -97.97 -78.12 
APCI+ APCI- -9.46 0.065 -19.31 0.39 
            
*The mean difference is significant at the confidence level α = 0.05   
 
An ANOVA test demonstrated that the mean SSE values applying different ionization modes 
significantly differ (p-value < 0.001). By further Tukey multiple comparison analysis, it was 
shown that significant differences were observed between ESI and APCI (p-values < 0.001) 
(Table 6.13). The SSE mean values between polarity modes, namely, ESI+ and ESI- (p-value = 
0.204), and APCI+ and APCI- (p-value = 0.065), were not significantly different (Table 6.13). 
When choosing ion source and ionization mode for the LC-MS analysis of ergot alkaloids, it 
should be considered that these compounds give a much higher signal in ESI+ than in other 
modes, as was also observed by other authors (Krska et al., 2008). On the other hand, 
notably high standard deviations of SSE values observed in APCI do not give preference to 
this ionization mode (Fig. 6.11). 
 
6.3.3.3. Influence of chromatography 
To minimize matrix effects, a good chromatographic separation of an analyte from matrix 
components can play an important role. For this purpose, UPLC (instead of HPLC) can be 
applied, since the use of a column with smaller particle size leads to sharper peaks and 
therefore to an improved chromatographic resolution (Kokkonen and Jestoi, 2010). 
Consequently, a better separation between analytes and matrix components can be 
expected, leading to reduced matrix effects. 
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The rye samples fortified with ergot alkaloids underwent the LLE (section 6.3.2.4.1) and were 
analyzed either by HPLC-MS/MS using a C18 XBridge column or by UPLC-MS/MS using C18 
ACQUITY BEH and C18 Zorbax RRHD Eclipse columns (sections 6.3.2.5 and 6.3.2.6). 
In the conditions applied, a significant difference between the chromatographic systems was 
found (ANOVA, p-value = 0.002). The Tukey multiple comparison test showed that HPLC and 
UPLC using ACQUITY BEH (p-value = 0.009), or HPLC and UPLC using Zorbax column (p-value 
= 0.012) had significantly different SSE profiles; whereas both UPLC columns demonstrated 
similar SSE means (p-value = 0.994) (Table 6.14). Compared to Zorbax, the ACQUITY BEH 
column provided higher signal suppression for ergometrinine (about 20 % difference) and 
ergocorninine (30 %) (Fig. 6.12). In turn, the Zorbax column accounted for lower SSE values 
for ergokryptine (about 40 % difference) and ergosinine (about 20 %). Regarding the early 
eluting ergometrine, improvement in matrix effect using UPLC was not achieved; the SSE 
values were still below 45 %.   
In general, UPLC was shown to be a suitable option for minimizing matrix effects and would 
be preferred in routine ergot alkaloid analysis. 
 
Table 6.14. Tukey multiple comparisons for the different chromatographic conditions. 
 
            
Chromatography Mean difference p-value 
95 % confidence interval 
Lower 
bound 
Upper 
bound 
HPLC 
UPLC BEH -12.28* 0.009 -21.94 -2.62 
UPLC Zorbax -11.78* 0.012 -21.44 -2.12 
UPLC BEH UPLC Zorbax 0.50 0.994 -10.66 11.66 
            
*The mean difference is significant at the confidence level α = 0.05   
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Figure 6.12. SSE (%) for the different chromatographic conditions. 
 
6.3.3.4. Comparison of different sample preparation procedures 
As matrix effect is caused by interference of matrix components with the analyte peak, it can 
be reduced by applying a suitable sample preparation. This step in the analysis is the most 
critical, since grain is considered as a complex matrix. In this study, different sample 
preparation procedures, namely LLE and SPE using PSA, MIP, MycoSep and SCX columns 
(section 6.3.2.4) were evaluated with regard to matrix effects (Fig. 6.13).  
 
Figure 6.13. SSE (%) applying different sample preparation procedures (for reasons of clarity 
only ergot alkaloids with the most pronounced matrix effects are shown). 
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A great difference in matrix effects was observed for the different sample preparation 
procedures tested and the ergot alkaloids studied. Overall, the highest signal suppression 
was observed for ergometrine and ergometrinine. Applying LLE, the signal suppression 
observed for these compounds was less pronounced as compared to the other sample 
preparation procedures. The use of a relatively less polar solvent (EtOAc) could account for 
these observations.  
The use of SCX and multifunctional SPE cartridges resulted in almost no signal suppression or 
signal enhancement for the later eluting ergot alkaloids. Owing to easy handling and 
elimination of matrix interferences for the majority of ergot alkaloids, MycoSep® 
multifunctional columns could be preferred for the clean-up with the only limitation that 
recovery of ergometrine was below 15 % combined with about 90 % of signal suppression. 
The use of MIP and PSA as solid sorbents for clean-up was less effective with regards to 
matrix effects compared to the two above-mentioned SPE columns, but SSE values still 
exceeded 60 % for the later eluting analytes.  
Additionally to matrix effects, the influence of the sample preparation procedure on 
epimerization rate of the ergot alkaloids was also taken into consideration as it can affect 
the results of analysis. Ergot alkaloids, having asymmetric carbon at the C8-position, form 
two epimeric configurations which possess different bioactivity (Pierri et al., 1982; Smith and 
Schappell, 2002). It is known that bidirectional epimerization is observed under both acidic 
and alkaline conditions (Komarova and Tolkachev, 2001). Fig. 6.14 presents the 
epimerization rates of the investigated ergot alkaloids applying the different extraction 
protocols. LLE procedure overall induced lesser epimerization (or no epimerization as in the 
case of ergometrine and ergometrinine) compared to the other extraction protocols. The 
composition  of  the extraction solvent and cautions in the extraction steps could account for 
this. Although carbonate buffers pH 8.5 and pH 10 (required for optimal extraction) were 
applied, these were not allowed to interact with the ergot alkaloids for an extended time. In 
another study, application of LLE for extraction of ergot alkaloids in acidic conditions caused 
their epimerization with equilibrium shifted towards the epimers (Sulyok et al., 2007). Other 
data showed that almost no epimerization occurred using Oasis® HLB SPE cartridges, 
however, using Oasis® MCX SPE cartridges, designed for bases, the epimerization (up to 27 % 
ergosinine) was promoted more strongly due to presence of 5 % NH3 in the elution solvent 
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(Krska et al., 2008). Current results demonstrated higher degree of epimerization using SCX 
for clean-up step; the highest rate was noted for ergotaminine (57 %). This can be attributed 
to elution of ergot alkaloids with a solvent containing a higher concentration of NH3 (20 %). 
The same reasoning can be applied for epimerization rates up to 70 % using MIP; here, 
triethylamine was applied as a component of the elution mixture. It has been previously 
reported that in alkaline conditions tendency for ergot alkaloid conversion increases (Smith 
and Schappell, 2002). Krska et al. (Krska et al., 2008) reported non-significant epimerization 
employing PSA in the ergot alkaloid sample preparation. Data of the present study showed 
elevated epimerization rates, up to 40 %. This can be ascribed to the introduction of a drying 
step in the present experiment set-up. The concentration of extract was required to increase 
sensitivity; however, temperature has been shown to cause epimerization in other studies 
(Hafner et al., 2008; Smith and Schappell, 2002). 
 
 
 
 
Figure 6.14. Epimerization rate (%) of ergot alkaloids applying different sample preparation 
procedures. 
(Difference in MS signal of the main compound and the epimer as well as epimerization in standard 
mixture was taken into account) 
Em: ergometrine; Emn: ergometrinine; Es: ergosine; Esn: ergosinine; Et: ergotamine; Etn: 
ergotaminine; Eco: ergocornine; Econ: ergocorninine; Ekr: ergokryptine; Ekrn: ergokryptinine; Ecr: 
ergocristine; Ecrn: ergocristinine.  
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Generally, the two lysergic acid derivatives, ergometrine and ergometrinine, were more 
stable with regards to epimerization compared to other ergot alkaloids included in this work. 
The interconversion of the epimers into their corresponding main ergot alkaloids was 
observed for all extractions applied and all ergot alkaloids investigated. The exception was 
ergometrinine, which epimerized to its main compound only using MIP in sample 
preparation. 
 
6.3.4. Conclusions 
Matrix effects can lead to inaccurate quantification. With the goal of ensuring accuracy and 
robustness in LC-MS/MS analysis of ergot alkaloids, matrix effects and different ways to 
minimize/eliminate them were systematically investigated. Initially, it was observed that 
signal suppression or enhancement for ergot alkaloids varied not only between grain types, 
with the most pronounced effect in oat, but also to a lesser extent within one grain type. 
These findings should be definitely considered when preparing/searching an appropriate 
blank grain sample for preparation of a matrix-matched calibration. 
The ionization technique was also found to have an influence on matrix effect occurrence. 
Generally, suppressive effects were characteristic for ESI. The use of APCI instead was not a 
good option, since it showed a tremendous signal enhancement for most ergot alkaloids 
leading to overestimation of concentration in a sample. The differences between ionization 
modes were not significant with regard to matrix effect. 
In general, ergometrine was the most susceptible ergot alkaloid to matrix effect which can 
be attributed to its early and thereby simultaneous elution with matrix interferences in the 
HPLC system. Application of UPLC in this case did not solve the problem of signal 
suppression, whereas considering the later eluting compounds, this technique was 
preferred.  
The observed matrix effects were affected by the sample preparation procedure. In this 
work, an LLE procedure using EtOAc was compared to SPE done on different sorbents. For all 
the procedures tested, no clear signal enhancement was noted. A more effective clean-up 
which could be expected from MycoSep® and MIP columns developed especially for ergot 
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alkaloids did not demonstrate improvements for ergometrine. For the later eluting ergot 
alkaloids, MycoSep® and SCX cartridges were useful in minimization of signal suppression. 
The “dilute-and-shoot” approach, another way of eliminating matrix effect, was not included 
in the study, since it necessitates the use of a highly sensitive LC-MS instrument to achieve 
low limits of detection. 
 
6.3.5. Acknowledgements 
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6.4. Rapid and sensitive LC-MS/MS determination of ergot alkaloids in buffered solutions: 
Application to in vitro testing of clay-based mycotoxin binder 
6.4.1. Introduction 
Several strategies are known in management of mycotoxins in livestock such as regulation, 
monitoring, prevention, avoidance, decontamination, detoxification and animal treatments. 
The ideal strategy consisting of prevention cannot be fully implemented, because toxin 
production is modulated by environmental factors that are, in fact, uncontrollable. 
Detoxification strategies are required when contamination cannot be managed (Dӧll et al., 
2004). These strategies include physical, chemical and biological methods (Sinha, 1998). 
Detoxification using binders has great prospects in routinely minimizing mycotoxin exposure. 
A binder is generally mixed with feed and decontaminates mycotoxins by binding them in 
the digestive tract and thereby preventing their absorption. The degree of adsorption 
depends on the chemical nature of the mycotoxin and the surface properties and geometry 
of adsorbent (Dänicke, 2002).  
Mycotoxin binder research has gained its importance and several reviews have been already 
published (Avantaggiato et al., 2005; EFSA, 2009; Huwig et al., 2001; Kolosova and Stroka, 
2011; Ramos and Hernandez, 1997). Efficacy of a mycotoxin binder should be evaluated 
through in vitro and in vivo experiments (EFSA, 2010). Addition of modified glucomannans to 
the ergot alkaloid-contaminated wheat reduced negative effects of mycotoxicosis (reduced 
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egg production, mortality) in layers (Dvorska, 2005). Clays (Huebner et al., 1999) and 
hydrated sodium calcium aluminosilicates (Chestnut et al., 1992) demonstrated high affinity 
for ergotamine in vitro, removing more than 90 % of this toxin if the latter binder was used. 
Another in vitro binding study showed that surfactant-modified zeolites could effectively 
adsorb ergosine, ergotamine, ergocornine, ergokryptine and ergocristine (Tomašević-
Čanović et al., 2003).  
The aim of the present study was to develop an LC-MS/MS-based strategy to simultaneously 
monitor six major ergot alkaloids and their corresponding epimers in buffered solutions from 
in vitro studies. The method was validated and applied to an in vitro binding efficacy study of 
a clay-based mycotoxin binder towards ergot alkaloids. Three model ergot alkaloids 
(ergometrine, ergosine and ergocornine) were selected for the study. 
 
6.4.2. Experimental 
6.4.2.1. LC-MS/MS method 
6.4.2.1.1. Standards  
The standards of ergot alkaloids used in the study were as described in section 6.2.2.1. 
  
6.4.2.1.2. Chemicals and material 
LC-MS grade MeOH and ACN were bought from Biosolve (Valkenswaard, the Netherlands). 
EtOAc was purchased from Acros Organics (Geel, Belgium). H3PO4 (85 %), sodium 
dihydrogen phosphate monohydrate (NaH2PO4*H2O) and sodium hydroxide (NaOH) were 
supplied by Merck (Darmstadt, Germany). Sodium dihydrogen phosphate dodecahydrate 
(NaH2PO4*12H2O) was obtained from Merck Eurolab (Leuven, Belgium). Sigma-Aldrich was 
a supplier of NH4HCO3. Concentrated NH3 (25 %) was purchased from Vel (Leuven, Belgium). 
For purification of demineralized H2O a Milli-Q purification system (Millipore, Brussels, 
Belgium) was used.  
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6.4.2.1.3. Buffers 
0.1 M phosphate buffer at pH 3.0 and 6.8 was used as the aqueous media in the in vitro 
binding efficacy study. Therefore, these buffers were also applied during the development 
and optimization of the LC-MS/MS method. They were obtained by mixing the necessary 
volume of 0.1 M H3PO4 and 0.1 M NaH2PO4 (for buffer pH 3.0) or 0.1 M NaH2PO4 and 0.1 M 
Na2HPO4 (for buffer pH 6.8). 
The alkaline buffers examined during extraction optimization were phosphate and 
bicarbonate buffers both at pH 8.5 and 10; their suitability was tested at two different 
concentrations (0.1 and 0.5 M). The defined portions of NH4HCO3 or Na2HPO4 were 
dissolved in H2O; the required pH was adjusted with NH3 conc. or NaOH conc., respectively. 
 
6.4.2.1.4. Sample preparation 
Four mL 0.5 M NH4HCO3 (pH 10) were added to 4 mL of sample (0.1 M phosphate buffer pH 
3.0 or pH 6.8) to adjust sample pH till 10 and the ergot alkaloids were extracted with 20 mL 
of EtOAc on an Agitelec overhead shaker (J. Toulemonde & Cie, Paris, France) during 15 min. 
After centrifugation, 5 mL of supernatant were evaporated till dryness under a stream of 
nitrogen at 40 °C. Prior to LC-MS/MS analysis, the dried residue was reconstituted in 200 µL 
injection solvent MeOH:ACN:H2O (20:40:40, v/v/v). 
 
6.4.2.1.5. LC-MS/MS conditions 
The LC-MS/MS conditions applied were as described in section 6.2.2.7. 
 
6.4.2.1.6. Validation 
During validation process the following parameters were evaluated: linearity of the method, 
LOD and LOQ, apparent recovery, repeatability, within-laboratory reproducibility, 
measurement uncertainty and matrix effects. In addition, evaluation of the method 
robustness was performed.  
The calculation of method parameters were as described in sections 6.2.2.8 and 6.3.2.7. 
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The assessment of the method robustness was based on evaluation of extraction recoveries 
of ergot alkaloids varying the following parameters: pH and concentration of extraction 
buffer, shaking time and drying temperature. These factors were selected as potential 
sources of variability when performing the analysis. The intervals of the factors were set at 
values which slightly exceed the variations that can be expected when a method is 
transferred from one laboratory to another (Table 6.15). To evaluate the effect of the 
investigated factors on the response, a fractional factorial design was constructed using 
Modde 9.1  statistical software (Umetrics, Umeå, Sweden). Having included four factors, the 
total number of runs was equal to 11 including three replicates of the centre-point.  
Epimerization of ergot alkaloids was minimized by maintaining the autosampler at 4 °C and 
immediate analysis of the samples. 
 
Table 6.15. Experimental design for robustness evaluation. 
Exp. No 
pH of extraction 
buffer 
Buffer concentration 
(mol/L) 
Shaking time 
(min) 
Temperature of 
drying (°C) 
1 9.8 0.48 17 43 
2 10.2 0.48 13 37 
3 9.8 0.48 17 37 
4 10.2 0.48 13 43 
5 9.8 0.52 13 43 
6 10.2 0.52 17 37 
7 9.8 0.52 13 37 
8 10.2 0.52 17 43 
9 10.0 0.50 15 40 
10 10.0 0.50 15 40 
11 10.0 0.50 15 40 
 
 
6.4.2.2. In vitro testing 
6.4.2.2.1. Experimental set-up 
The in vitro testing was based on an aqueous binding experiment at isothermal conditions 
i.e., including single-concentration sorption. The experiment was performed at two different 
pH (3.0 and 6.8) to encompass the pH range encountered in the gastro intestinal tract. An 
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ergot alkaloid binder comprising of a mixture of activated clays was obtained from Kemin 
Europa NV (Herentals, Belgium). 0.1 M phosphate buffer at pH 3.0 and 6.8 was used as the 
aqueous media in the in vitro binding efficacy study. These buffers were obtained by mixing 
the necessary volume of 0.1 M NaH2PO4 and H3PO4 (for buffer pH 3.0) or 0.1 M Na2HPO4 
and 0.1 M NaH2PO4 (for buffer pH 6.8). A toxin working solution (separate for each ergot 
alkaloid) was prepared in the buffers by diluting ergometrine (Coring System Diagnostix 
GmbH), ergosine (Coring System Diagnostix GmbH) and ergocornine (Sigma-Aldrich, Buchs, 
Switzerland) in buffer pH 3.0 at a concentration of 250 µg/L. 
Initially, mycotoxin adsorption was evaluated. Toxin binder (100 ± 5 mg) was placed in a 50 
mL NalgeneTM oak ridge PPCO centrifuge tube (Nalge Nunc International, USA) with two 
glass boiling stones. Twenty mL of the ergot alkaloid working solution (prepared in the 
phosphate buffer pH 3.0) were added into the tube. The tube was incubated on an orbital 
shaker (GFL3500, GFL, Burgwedel, Germany) for 60 min at ambient temperature followed by 
centrifugation (MR1822 centrifuge (Jouan, USA)) for 10 min at 10,000 g. An aliquot of 
supernatant was collected in a test tube, labeled as ‘adsorption’. To investigate mycotoxin 
desorption, the remaining supernatant was decanted and precipitates were resuspended in 
20 mL phosphate buffer pH 6.8 free of ergot alkaloids. The following steps were as described 
above (evaluation of mycotoxin adsorption). An aliquot of supernatant was transferred into 
a test tube, labeled as ‘desorption’. The binding experiments were executed in triplicate. 
 
6.4.2.2.2. Calculation of binding efficacy 
Calculation of the ergot alkaloid concentration was done using a matrix-matched calibration 
prepared in the phosphate buffer (all samples were analyzed by LC-MS/MS as described in 
section 6.4.2.1.). The adsorption and desorption percentage, as well as the binding efficacy 
were computed as follows: 
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6.4.3. Results and discussion 
6.4.3.1. Optimization of sample preparation 
In vitro testing of binding efficacy implies analysis of buffered sample solutions. The major 
focus in the optimization of the sample preparation procedure was sample concentration as 
well as the removal of salts (that are not compatible with MS-detection) without significant 
loss of analytes. As pKa values of the investigated ergot alkaloids vary from 4.8 to 6.2 
(Lorenz, 1979), these compounds are positively charged at the N6-position in acidic solutions 
and neutral at higher pH. Considering this, extraction can be performed either with non-
polar organic solvents under alkaline conditions or with polar solvents under acidic 
conditions. In this work, a H2O-immiscible organic solvent, namely EtOAc, was chosen. To 
alkalinize the sample, phosphate and bicarbonate buffers were evaluated at different 
concentrations and pH. Buffer volumes were experimentally determined to achieve the 
required pH of the sample. As it was the intention to develop a universal extraction for the 
samples in aqueous media buffered at both pH 3.0 and 6.8, the optimization was oriented 
towards the more acidic buffer (pH 3.0). Fig. 6.15 shows that use of the phosphate buffer did 
not provide sufficient extraction of ergot alkaloids from the aqueous medium at pH 3.0.  
The extraction was more efficient using bicarbonate buffer, especially at higher pH (pH 10) 
with recoveries of all ergot alkaloids above 70 % (for 0.5 M bicarbonate buffer). As for the 
samples in medium at pH 6.8, overall good results were achieved using both buffers (Fig. 
6.16). Noticeably high variation in recoveries (up to 29 % RSD) was observed for 0.1 M 
NH4HCO3 pH 8.5. Using 0.5 M NH4HCO3 pH 10, recoveries in the range from 93 to 105 % for 
the main ergot alkaloids and their corresponding epimers were obtained with good 
precision. 
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (%) =  𝑅𝑅𝑅𝑅𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑅𝑅 250 𝐴𝐴𝐴𝐴𝑝𝑝 𝐴𝐴𝐴𝐴𝑡𝑡𝐴𝐴𝐴𝐴 𝐴𝐴𝐴𝐴 𝑝𝑝𝑏𝑏𝑏𝑏𝑏𝑏𝑅𝑅𝐴𝐴 𝐴𝐴𝑝𝑝 3.0 − 𝑝𝑝𝑎𝑎 − 𝑅𝑅𝑅𝑅𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑅𝑅 𝐴𝐴𝐴𝐴𝑡𝑡𝐴𝐴𝐴𝐴 𝐴𝐴𝐴𝐴 𝐴𝐴𝑏𝑏𝐴𝐴𝑅𝑅𝐴𝐴𝐴𝐴𝑎𝑎𝐴𝐴𝑎𝑎𝐴𝐴𝐴𝐴 ′𝑎𝑎𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴′ − 𝑝𝑝𝑎𝑎
𝑅𝑅𝑅𝑅𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑅𝑅 250 𝐴𝐴𝐴𝐴𝑝𝑝 𝐴𝐴𝐴𝐴𝑡𝑡𝐴𝐴𝐴𝐴 𝐴𝐴𝐴𝐴 𝑝𝑝𝑏𝑏𝑏𝑏𝑏𝑏𝑅𝑅𝐴𝐴 𝐴𝐴𝑝𝑝 3.0 − 𝑝𝑝
𝑎𝑎
× 100 
𝐷𝐷𝑅𝑅𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (%) = 𝑅𝑅𝑅𝑅𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑅𝑅 𝐴𝐴𝐴𝐴𝑡𝑡𝐴𝐴𝐴𝐴 𝐴𝐴𝐴𝐴 𝐴𝐴𝑏𝑏𝐴𝐴𝑅𝑅𝐴𝐴𝐴𝐴𝑎𝑎𝐴𝐴𝑎𝑎𝐴𝐴𝐴𝐴 ′𝐴𝐴𝑅𝑅𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴′ − 𝑝𝑝𝑎𝑎
𝑅𝑅𝑅𝑅𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑅𝑅 250 𝐴𝐴𝐴𝐴𝑝𝑝 𝐴𝐴𝐴𝐴𝑡𝑡𝐴𝐴𝐴𝐴 𝐴𝐴𝐴𝐴 𝑝𝑝𝑏𝑏𝑏𝑏𝑏𝑏𝑅𝑅𝐴𝐴 𝐴𝐴𝑝𝑝 6.8 − 𝑝𝑝
𝑎𝑎
× 100 
𝐸𝐸𝑏𝑏𝑏𝑏𝐴𝐴𝐸𝐸𝑎𝑎𝐸𝐸𝐸𝐸 (%) = 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (%) − 𝐷𝐷𝑅𝑅𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (%) 
𝑤𝑤ℎ𝑅𝑅𝐴𝐴𝑅𝑅 𝑴𝑴 𝐴𝐴𝐴𝐴 𝐴𝐴ℎ𝑅𝑅 𝐴𝐴𝑠𝑠𝐴𝐴𝐴𝐴𝑅𝑅 𝑎𝑎𝐴𝐴𝐴𝐴 𝒃𝒃 𝐴𝐴𝐴𝐴 𝐴𝐴ℎ𝑅𝑅 𝐴𝐴𝐴𝐴𝐴𝐴𝑅𝑅𝐴𝐴𝐸𝐸𝑅𝑅𝐴𝐴𝐴𝐴 𝐴𝐴𝑏𝑏 𝐴𝐴ℎ𝑅𝑅 𝑅𝑅𝑒𝑒𝑏𝑏𝑎𝑎𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝐴𝐴𝑏𝑏 𝐴𝐴ℎ𝑅𝑅 𝐴𝐴𝑅𝑅𝐴𝐴𝐴𝐴𝑅𝑅𝐸𝐸𝐴𝐴𝐴𝐴𝑟𝑟𝑅𝑅 𝑠𝑠𝐴𝐴𝐴𝐴𝑅𝑅𝑎𝑎𝐴𝐴 𝐴𝐴𝐴𝐴𝑅𝑅𝐴𝐴𝐴𝐴 𝑠𝑠𝐴𝐴𝐴𝐴𝑅𝑅𝐴𝐴 𝑎𝑎𝐴𝐴 𝐴𝐴𝑝𝑝 3.0 𝑎𝑎𝐴𝐴𝐴𝐴 𝐴𝐴𝑝𝑝 6.8. 
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Figure 6.15. Optimization of extraction buffer for main ergot alkaloids (a) and their 
corresponding epimers (b) in aqueous medium at pH 3.0. 
 
 
 
Figure 6.16. Optimization of extraction buffer for main ergot alkaloids (a) and their 
corresponding epimers (b) in aqueous medium at pH 6.8. 
(b) 
(a) 
(a) 
(b) 
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Finally, 0.5 M NH4HCO3 pH 10 was chosen for pH adjustment prior to liquid-liquid extraction 
of the ergot alkaloids from both sample types (pH 3.0 and pH 6.8). 
 
6.4.3.2. Method validation 
The developed LC-MS/MS method for the binding efficacy study proved to be sensitive; LOD 
values for both media were overall below 0.5 µg/L, whereas LOQ values ranged from 0.19 to 
1.45 µg/L (Tables 6.16 and 6.17). 
 
Table 6.16. Validation data for the medium at pH 3.0. 
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Table 6.17. Validation data for the medium at pH 6.8. 
 
 
Linearity of the method over a concentration range of 1-200 µg/L was supported by high 
coefficients of determination (R2) which were between 0.953 (ergocristinine) and 0.999 
(ergometrine) (Tables 6.16 and 6.17). A good fit of the data with a linear model was 
confirmed by p-values for the lack of fit test above 0.05. Additionally, residual plots 
demonstrated no systematic trend as the residuals were randomly distributed around zero. 
The standard errors (Syx) were all below 1.5 % of the estimate as calculated by expressing Syx 
as a percentage of y at the different concentration levels of the analyte. 
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Apparent recoveries of the investigated ergot alkaloids in the medium at pH 3.0 and 6.8 
were tested at three concentration levels and were in the range 94-123 % and 91-114 %, 
respectively (Tables 6.16 and 6.17). 
Precision of the method expressed as RSD was determined at three concentration levels. 
Repeatability did not exceed 23 % (ergocorninine) at low concentration level and was overall 
below 4 % at 200 µg/L (Tables 6.16 and 6.17). Within-laboratory reproducibility ranged from 
0.3 % (ergometrinine) to 22 % (ergocorninine). Generally, the corresponding values of 
repeatability and within-laboratory reproducibility were similar for both media used in the 
study. 
Expanded measurement uncertainties for each of the ergot alkaloids are presented in Tables 
6.16 and 6.17. At lowest concentration level, the uncertainty did not exceed 47 %, whereas it 
was below 10 % at the highest level. 
Matrix effects were also investigated for the two sample types – buffered solution pH 3.0 
and pH 6.8 (Fig. 6.17). For most of the ergot alkaloids, the influence of matrix components 
on the MS signal was moderate. However, substantial matrix effects were observed for 
ergometrine and ergometrinine (SSE below 60 %). Furthermore, slight differences in SSE 
values were noted between the two sample types, therefore, a matrix-matched calibration 
was applied to ensure correct quantification. 
 
Figure 6.17. Signal suppression-enhancement (SSE) data. Em: ergometrine; Emn: 
ergometrinine; Es: ergosine; Esn: ergosinine; Et: ergotamine; Etn: ergotaminine; Eco: 
ergocornine; Econ: ergocorninine; Ekr: ergokryptine; Ekrn: ergokryptinine ; Ecr: ergocristine; 
Ecrn: ergocristinine. 
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Further validation implied the investigation of method robustness. A fractional factorial 
design was used to assess the effect of small changes in the sample preparation parameter 
settings on the accuracy of the results. It was observed that for each of the investigated 
parameters (extraction buffer pH, extraction buffer concentration, shaking time and drying 
temperature), the changes in recovery were not significant (α = 0.05) when varying the 
method parameters from their low to high values (Appendix V). Therefore, the developed 
LC-MS/MS method was considered to be robust and is expected to be easily used in a 
different laboratory or operated by a different analyst.  
 
6.4.3.3. Application of the method for in vitro efficacy testing of a mycotoxin binder 
The method was applied to monitor the ergot alkaloid content in solutions from an in vitro 
model aiming at determining the efficacy of a clay-based binder towards ergot alkaloids. As 
examples, a lysergic acid derivative (ergometrine) as well as two peptide ergot alkaloids 
(ergosine and ergocornine) were included in the investigation. Data (Table 6.18) indicated a 
binding efficacy above 93 % for the peptide ergot alkaloids, while a binding efficacy of 24 % 
was observed for ergometrine. The lower binding efficacy of this lysergic acid derivative can 
be attributed to its relatively higher solubility in aqueous media. It has to be noted that no or 
negligible epimerization of the main ergot alkaloids occurred during in vitro study and LC-
MS/MS analysis.  
Table 6.18. Binding efficacy of a clay-based binder towards ergometrine, ergosine and 
ergocornine. 
Ergot alkaloid Adsorption (%) Desorption (%) Binding efficacy (%) ± SD 
Ergometrine 
69.74 66.58 
23.60 ± 22.32 80.16 59.93 
81.73 34.32 
Ergosine 
95.19 2.69 
93.28 ± 0.86 95.67 1.46 
95.18 2.07 
Ergocorninea 
97.97 1.01 
96.97 ± 0.00 97.97 1.01 
97.97 1.01 
a The responses were below the response of the lowest calibration standard.  
  Therefore, the responses were set to the same level as for that standard. 
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6.4.4. Conclusions 
Mycotoxin contamination of feed is a great concern in livestock as it can harmfully affect the 
animal whealth and in some cases lead to death. One of the ways to cope with this is the use 
of detoxifying agents which prevent digestive absorption of feed-borne mycotoxins. Before 
applying the adsorbent, it has to be evaluated for its binding efficacy. Such study 
necessitates suitable methodologies for analyte determination. Here, a validated rapid and 
sensitive LC-MS/MS method is proposed suitable for monitoring of six main ergot alkaloids 
with their corresponding epimers in buffered solutions. The method was successfully applied 
in an in vitro efficacy testing of a clay-based binder towards ergot alkaloids. 
The applied extraction procedure demonstrated good recoveries (more than 70 %) of the 
ergot alkaloids and allowed a simple and fast analysis. An alkaline bicarbonate buffer (pH 10) 
was required for sufficient extraction of the compounds. The validation report demonstrated 
that the method was sensitive, precise and robust.  
Additionally, the developed LC-MS/MS method can easily be used in in vitro evaluation 
studies of a wider range of binders for ergot alkaloids, as well as in other in vitro biomedical 
applications implying ergot alkaloid-containing buffered solutions; for instance, Franz 
diffusion cell (FDC) experiments (Boonen et al., 2012).  
Binder efficacy should also be tested in an in vivo experiment, as adsorbents in vitro might 
not necessarily demonstrate the same result when applied in a living organism due to 
influence of physiological variables. Furthermore, the binder safety has to be proven as well. 
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6.5. Holistic approach based on high resolution and multiple stage mass spectrometry to 
investigate ergot alkaloids in cereals 
6.5.1. Introduction 
The majority of ergot alkaloids are commonly comprised of ergoamides, ergopeptines (or 
ergopeptides), also called cyclol ergot alkaloids, and the lactam ergot alkaloids, also named 
ergopeptams (Bennet and Klich, 2003; Komarova and Tolkachev, 2001). The ergoamides are 
D-lysergic acid amides (Fig. 6.18a), whereas the ergopeptines are D-lysergic acid peptides 
containing lysergic acid and three amino acids in their structure (Fig. 6.18b). The 
ergopeptams are tripeptidic non-cyclol ergot alkaloids (Fig. 6.18c). Their structure is similar 
to that of ergopeptines except that L-proline is exchanged by D-proline, and the tripeptide 
chain is a non-cyclol lactam (Komarova and Tolkachev, 2001). 
To date, more than 40 ergot alkaloids are known. Several analytical techniques have been 
used to study the fragmentation of these compounds and attempts have been made to 
identify novel derivatives. In the last years, a number of new ergot alkaloids have been 
discovered (Cvak et al., 2005; Lehner et al., 2005; Lehner AF et al., 2011; Uhlig et al., 2011). 
Mohamed et al. (Mohamed et al., 2006) used triple quadrupole and multiple stage MS to 
characterize six ergot alkaloids belonging to lysergic acid and peptide-type derivatives and 
could confirm the presence of ergosine in a rye flour extract at trace levels. Lehner et al. 
(Lehner et al., 2004; Lehner AF et al., 2011) using HPLC coupled to tandem quadrupole MS 
and ion trap MS was able to establish the fragmentation patterns of eight ergot alkaloids and 
subsequently elucidate a new ergot alkaloid-related compound. Uhlig and Petersen (Uhlig 
and Petersen, 2008) obtained structural information of four ergopeptams using HPLC-ion 
trap MS.  
In the above-mentioned studies, fragment assignment was supported by 
hydrogen/deuterium exchange (Mohamed et al., 2008) and/or comparison of the 
fragmentation behaviour of known ergot alkaloids, using unit mass resolution data acquired 
by triple quadrupole and ion trap instruments. Along with fragmentation trees, accurate 
mass measurement is a highly important feature for correct structure elucidation (Kind and 
Fiehn, 2010). Orbitrap MS is becoming a more and more popular platform for identification 
purposes in natural product analysis.  
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Figure 6.18. Common structures of ergoamides (a), ergopeptines (b) and ergopeptams (c) and representative ergot alkaloids for each 
class. M: molecular weight. 
(a)
R1 R2 R3
Ergometrine (M= 325 Da) -CH3 -H -H
Methylergometrine (M=339 Da ) -CH2CH3 -H -H
Methysergide (M=352 Da ) -CH2CH3 -H -CH3
R1 R2 R3
Ergocristam (M=593 Da ) -CH(CH3)2 -CH2Ph -H
Ergocryptam (M=559 Da) -CH(CH3)2 -CH2CH(CH3)2 -H
Ergocornam (M=545 Da) -CH(CH3)2 -CH(CH3)2 -H
Ergostam (M=579 Da) -C2H5 -CH2Ph -H
Ergoptam (M=546 Da) -C2H5 -CH2CH(CH3)2 -H
Ergonam (M=531 Da) -C2H5 -CH(CH3)2 -H
Ergotamam (M=565 Da) -CH3 -CH2Ph -H
Ergosam (M=531 Da) -CH3 -CH2CH(CH3)2 -H
Ergovalam (M=517 Da) -CH3 -CH(CH3)2 -H
(c)
(b)
R1 R2 R3
Ergosine (M=547 Da) -CH3 -CH2CH(CH3)2 -H
Ergotamine (M=581 Da) -CH3 -CH2Ph -H
Ergocristine (M=609 Da) -CH(CH3)2 -CH2Ph -H
Ergokryptine (M=575 Da) -CH(CH3)2 -CH2CH(CH3)2 -H
Ergocornine (M=561 Da) -CH(CH3)2 -CH(CH3)2 -H
R1 R2 R3
Dihydroergotamine (M=583 Da) -CH3 -CH2Ph -H
Dihydroergocristine (M=611 Da) -CH(CH3)2 -CH2Ph -H
Dihydroergocryptine (M=577 Da) -CH(CH3)2 -CH2CH(CH3)2 -H
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Regarding the secondary fungal metabolites and more specifically ergot alkaloids, this type of 
MS has been utilized only in targeted analysis (Zachariasova et al., 2010) or in a pre-selected 
screening using a limited database (Lehner SM et al., 2011). The full-scan accurate mass 
capability of Orbitrap MS remains to be exploited in untargeted screening of ergot alkaloid 
derivatives.  
In this work, a method based on high resolution mass spectrometry (HRMS) and ion trap MS 
technology is proposed for the study of the fragmentation pattern of ergot alkaloids and the 
identification of less studied or novel ergot alkaloid derivatives. In particular, Orbitrap MS was 
used, which allows to achieve high mass resolution (up to 100,000 FWHM) and high mass 
accuracy (mass error < 2 ppm), thereby leading to higher sensitivity, dynamic range and 
selectivity for the analysis of complex matrices (Hu et al., 2005). The fragmentation of twelve 
ergot alkaloids, namely ergometrine, ergosine, ergotamine, ergocornine, ergokryptine, 
ergocristine, methylergometrine, methysergide, dihydroergotamine, ergocornam, ergocryptam 
and ergocristam was studied with the aim of establishing a simple strategy for identification of 
novel ergot alkaloid derivatives.  
 
6.5.2. Experimental 
6.5.2.1. Standards 
The standards of ergot alkaloids were as described in section 6.2.2.1. Methysergide (MeErgi) (as 
methysergide maleate) was purchased from Sigma-Aldrich (Bornem, Belgium).  
 
6.5.2.2. Chemicals and material 
MeOH and ACN (both of LC-MS grade) were supplied by Biosolve (Valkenswaard, the 
Netherlands). NH4HCO3 was obtained from Sigma-Aldrich. (NH4)2SO4 and NH3 (25 %) were 
supplied by Merck (Darmstadt, Germany). ACN and MeOH  (both of HPLC grade), and n-hexane 
were purchased from VWR International (Zaventem, Belgium). EtOAc was obtained from Acros 
Organics (Geel, Belgium). 
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A Milli-Q purification system (Millipore, Brussels, Belgium) was used to purify demineralized 
H2O. Ultrafree®-MC centrifugal filter units (0.22 µm) were purchased from Millipore 
(Darmstadt, Germany). 
 
6.5.2.3. Sample preparation  
Sample preparation procedure was as described in section 6.2.2.4.1.  
 
6.5.2.4. HPLC-MS/MS analysis 
The HPLC-MS/MS analysis was performed as described in section 6.2.2.7.  
The gradient elution was as follows: 0-30 min: 55 % B; 30-35 min: 55-65 % B; 35-90 min: 65 % B; 
90-100 min: 65-55 % B; 100-120 min: 55 % B. 
ESI+ mode was used throughout the work as it provided higher MS signal for ergot alkaloids (see 
section 6.2). 
 
6.5.2.5. HPLC-MSn analysis 
LC analyses were performed on a Surveyor Plus HPLC System (Thermo Fisher Scientific, San Jose, 
CA, USA). The column was XBridge MS C18 column (3.5 µm, 150 x 2.1 mm) with an XBridge 
Sentry guard column (3.5 µm, 10 x 2.1 mm i.d.) both supplied by Waters (Milford, MA, USA). The 
mobile phases were as described in section 6.2.2.7. Flow rate was 0.25 mL/min. The gradient 
elution profile was as follows: 0-10 min: 10-35 % B; 10-30 min: 35 % B; 30-45 min: 35-60 % B; 
45-50 min: 60-99 % B; 50-55 min: 99 % B; 55-57 min: 99-10 % B; 57-65 min: 10 % B. The 
temperature of the column was 40 °C and the injection volume was 5 µL. 
Mass spectra were acquired using an LTQ linear ion trap mass spectrometer (Thermo Fisher 
Scientific) equipped with an ESI source. The mass spectrometer was operated in the ESI+ mode. 
The MS parameters were as follows: spray needle voltage 5 kV, capillary voltage 17 V, capillary 
temperature 200 °C, nitrogen sheath gas flow 35 a.u., auxiliary gas flow 10 a.u. When 
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performing MSn experiments, the precursor ion was isolated in the ion trap with an isolation 
width of 3 Da and activated at different CELs to find the optimal conditions for distinct 
fragmentation. XcaliburTM 2.0.7 software (Thermo Fisher Scientific) was used for instrument 
control, data acquisition and processing. 
 
6.5.2.6. UHPLC-HRMS analysis 
LC analyses were performed on a Thermo Accela UHPLC system (Thermo Fisher Scientific). The 
mobile phases were as described in section 6.5.2.5. The column used was ZORBAX RRHD Eclipse 
Plus C18 (1.8 µm, 2.1 x 100 mm) from Agilent Technologies (Diegem, Belgium). The gradient 
elution program was set as follows: 0-1 min: 0 % B; 1-5 min: 0-25 % B; 5-15 min: 25-35 % B; 15-
25 min: 35-40 % B; 25-40 min: 40-70 % B; 40-47 min: 70-98 % B; 47-50 min: 98 % B; 50-51 min: 
98-0 % B; 51-55 min: 0 % B. The mobile phase flow rate was 0.4 mL/min and the injection 
volume was 5 μL. 
Accurate mass measurements of the precursor and product ions were carried out on an 
Orbitrap ExactiveTM mass analyzer (Thermo Fisher Scientific) equipped with an ESI interface. The 
mass spectrometer was operated in the ESI+ mode. The MS parameters were the following: 
spray voltage 4.5 kV, capillary temperature 250 °C, heater temperature 250 °C, sheath gas flow 
rate 45 a.u., auxiliary gas flow rate 10 a.u. The data were processed using XcaliburTM 2.1 
(Thermo Fisher Scientific). The instrument was operated in full scan mode with a resolution of 
100,000 FWHM. The maximum injection time was 200 ms and the number of microscans per 
scan was 1. Each full scan was followed by a same-polarity “all ion fragmentation” higher energy 
collisional dissociation scan.  
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6.5.3. Results and discussion 
6.5.3.1. Fragmentation pattern of ergot alkaloids 
6.5.3.1.1. Ergopeptine and ergoamide alkaloids 
The ergopeptines and ergoamides are structurally related compounds that share a common 
skeleton (see Fig. 6.18). This characteristic was exploited to establish a strategy for the 
screening and identification of unknown ergot alkaloid derivatives. This was achieved through a 
careful study of the fragmentation pattern of known derivatives, including six ergopeptines 
(ergosine, ergotamine, ergocornine, ergokryptine, ergocristine and dihydroergotamine) and 
three ergoamides (ergometrine, methylegometrine and methysergide).  
MSn fragmentation data of the ergopeptine alkaloids are summarized in Table 6.19. It was 
observed that all the studied ergopeptines initially underwent a loss of a water molecule (-18 
Da). Subsequently, in MS3 and MS4 experiments, neutral losses of 28 and 18 Da (corresponding 
to CO and H2O) were observed. In further MS5 experiments, losses of 91 Da (ergocristine, 
ergotamine and dihydroergotamine), 56 Da for ergosine and ergokryptine; 42 Da for 
ergocornine) occurred (Fig. 6.19). Taking into consideration the structural differences between 
the ergopeptines studied and the accurate mass data, these losses of 91, 56 and 42 Da were 
attributed to the radical R2. The observed losses are consistent with a homolytic cleavage of the 
implied C-C bond. This would represent a violation of the even-electron fragmentation rule, 
however such a phenomenon has previously been described (Mohamed et al., 2006). While the 
loss of 91 Da (ergocristine, ergotamine and dihydroergotamine) could be inferred from the 
homolytic cleavage in a straightforward fashion, the fragmentation mechanism for ergosine, 
ergokryptine and ergocornine implied the transfer of one hydrogen atom to the leaving 
fragment, leading to the formation of a double bond in the lost entity (Fig. 6.20).  
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Table 6.19.  MSn fragmentation data for ergotamine (Et), ergocornine (Eco), ergocristine (Ecr), ergokryptine (Ekr), ergosine (Es) and 
dihydroergotamine (DHEt).  
 
Es Ekr Ecr Eco Et DHEt Fragment assignmenta 
548 576 610 562 582 584 [M+H]+ 
530 558 592 544 564 566 [M+H]+- H2O 
502 530 564 516 536 538 [M+H]+- H2O - CO 
484 512 546 498 518 520 [M+H]+- H2O - CO - H2O 
428 456 455 466 427 429 [M+H]- H2O - CO - H2O - R2 
320 348 348 348 320 322 Cleavage within and loss of most of peptide ring system  [M+H]+ - C7H11N2O3-R2 
292 320 320 320 292 294 Loss of CO from 320, 348 or 322        [M+H]+ - C7H11N2O3 - R2 - CO 
277 305 305 305 277  Cleavage within the lysergic D ring system 
268 270 Loss of R1 from 292, 320 or 294 
251 253 Loss of NH3 from 268 or 270 
223 225 Loss of CO from 251 or 253 
208 210 Loss of -CH3 from 223 or 225 
208  Cleavage within the lysergic D ring and loss of R1-C(CO)-NH 
197 197 Cleavage within and loss of D ring from 251 or 253 
194  Cleavage within the lysergic D ring and loss of N-CH3 from 223 
182  182 Cleavage within lysergic D ring and loss of –CH-N-CH3 from 223 
182 182 Loss of -CH3 from 197 
180  Cleavage within lysergic D ring and loss of N-CH2- from 208 or 210 
aR1 and R2 are as defined in Fig. 6.18  
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Figure 6.19. Fourth-generation CID spectra acquired for ergotamine (a), ergokryptine (b) and 
ergocornine (c) demonstrating the loss of the R2 substituent from the main skeleton.                   
R2: -CH2Ph (for ergotamine), -CH2CH(CH3)2 (for ergokryptine) and -CH(CH3)2 (for ergocornine). 
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          (a) 
 
           (b) 
 
 
Figure 6.20. Proposed fragmentation mechanism for the loss of R2 substituent from the main 
skeleton of ergosine and ergokryptine (a), and ergocornine (b). 
 
Besides the loss of R2 radical, the ergopeptines underwent, subsequent to the losses of H2O 
and, CO and H2O, a loss of most of the peptide ring system (Fig. 6.21). For ergokryptine, 
ergocristine and ergocornine (where R1 is an isopropyl radical), an ion with a m/z of 348.1698 Da 
was obtained, corresponding to C21H22N3O2 (mass error: -2.4 ppm). The ergopeptines having a 
methyl group at R1 position (i.e. ergotamine, ergosine) produced a fragment with m/z 320.1388 
Da (C19H18N3O2; -1.7 ppm). Dihydroergotamine (an ergotamine-derivative having a saturated 
C9-C10 bond) rather produced an ion at m/z 322.1549 assigned as C19H20N3O2 (-0.5 ppm). The 
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resulting fragments further underwent a loss of CO (- 28 Da), yielding m/z 320.1750 (C20H22N3O, 
-2.2 ppm) and m/z 292.1439 (C18H18N3O, -1.8 ppm) for the derivatives with an isopropyl and 
methyl R1 radicals, respectively (Fig. 6.22). A fragment at m/z 294.1597 (assigned as C18H20N3O; 
-0.4 ppm) was obtained for dihydroergotamine. Subsequent loss of the R1-C-NH moiety gave an 
ion at m/z 251.1175 corresponding to C16H15N2O (-1.5 ppm) for all ergopeptines, except for 
dihydroergotamine, for which the corresponding ion at m/z 253.1332 (C16H17N2O; -0.3 ppm) 
was obtained. Fragmentation of the ion at m/z 251 yielded, among others, an ion at m/z 
223.1227 (C15H15N2; -1.4 ppm) through the loss of CO (- 28 Da). The corresponding ion for the 
dihydro-derivatives (m/z 253) yielded a fragment at m/z 225.1384 (C15H17N2; -0.2 ppm). The 
product ion at m/z 223 (m/z 225 for dihydroergotamine) proved to be the most abundant 
common fragment of the different ergopeptines. The product ion spectrum (Fig. 6.22) of this 
common ion indicated that subsequently, a homolytic cleavage of the N–CH3 bond in the D ring 
took place, giving rise to the radical cation at m/z 208.0993 (C14H12N2; -0.8 ppm) for the 
ergopeptines and m/z 210.1151 (C14H14N2; -0.1 ppm) for the dihydroergopeptines, as also 
reported by Mohamed et al. (Mohamed et al., 2006). 
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Figure 6.21. Second-generation CID spectra acquired for ergokryptine (a) and ergotamine (b) 
demonstrating loss of most of the peptide ring system (shown in red).  
The resulting fragments, i.e. m/z 348 (ergokryptine) and m/z 320 (ergotamine) underwent a loss of CO (-
28 Da) followed by the loss of the R1-C-NH moiety (69 Da for ergokryptine and 41 Da for ergotamine), 
yielding a common ion at m/z 251. 
 
 
        
150 200 250 300 350 400 450 500 550
m/z
0
10
20
30
40
50
60
70
80
90
100
R
el
at
iv
e 
A
bu
nd
an
ce
348
305
291
268
223 540
277261 530209181 251 320 350 402 514164 338 445 541461 497366 415
(b)
- 28 Da
(a)
 
        
200 250 300 350 400 450 500 550
m/z
0
10
20
30
40
50
60
70
80
90
100
R
el
at
iv
e 
A
bu
nd
an
ce
277
297
268223
320
221
546536249207191
251233 292180 322167 518298 475436 503338 547459389 417380
T: ITMS + c ESI Full m3 576.00@cid60.00 558.00@cid60.00
T: ITMS + c ESI Full m3 582.00@cid60.00 564.00@cid60.00
- 69 Da
- 28 Da
-28 Da- 41 Da
- 28 Da
- 244 Da
- 210 Da
 
272 
 Chapter 6 
 
Figure 6.22. Third-generation CID spectrum acquired for ergosine shown as an example of the 
fragmentation pattern of the common ion at m/z 223. This product ion at m/z 223 was isolated 
and collisionally activated at 60 % CEL. 
 
It was observed that the ions at m/z of 348 (ergokryptine, ergocristine) and m/z 320 
(ergocornine, ergotamine and ergosine), described above, followed an alternative 
fragmentation pathway. A fragment at m/z 305.1280 (C19H17N2O2; -0.4 ppm) or m/z 277.0969 
(C17H13N2O2; -0.2 ppm) was obtained by cleavage within the lysergic D ring system for 
derivatives with isopropyl R1 radical (ergokryptine, ergocristine) or methyl R1 radical 
(ergocornine, ergotamine, ergosine), respectively. A subsequent loss of CO (- 28 Da) gave m/z 
277.1332 (ergokryptine, ergocristine) and m/z 249.1020 (ergocornine, ergotamine, ergosine) 
(assigned as C18H17N2O; -0.3 ppm and C16H13NO; -0.3 ppm, respectively). A loss of the R1-C(CO)-
NH moiety from these fragments yielded a common ion at m/z 208.0756 (C14H10NO; -0.1 ppm).  
Loss of the lysergic ring-CONH2 moiety from protonated molecule was also observed. The 
resulting fragment (Fig. 6.23) subsequently lost a CO moiety or the radical R2. Interestingly, the 
fragment obtained upon loss of R2 confirmed the homolytic cleavage fragmentation mechanism 
 
273 
Ergot alkaloids in cereals  
described above for ergokryptine, ergosine and ergocornine, i.e., the transfer of one hydrogen 
atom to the leaving fragment (Fig. 6.20). 
 
 
 
Figure 6.23. Fragmentation mechanism of ergopeptines showing the loss of the lysergic acid 
moiety.  
 
Measured m/z Formula Error (ppm)
Ecr 325.1552 C19H21N2O3+ 1.7
Ekr 291.1697 C16H23N2O3+ -2.1
Es 263.1396 C14H19N2O3+ 2.1
Eco 277.1541 C15H21N2O3+ - 2.1
Et, DHEt 297.1228 C17H17N2O3+ - 0.5
Measured m/z Formula Error (ppm)
Ecr 297.1603 C18H21N2O2+ 1.8
Ekr 263.1752 C15H23N2O2+ - 0.9
Es 235.1447 C13H19N2O2+ 2.3
Eco 249.1603 C14H21N2O2+ 2.2
Et, DHEt 269.1282 C16H17N2O2+ -1.0
Measured m/z Formula Error (ppm)
Ecr 234.1004 C12H14N2O3+
. 2.3
Et, DHEt 206.0691 C10H10N2O3+
. 2.7
Measured m/z Formula Error (ppm)
Ekr, Eco 235.1082 C12H15N2O3+ 2.3
Et, DHEt 207.0770 C10H11N2O3+ 2.6
- R2
- CO
R1 R2 R3 Formula [M+H]+
Ekr -CH(CH3)2 CH2CH(CH3)2 -H C32H42N5O5+ 576
Ecr -CH(CH3)2 -CH2Ph -H C35H40N5O5+ 610
Eco -CH(CH3)2 -CH(CH3)2 -H C31H40N5O5+ 562
Et -CH3 -CH2Ph -H C33H40N5O5+ 582
Es -CH3 CH2CH(CH3)2 -H C30H38N5O5+ 548
R1 R2 R3 Formula [M+H]+
DHEt -CH3 -CH2Ph -H C33H42N5O5+ 584
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MSn fragmentation data of the ergoamide alkaloids are summarized in Table 6.20. A 
fragmentation pattern similar to that of ergopeptines was observed for this group of ergot 
alkaloids. Initially, all the studied ergoamides lost a water molecule or –CH3 by homolytic 
cleavage. The fragment at m/z 251 (m/z 265 for MeErgi) was obtained through a loss of R1-
CH(CH2OH)-NH2 from a protonated ion [M+H]+, and followed a common pathway with the 
ergopeptines (Fig. 6.24). The ergoamides also underwent a cleavage within the lysergic D ring as 
shown in Fig. 6.25. 
 
Table 6.20. MSn fragmentation data for ergometrine (Em), methylergometrine (MeEm) and 
methysergide (MeErgi). 
 
Em MeEm MeErgi Fragment assignmenta 
326 340 354 [M+H]+ 
311 325 339 [M+H]+- CH3 
308 322 336 [M+H]+- H2O 
283 297 311 Cleavage within the lysergic D ring and loss of C2H5N 
265 279 293 Loss of H2O from 283, 297 or 311 
251 265 Loss of R1-CH(CH2OH)-NH-R
2 from [M+H]+ 
223 237 Loss of CO from 251 or 265 
208 222 Loss of -CH3 from 223 or 237 
197 211 Cleavage within the lysergic D ring from 251 or 265 
194 208 Cleavage within the lysergic D ring and loss of N-CH3 from 223 or 237 
182 196 Cleavage within the lysergic D ring and loss of –CH-N-CH3 from 223 or 237 
182 196 Loss of -CH3 from 197 or 211 
180 194 Cleavage within the lysergic D ring and loss of N-CH2- from 208 or 222 
aR1 and R2 are as defined in Fig. 6.18  
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Figure 6.24. Proposed common fragmentation pathway of ergopeptines and ergoamides. 
Ekr, Ecr, Eco
Measured m/z: 348.1698
Formula: C21H22N3O2+
Error: - 2.4 ppm
Et, Es
Measured m/z: 320.1388
Formula: C19H18N3O2+
Error: - 1.7 ppm
Ekr, Ecr, Eco
Measured m/z: 320.1750
Formula: C20H22N3O+
Error: -2.2 ppm
Et, Es
Measured m/z: 292.1439
Formula: C18H18N3O+
Error: - 1.8 ppm
Ekr, Ecr, Eco, Et, Es, 
Em, MeEm
Measured m/z:208.0993
Formula: C14H12N2+
.
Error : -0.8 ppm
MeErgi
Measured m/z: 222.1153
Formula: C15H14N2+
.
Error: 0.2 ppm
Ekr, Ecr, Eco, Et, Es, 
Em, MeEm
Measured m/z: 180.0806
Formula: C13H10N
Error: - 1.3 ppm
MeErgi
Measured m/z: 194.0965
Formula: C14H12N
Error: 0.03 ppm
R1 R2 R3 Formula [M+H]+
Em -CH2CH3 -H -H C19H25N3O2+ 326
MeEm -CH3 -H -H C20H27N3O2+ 340
MeErgi -CH2CH3 -H -CH3 C21H29N3O2+ 353
R1 R2 R3 Formula [M+H]+
Ekr -CH(CH3)2 CH2CH(CH3)2 -H C32H42N5O5+ 576
Ecr -CH(CH3)2 -CH2Ph -H C35H40N5O5+ 610
Eco -CH(CH3)2 -CH(CH3)2 -H C31H40N5O5+ 562
Et -CH3 -CH2Ph -H C33H40N5O5+ 582
Es -CH3 CH2CH(CH3)2 -H C30H38N5O5+ 548
Ekr, Ecr, Eco, Et, Es, 
Em, MeEm
Measured m/z: 251.1175
Formula: C16H15N2O+
Error : - 1.5 ppm
MeErgi
Measured m/z: 265.1334
Formula: C17H17N2O+
Error: - 0.1 ppm
Ekr, Ecr, Eco, Et, Es, 
Em, MeEm
Measured m/z: 223.1227
Formula: C15H15N2+
Error: - 1.4 ppm
MeErgi
Measured m/z: 237.1385
Formula: C16H17N2+
Error: - 0.1 ppm
Ekr, Ecr, Eco, Et, Es, 
Em, MeEm
Measured m/z: 197.1071
Formula: C13H13N2+
Error: - 1.1 ppm
MeErgi
Measured m/z: 211.1229
Formula: C14H15N2+
Error: - 0.04 ppm
Ekr, Ecr, Eco, Et, Es, 
Em, MeEm
Measured m/z: 182.0961
Formula: C13H12N+
Error: - 0.3 ppm
MeErgi
Measured m/z: 196.1121
Formula: C14H14N+
Error: 0.03 ppm
Ekr, Ecr, Eco, Et, Es, 
Em, MeEm
Measured m/z: 182.0837
Formula: C12H10N2+
.
Error: - 0.1 ppm
MeErgi
Measured m/z: 196.0995
Formula: C13H12N2+
.
Error: -0.01 ppm
Ekr, Ecr, Eco
Measured m/z: 305.1280
Formula: C19H17N2O2+
Error: - 0.4 ppm
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Figure 6.25. Fragmentation mechanism of ergoamides showing cleavage within the lysergic D 
ring.  
 
6.5.3.1.2. Ergopeptam alkaloids 
Reference standards for the ergopeptams were not available during the course of this work. The 
study of their fragmentation pattern was achieved using a sample that was presumed to  
contain these ergot alkaloids based on the levels and pattern of ergot alkaloids for which 
commercial standards were available. Using accurate mass measurements and fragmentation 
data, three known ergopeptams (Komarova et al., 2002; Olsovska et al., 2008; Uhlig and 
Petersen, 2008), namely ergocornam (C31H40N5O4, m/z 546.3072; -0.5 ppm), ergocryptam 
(C32H42N5O4, m/z 560.3234; 0.5 ppm) and ergocristam (C35H40N5O4, m/z 594.3078; 0.5 ppm) 
were detected in this sample. The fragmentation of these compounds is summarized in Table 
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elimination of a water molecule) observed for ergopeptines did not occur for the ergopeptam 
derivatives. The studied compounds underwent a loss of the dipeptide ring system in MS2 
experiments of the protonated ions, resulting in a common and abundant fragment at m/z 350 
(Fig. 6.26). This ion at m/z 350 was attributed to the fragment depicted in Fig. 6.27, where the 
radical R1, in accordance with the structure of the studied compounds, is –CH(CH3)2. A loss of 
CO from this fragment yielded an ion at m/z 322. A subsequent fragmentation yielded the ion at 
m/z 251, identical to that obtained for ergopeptines (Fig. 6.24), as revealed by the further 
fragmentation. Based on the above-mentioned data, a fragmentation pathway of the 
ergopeptams was proposed (Fig. 6.27).   
 
Table 6.21. MSn fragmentation data for ergopeptam alkaloids. 
Ergocornam Ergocryptam  Ergocristam Fragment assignmenta 
546 560 594 [M+H]+ 
350 Loss of the dipeptide ring system 
322 Loss of CO from 350 
307 Cleavage within the lysergic D ring system 
279 Cleavage within the lysergic D ring and loss of CO 
251 Loss of NH-CH-R1 from 322 
223 Loss of CO from 251 
208 Loss of -CH3 from 223 
208 Cleavage within the lysergic D ring and loss of R1-C(CO)-NH 
197 Cleavage within and loss of D ring from 251 
194 Cleavage within the lysergic D ring and loss of N-CH3 from 223 
182 Cleavage within the lysergic D ring and loss of -CH-N-CH3 from 223 
182 Loss of -CH3 from 197 
180 Cleavage within the lysergic D ring and loss of N-CH2- from 208 
aR1 is as defined in Fig. 6.18  
 
  
 
278 
 Chapter 6 
 
Figure 6.26. First-generation CID spectra acquired for ergocryptam (a), ergocornam (b) and 
ergocristam (c). 
 
       
150 200 250 300 350 400 450 500 550
m/z
0
10
20
30
40
50
60
70
80
90
100
R
el
at
iv
e 
A
bu
nd
an
ce
350
322
307
208 223 279
251 574207 477 535191 551447382280 364339 517507413 578168
 
       
150 200 250 300 350 400 450 500
m/z
0
10
20
30
40
50
60
70
80
90
100
R
el
at
iv
e 
A
bu
nd
an
ce
350
322
307
279223208
251197 503 528182 348237 454351266 291 486414396385 436 545
T: ITMS + c ESI Full ms2 594.00@cid60.00
(c)
T: ITMS + c ESI Full ms2 546.00@cid60.00
- 196 Da
(b)
- 244 Da
-28 Da-71 Da
- 28 Da
- 71 Da
- 28 Da
- 28 Da
- 15 Da
- 15 Da
- 71 Da
-28 Da-71 Da
- 28 Da
(a)
T: ITMS + c ESI Full ms2 560.00@cid60.00
- 210 Da- 28 Da
- 71 Da
-28 Da-71 Da
- 15 Da
- 28 Da
 
279 
Ergot alkaloids in cereals  
 
 
 
Figure 6.27. Proposed fragmentation pathway of ergopeptam ergot alkaloids. The fragment at m/z 223 was identical to that shown 
in Fig. 6.24, thereby following the same pathway. 
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6.5.3.2. Strategy for identification of novel ergopeptams and/or ergopeptines  
A strategy for the identification of novel or less studied ergot alkaloids was proposed (Fig. 6.28).  
Based on fragmentation pathways described in section 6.5.3.1, the ions at m/z 223 and m/z 251 
were found to be common for all the ergopeptines, ergoamides and ergopeptams, while for the 
dihydroergopeptines, ions m/z 225 and m/z 253 were characteristic. Therefore, it was proposed 
that monitoring of these ions can be used as the first step in screening of ergot alkaloids. 
Initially, the samples with possible ergot alkaloid derivatives were analysed using HRMS in MS2 
mode to screen for the fragment at m/z 223.1230 (C15H15N2) or m/z 225.1386 (C15H17N2). 
Eventually, this screening can be performed by applying a parent scan of the ions at m/z 223 
and m/z 225. The fragmentation of the possible ergot alkaloid derivatives is further studied by 
LC-MSn. Compound identification is performed according to the scheme indicated in Fig. 6.27, 
and is supported by accurate mass data.  
If the ions at m/z 223 or m/z 225 were observed in the spectrum, the next step is to check 
whether the molecule of interest looses water upon fragmentation of the protonated ion. 
Formation of dehydrate will indicate that the studied compound refers to ergopeptines or 
ergoamides. Noteworthy, if the cations at m/z 223 or m/z 225 were formed in HRMS analysis, 
but the loss of H2O from the protonated ion did not occur, the compound can be a possible 
ergopeptam.  
Assignment of R1 and R2 radicals can be performed following the steps shown in Fig. 6.28. As 
described in section 6.5.3.1, losses of 28 Da and 18 Da were characteristic features for 
ergopeptines during MS3 and MS4 fragmentation, respectively. Therefore, from the 
fragmentation spectrum of the ion corresponding to ([M+H]+-64), the radical R2 can be deduced 
(Fig. 6.28, step 1). Subsequently, R1 can be determined (see step 2 in Fig. 6.28), based on its 
mass calculated using Equation 6.6.  
 
R1 = [M+H]+- 448 - R2         (Eq. 6.6) 
where 448 corresponds to the ergopeptine structure without radicals 
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For ergopeptams, the ion with the greatest m/z value (Mg), originating from MS2 of the 
protonated ion, should be further fragmented. At this stage, a loss of 28 Da should be noted. 
Considering that the fragment at m/z 251 is obtained from consecutive losses of a 28 Da-
moiety, R1 and another 28 Da-moiety from the greatest fragment, R1 can be calculated as 
follows (Equation 6.7): 
 
R1 = Mg - 307        (Eq. 6.7) 
where Mg is the greatest fragment 
 
R2 is in turn calculated according to Equation 6.8. 
 
R2 = [M+H]+- Mg - 153        (Eq. 6.8) 
where 153 corresponds to the ergopeptam dipeptide ring withour R2 
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Figure 6.28. Proposed strategy for identification of novel ergopeptines and ergopeptams. 
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6.5.3.3. Screening and identification of ergot alkaloid derivatives in grain samples  
The fragmentation study of ergot alkaloids standards showed that the ion at m/z 223 was 
common for all the ergopeptines, ergoamides and ergopeptams. This observation has been 
previously described (Lehner et al., 2004; Mohamed et al., 2006). Therefore, detection of MS 
signal in m/z 223-parent scan experiments can point to possible occurrence of ergot 
alkaloids in a sample. The proposed identification strategy was applied for the screening of 
ergot alkaloid derivatives in grain samples. Parent scan monitoring of the m/z 223 ion 
revealed the presence of possible ergot alkaloid derivatives in several feed samples. Among 
19 analyzed samples, four were free of ergot alkaloids. Ergometrine, ergosine, ergotamine, 
ergocornine, eegokryptine, ergocristine and their corresponding -inine epimers were 
identified in the samples by comparison with reference standards. Other presumed ergot 
alkaloid derivatives could not be identified at this stage. These unknowns were studied by 
fitting their mass spectral data into the proposed fragmentation pathway (described in 
section 6.5.3.1). Firstly, the authenticity of the ion at m/z 223 was checked through accurate 
mass measurement. Then, the ion trap fragmentation study was carried out for each 
unknown ergot alkaloid derivative. The obtained information was coupled with the exact 
mass data obtained with Orbitrap instrument.  
A TIC of a rye feed sample (sample 1) is given as example (Fig. 6.29). Besides the known 
ergot alkaloids, ten putative ergot alkaloid derivatives were detected in this sample. Among 
these unknown derivatives, four (Unks 1, 3, 4 and 5) followed the same fragmentation 
pathway as observed for the ergopeptams, while the others, Unks 2, 6, 7, 8, 9 and 10, 
showed similarity with the fragmentation pathway of ergopeptines. Eventually, these 
compounds were identified as described in Table 6.22. These compounds, namely 
ergocornam, ergovaline, ergocryptam, ergocristam, ergostine, ergoptine and ergogaline, 
have been previously reported in grain and grass samples (Cvak et al., 1994; Lehner et al., 
2005; Uhlig and Petersen, 2008). Overview of ergot alkaloid derivatives identified in other 
grain samples is presented in Table 6.22. 
Among the identified ergot alkaloids, some were accompanied by their respective epimers. 
Epimerization, with respect to the centre of symmetry at C8, is a characteristic feature of 
ergot alkaloids that have a double bond between C9 and C10, resulting in rotating (C8-(S) 
configuration) isomers (Komarova and Tolkachev, 2001; Krska and Crews, 2008). Since both 
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forms are found together in naturally contaminated samples (Komarova and Tolkachev, 
2001), this feature was used as additional confirmation of the identification. 
 
 
 
Figure 6.29. Parent scan total ion chromatogram of a rye feed sample.  
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Table 6.22. Ergot alkaloid derivatives identified in grain samples (only positive samples are shown). 
Elemental Measured Calculated Error 
composition m/z m/z (ppm) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Ergometrine C19H24N3O2 326.1858 326.1863 -1.5 + + + + + + + + + + + + + + +
Ergometrinine C19H24N3O2 326.1857 326.1863 -1.8 + + + + + + + + + + + + + + +
Ergosine C30H38N5O5 548.2863 548.2867 -0.7 + + - + - + + + + + + + + + +
Ergosinine C30H38N5O5 548.2862 548.2867 -0.9 + + - + - + + + + + + + + + +
Ergotamine C33H36N5O5 582.2702 582.2711 -1.5 + + - + + + + + + + + + + + +
Ergotaminine C33H36N5O5 582.2702 582.2711 -1.5 + + + + + + + + + + + + + + +
Ergocornine C31H40N5O5 562.3019 562.3024 -0.9 + + - + - + + + + + + + + + +
Ergocorninine C31H40N5O5 562.3019 562.3024 -0.9 + - - + - + + + + + + + + + +
Ergokryptine C32H42N5O5 576.3174 576.3180 -1.0 + + - + - + + + + + + + - + +
Ergokryptinine C32H42N5O5 576.3175 576.3180 -0.9 + + - + - + + + + + + + - + +
Ergocristine C35H40N5O5 610.3016 610.3024 -1.3 + + - + - + + + + + + + - + +
Ergocristinine C35H40N5O5 610.3017 610.3024 -1.1 + + - + - + + + + + + + - + +
Ergocornam (= Unk 1) C31H40N5O4 546.3072 546.3075 -0.5 + - - + - + + + + + + - - - +
Ergovaline (= Unk 2) C29H36N5O5 534.2708 534.2716 -1.5 + - - + - - + + + + + - - + +
Ergocryptam (= Unk 3) C32H42N5O4 560.3233 560.3231 0.4 + - - - - - + + + + + - - - +
Ergocryptam isomer (= Unk 4) C32H42N5O4 560.3231 560.3231 0.0 + - - - - - + + + + + - - - +
Ergocristam (= Unk 5) C35H40N5O4 594.3078 594.3075 0.5 + - - + - - + + + + - - - - +
Ergostine (= Unk 6) C34H38N5O5 596.2886 596.2873 2.2 + - - - - - - - - - - - - - +
Ergoptine (= Unk 7) C31H40N5O5 562.3036 562.3029 1.2 + - - + - - + + + + + + - + +
Ergogaline (= Unk 8) C33H44N5O5 590.3331 590.3342 -1.9 + - - + - - + - + + + - - - +
Ergostinine (= Unk 9) C34H38N5O5 596.2888 596.2873 2.5 + - - - - - - - - - - - - - +
Ergokryptine isomer (= Unk 10) C32H42N5O5 576.3195 576.3186 1.6 + - - - - - + + + + + + - + +
a '+': detected; '-': not detected
Metabolite Sample
a
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6.5.4. Conclusions 
A holistic approach based on high resolution and multiple stage MS was developed for 
identification of less studied or novel ergot alkaloid derivatives. Initially, the fragmentation 
of nine known ergot alkaloids was studied to establish a strategy for the identification of 
novel ergot alkaloids. The ions at m/z 223 and m/z 251 were found to be common for all the 
ergopeptines, ergoamides and ergopeptams. Subsequently, the parent scan experiments 
using these ions were performed to screen grain samples for the presence of possible ergot 
alkaloid derivatives. Besides the six most common ergot alkaloids and their corresponding 
epimers (for which standards were available), ten other ergot alkaloid derivatives were  
identified following the proposed strategy.  
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 Conclusions and Perspectives 
Secondary fungal metabolites are an enormous group of structurally-diverse natural 
compounds. Due to their beneficial (e.g., used as drugs) and non-favourable (e.g., 
mycotoxins) impact on the society, these chemicals have been a focus of many studies. 
Considering the great number of fungi distributed world-wide and that each of them is able 
to produce several secondary metabolites, a considerable part of the work in the field of 
fungal metabolites still remains to be done.  
The current PhD dissertation represents a valuable contribution into the field of secondary 
fungal metabolites providing sensitive analytical methods for detection and quantification of 
targeted toxic metabolites in different matrices, as well as strategies for untargeted 
screening of less studied or novel compounds. Liquid chromatography - mass spectrometry 
(LC-MS) was chosen as a main tool for the secondary fungal metabolite investigation owing 
to its broad applicability, sensitivity and selectivity. Advantageous features of several mass 
analyzers, namely triple quadrupole, time-of-flight (TOF), Orbitrap and ion trap MS were 
utilized in the study aiming at collecting as complete as possible information on the analytes 
present in a given sample. The most important considerations of LC-MS analysis (e.g., 
epimerization of ergot alkaloids during sample preparation, choice of chromatographic 
conditions, ionization issues of patulin, matrix effects) were extensively studied and 
suggestions were made to overcome the problems. Among these issues, it is worth to point 
out the case of the mycotoxin patulin, which was omitted in some previously developed LC-
MS methods due to low MS signal. In this study, a significant improvement in LC-MS/MS 
analysis of this compound, i.e. a higher and more useful MS signal in positive electrospray 
ionization (ESI) compared to the commonly used negative ESI, was achieved through a 
careful optimization of the mobile phase composition, thereby making possible inclusion of 
this toxin into multi-analyte methods.  
Given the overall distribution of fungi, the analytical methods developed in the framework of 
the study are applicable to a variety of matrices. The most important exposure route to 
secondary fungal metabolites, specifically to mycotoxins, ingestion through consumption of 
contaminated food or feed, was studied in more detail. In this regard, the LC-MS/MS method 
developed for toxic metabolites of Claviceps spp., ergot alkaloids, in grain and grain products 
can be emphasized. This fast and sensitive method was applied in a comprehensive survey of 
cereal foods and feeds disclosing occurrence and pattern of ergot alkaloids in products 
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(grain, flour, bread, bran and biscuit) consumed within the European Union Member States. 
Furthermore, the method was optimized for buffered solutions. Subsequently, its 
applicability was demonstrated in an in vitro efficiency study of a clay-based binder towards 
ergot alkaloids in feed. Promising results were obtained for the model ergot alkaloids using 
this binder. To uncover ergot alkaloid derivatives, which were not caught by the targeted 
methods, an approach based on high resolution and multiple stage MS was applied. 
Eventually, identification of a number of ergot alkaloids, for which commercial standards 
were not available, was proposed. During the investigation, a fragmentation pathway of the 
different classes of ergot alkaloids as well as a simple strategy for identification of ergot 
alkaloid-related compounds were established. This information can be of a great value for 
other researchers studying ergot alkaloids.  
An LC-MS/MS method for a selected group of toxic metabolites (aflatoxin B1, T2-toxin, 
fumonisin B1, ochratoxin A, patulin, zearalenone and citrinin) was established for the fluids 
from an in vitro study of mycotoxin penetration through the human skin. Solid-phase 
extraction using polymeric sorbent was exploited for the clean-up, more specifically for 
elimination of salts, incompatible with the MS equipment, from the samples. The samples 
from the in vitro study were applied directly, without additional pre-treatment, onto the 
cartridge, which speed up the procedure. 
Keeping in mind that the inhalation route is one of the ways of mycotoxin exposure, indoor 
environment was also under consideration in this study. Initially, a workflow for 
identification of untargeted compounds (without a need of a reference standard) was 
evaluated using extracts of fungal cultures, and further applied to “real-world” samples. A 
screening of the samples collected in mouldy houses where inhabitants experienced non-
specific health problems, revealed presence of some secondary fungal metabolites. Thus, 
the obtained results enriched the existing information on fungal metabolite occurrence 
indoor, aiding in understanding the not fully-described relationship “fungi - indoor 
environment - health”. 
Besides the direct untargeted screening of metabolites (collect → extract → analyze) which 
was described above, discovery/detection of novel/less studied metabolites can also be 
performed with prior gene manipulation experiments. The scope of the work also included 
investigation of a secondary metabolism gene cluster (namely cluster 27) in Aspergillus 
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flavus using comparative metabolomics. Through inactivation of the cluster 27 pks gene and 
using high resolution MS, a number of metabolites differentially expressed in the wild-type 
and mutant strains were detected. Eventually, these metabolites were found to be only 
specific to the wild-type A. flavus, and were assigned as asparasone A (an anthraquinone 
pigment previously isolated from A. parasiticus cultures) and three novel metabolites having 
structures that are likely to derive from asparasone A. Using ion trap MS, the ESI 
fragmentation pattern of asparasone A has been elucidated for the first time. The proposed 
approach can be used straightforward, without the need of tedious isolation techniques, to 
study other gene clusters in A. flavus and in other fungi. The acquired data can help to fill the 
missing blocks in a scheme of secondary fungal metabolism. 
Although a considerable work on determination of secondary fungal metabolites has been 
done in the scope of this PhD thesis, there is still room for future research. 
First of all, the function of metabolites newly identified in the PhD study has to be 
determined. For this purpose, a response to changing environmental stimuli can be 
suggested for understanding the role of these products in the biology of the fungus. Isolation 
of the compound of interest and subsequent in vitro toxicity studies should also be carried 
out. This may ultimately lead to discovery of activities potentially interesting to humans with 
regards to medicine, industry or agriculture.  
The predicted genes in the A. flavus gene cluster 27 did not include an oxidoreductase that is 
required in the set of reactions leading to the production of asparasone A from the anthrone 
precursor. We hypothesized that asparasone A biosynthesis could take advantage of the AflD 
oxidoreductase in aflatoxin biosynthesis. This can be verified through the investigation of 
metabolites affected by knocking out the AflD gene, using the comparative metabolomics 
approach described in this thesis.  
The cluster 27 pks represents only one of the genes that were found to be significantly 
downregulated upon knock out of the A. flavus global regulator VeA. Other biosynthetic 
gene clusters significantly downregulated in the downregulated mutant include clusters 5, 
20, 39, 41, 42 and 51. The function of these gene clusters can also be determined using an 
MS-based comparative metabolomics approach. Genome analysis using the SMURF software 
predicted many other putative secondary metabolite gene clusters in A. flavus. Some of 
these gene clusters are presumably "silent", i.e., the genes in the cluster are not expressed 
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under laboratory growth conditions, and therefore the necessary biosynthetic enzymes are 
not made. By over-expressing key regulatory genes (identified by conserved domain search 
in GenBank) for many of the putative metabolite-producing gene clusters, "silent" gene 
clusters can be activated by stimulating the overproduction of enzymes critical for 
metabolite formation from gene clusters that may be active but only at a very low level of 
production and only under certain growth conditions. Subsequently, the metabolites of 
interest can be identified applying MS-based comparative metabolomics approach. Recently, 
chromatin remodelling has been shown to alter the expression of many secondary 
metabolites, and to induce the expression of cryptic gene products. Shwab et al. (Shwab et 
al., 2007) demonstrated the importance of histone acetylation on the regulation of natural 
products in Aspergillus. Disruption of the hdaA gene encoding an A. nidulans histone 
deacetylase led to the increased production of sterigmatocystin and penicillin. Chromatin 
remodelling can therefore be applied in the context of the MS-based comparative 
metabolomics to discover new fungal metabolites. 
The number of sequenced fungal genomes is growing, and as for A. flavus, their analysis has 
also revealed the existence of a large number of genes putatively involved in secondary 
metabolite biosynthesis that is much greater than anticipated even in strains that have been 
extensively studied for the formation of natural products. Hence, the true biosynthetic 
potential of most secondary metabolite producing fungi remains to be determined, using the 
approaches mentioned above and advanced MS techniques structure elucidation of 
metabolites can be more feasible. The use of Fourier transform ion cyclotron resonance MS, 
possessing the highest mass accuracy among the currently available MS analyzers, can 
significantly improve the compound identification process. The next generation of TOF 
instruments, triple TOF, can be introduced into an arsenal of MS instruments used in 
secondary fungal metabolite identification. Apart from the accurate mass measurements, 
this MS analyzer provides higher sensitivity compared to commonly used TOF instruments, 
and at the same time high resolution with fast acquisition speed. It is important to mention 
that a combination of several analytical techniques might be necessary for the structure 
elucidation. In particular, NMR can be used, as a complementary tool to MS, to ascertain 
compound identification. These NMR studies and others, namely bioactivity studies, can be 
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facilitated by using fungal strains in which key genes are overexpressed to produce large 
quantities of the metabolites of interest.  
Occurrence data for the known toxic fungal metabolites should be continuously collected for 
monitoring of year-to-year contamination in order to prevent unexpected outbreaks of 
toxicosis (especially in animals). With the global warming, there may be new opportunities 
for fungal contamination of crops that were not previously affected. In this regard, 
untargeted analysis of toxic fungal metabolites should be favoured. In addition, attention 
should be paid to (re)-emerging issues, such as ergot alkaloids and Alternaria toxins. The 
significance of ergot alkaloid problem was demonstrated in this thesis. Regarding Alternaria 
toxins, it is worth noting that the fungus Alternaria alternata is becoming increasingly 
important due to its ability to produce a diverse range of mycotoxins and its presence in 
different food and feed commodities. Therefore, a global survey on Alternaria toxins would 
be of great value to establish the pattern of contamination. Risk assessment should be 
performed for some toxins followed by establishment of regulatory limits in food and feed 
commodities (example of ergot alkaloids). 
The MS based untargeted metabolic profiling approach applied in this thesis is useful for the 
identification of untargeted compounds from complex biological matrices. Traditionally, this 
is a tedious and difficult task. A trend is to use a network based analysis approach coupled 
with a high resolution MS instrument capable of MS/MS data acquisition. The network 
analysis relies on MS/MS fragmentation, is created through similarity scoring, and can be 
displayed as a network of nodes and edges. In this way structurally related analogues can be 
identified. Such analysis implies the acquisition of MS/MS data for all analytes present in the 
sample. In this regard, MS/MS data independent acquisition (DIA) algorithms will be 
preferred to data dependant acquisition (DDA). Traditionally, MS/MS DIA lacks specificity. 
The availability of high speed and resolution quadrupole TOF instruments has allowed the 
implementation a new DIA algorithm called SWATH (sequential window acquisition of all 
theoretical fragment ion spectra). SWATH acquisition overall results in improved specificity. 
SWATH is currently being applied in proteomics studies and is expected to also be an 
important acquisition approach for the untargeted study of fungal metabolites. In particular, 
this acquisition mode will play a crucial role in applications where the simultaneous 
identification of unknown metabolites and their (relative) quantification are desired. 
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More data are still required to fully understand the association of secondary fungal 
metabolites with health problems of inhabitants of mouldy environments. Therefore, a 
closer collaboration of clinical doctors, residents of problematic mouldy environments and 
analysts should be established; comprehensive surveys of health complaints from 
inhabitants of mouldy buildings combined with mycotoxin analysis of samples collected in 
these environments are strongly recommended.  
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 Summary 
Secondary fungal metabolites, a diverse group of organic compounds possessing a range of 
bioactivity, were the main focus of the current PhD dissertation. The emphasis of the study 
was specifically put on analytical tools and strategies which can help to acquire a broader 
knowledge of these natural products.  
The definition of secondary fungal metabolites and an overview on their classification were 
given in Chapter 1. Due to enormous diversity in chemical structures, biosynthetic origins 
and biological effects, classification of secondary fungal metabolites is a challenging task. 
Although only exemplary classifications were discussed, they formed a complete and clear 
picture of similarities and differences between the metabolites. Their impact on human and 
animal health was also mentioned. The different routes of human and animal exposure 
(ingestion, inhalation, dermal route) to the secondary fungal metabolites were further 
presented and supported by literature occurrence data.   
In Chapter 2 different analytical techniques applied in the analysis of secondary fungal 
metabolites were described. Eventually, for the study, it was opted for liquid 
chromatography coupled to mass spectrometry (LC-MS) owing to its high sensitivity, high-
throughput and possibility to confirm the identity of the components present in complex 
samples. The most advanced mass analyzers as well as major considerations in the MS 
analysis were discussed. Furthermore, a good insight was given into targeted and untargeted 
methods developed so far.  
Quadrupole time-of-flight MS (QTOF-MS) was utilized in Chapter 3 to investigate possible 
occurrence of secondary fungal metabolites in indoor environments. The study was 
undertaken in relation to the Sick Building Syndrome (SBS), a set of non-specific symptoms 
related to living or working in a particular building. Fungi and, as a consequence, their 
secondary metabolites were pointed as one of the causative agents of the SBS. An LC-QTOF-
MS method and strategy for identification of untargeted compounds were established and 
applied to fungal cultures grown on buildings materials and to samples collected in water-
damaged mouldy houses where inhabitants experienced health problems (allergy). The 
method implied full scan data acquisition with accurate mass measurement and statistical 
analysis (Principal Component Analysis) to extract potential markers from the LC-MS data. 
The screening revealed presence of a number of secondary metabolites. Some limitations of 
the method with regards to samples from mouldy houses were described.  
 
305 
Summary  
The aim of Chapter 4 was the metabolic profiling of Aspergillus flavus, one of the most 
important species in the Aspergillus genus. A. flavus is distributed world-wide and has been 
detected in various foods and feeds. In silico analysis computed 55 gene clusters associated 
with secondary metabolism in A. flavus; however, to date, many of these clusters remain 
uncharacterized with metabolites being assigned to only six clusters. In this study, a 
comparative metabolomics approach, based on high resolution (Orbitrap) and multiple stage 
(ion trap) MS, was applied to identify the metabolites associated with A. flavus cluster 27 
polyketide synthase (pks) gene. Several known compounds were yielded by wild-type and 
mutant A. flavus. Interestingly, four metabolites, asparasone A and its newly identified 
derivatives, were characteristic only to the wild-type, suggesting that pks 27 could possibly 
regulate their production. Moreover, the fragmentation pathway of asparasone A was 
elucidated for the first time. It was also found that asparasone A was a sclerotial pigment. 
The focus of Chapter 5 was on the improvement of LC-MS analysis of the mycotoxin patulin 
mostly produced by Penicillium spp. Methods to simultaneously analyze patulin and other 
toxic secondary fungal metabolites, described in the literature, are scarce and require 
polarity switching of the MS; patulin was omitted in some previous multi-mycotoxin LC-
MS/MS methods. In this work, a closer investigation of the electrospray ionization (ESI) of 
patulin was conducted with the goal of inclusion of this toxin in a single run multi-analyte LC-
ESI+-MS/MS method. Adduct formation of patulin appeared to be the only possibility to 
achieve the purpose of the study. Combining the advantageous features of ion trap and 
Orbitrap MS, a fragmentation pathway was proposed confirming the authenticity of the 
adduct. Further, patulin and 22 other toxic secondary metabolites were successfully included 
in an LC-ESI+-MS/MS method. The established method was validated for fluids from 
transdermal penetration studies with the prospect of assessing exposure to mycotoxins 
through dermal route. 
The issue of ergot alkaloids, toxic secondary metabolites of Claviceps spp., in cereals and 
cereal products was comprehensively studied in Chapter 6. Initially, a rapid LC-MS/MS 
method was developed and validated for the determination of six main ergot alkaloids and 
their corresponding epimers in cereals and cereal products. The method was applicable to a 
wide range of cereal matrices as well as grass and corn silages with, as major strength, the 
low limits of detection and quantification. Careful investigation of method parameters 
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served in minimizing undesired epimerization of the ergot alkaloids during analysis. A 
systematic assessment of matrix effects in the LC-MS analysis of these contaminants was 
carried out providing useful advices in choosing appropriate extraction, chromatographic 
and detection conditions to reduce MS signal suppression or enhancement, therefore 
leading to accurate quantitative measurements. The established method was further applied 
to a European survey of cereals and cereal products intended for human consumption and 
animal feeding. Representative data on the occurrence of ergot alkaloids were collected and 
statistically evaluated. The pattern of ergot alkaloids was defined in the different food and 
feed samples.  
A method for monitoring of the 12 ergot alkaloids in buffered solutions was developed. The 
method was validated and applied to an in vitro binding efficacy study of a clay-based binder 
towards ergot alkaloids with ergometrine, ergosine and ergocornine as model compounds. 
Finally, a holistic approach based on high resolution and multiple stage MS was proposed for 
identification of less studied or novel ergot alkaloid derivatives. Using ion trap MS, 
fragmentation trees of ergoamides, ergopeptines and ergopeptams were established. 
Applying the strategy, a number of ergot alkaloids were identified in grain samples. 
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 Samenvatting 
Secundaire schimmelmetabolieten, een diverse groep van organische componenten, die een 
verschillende bioactiviteit bezitten, waren de focus van het huidige proefschrift. Meer 
bepaald, er werd in dit onderzoek gestreefd naar het ontwikkelen van analytische 
strategieën die kunnen helpen om een beter inzicht over deze natuurlijke producten te 
verkrijgen. 
De definitie van secundaire schimmelmetabolieten en een overzicht van hun classificatie 
werden in Hoofdstuk 1 gegeven. Vanwege de enorme diversiteit in chemische structuren, 
biosynthetische oorsprong en biologische effecten, is de indeling van secundaire 
schimmelmetabolieten een uitdagende taak. Hoewel slechts een aantal voorbeelden van 
classificaties werden besproken, geven zij een volledig en duidelijk beeld van gelijkenissen en 
verschillen tussen de metabolieten. Hun invloed op de menselijke en dierlijke gezondheid 
werd ook besproken. De verschillende manieren van menselijke en dierlijke blootstelling 
(oraal, inademen, huidcontact) aan de secundaire schimmelmetabolieten werden verder 
gepresenteerd en werden door literatuurgegevens omtrent hun voorkomen onderbouwd.   
In Hoofdstuk 2 werden verschillende analytische technieken beschreven, die toegepast zijn 
voor de analyse van secundaire schimmelmetabolieten. Uiteindelijk werd er in de studie 
voor vloeistofchromatografie gekoppeld aan massaspectrometrie (LC-MS) gekozen vanwege 
de hoge gevoeligheid, snelheid van de analyse en de mogelijkheid om de identiteit van de 
componenten in complexe matrices te bevestigen. De meest geavanceerde 
massaspectrometers als ook de belangrijke punten in de MS analyse werden besproken. 
Verder werd een inzicht gegeven van targeted en untargeted methoden die tot nu toe 
ontwikkeld werden.  
Quadrupool time-of-flight MS (QTOF-MS) werd gebruikt in Hoofdstuk 3 om het mogelijke 
voorkomen van secundaire schimmelmetabolieten binnenshuis te onderzoeken. De studie 
werd uitgevoerd in verband met het Sick Building Syndrome (SBS), een reeks van niet-
specifieke symptomen die gerelateerd zijn aan het wonen of het werken in een bepaald 
gebouw. Schimmels en als bijgevolg hun secundaire metabolieten werden beschouwd als 
één van de oorzaken van het SBS. Een LC-QTOF-MS methode en strategie voor de 
identificatie van untargeted stoffen werden opgesteld en toegepast op schimmelculturen 
gegroeid op bouwmaterialen en monsters van vochtige, beschimmelde huizen waar 
bewoners gezondheidsproblemen (allergie) ervaren. De methode werd gebaseerd op full 
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scan data acquisitie met accurate massa metingen en statistische analyse (Principal 
Component Analysis) om potentiële merkers van de LC-MS gegevens te extraheren. De 
screening heeft de aanwezigheid van een aantal secundaire metabolieten aangetoond. 
Enkele beperkingen van de methode met betrekking tot monsters van beschimmelde huizen 
werden beschreven.  
Het doel van Hoofdstuk 4 was metabole profilering van Aspergillus flavus, één van de 
belangrijkste soorten van het Aspergillus genus. A. flavus is wereldwijd verspreid en wordt 
gedetecteerd in verschillende voedingsmiddelen en diervoeders. In silico analyse heeft 55 
gen clusters aangetoond die met een secundair metabolisme in A. flavus geassocieerd 
worden; toch zijn vele van deze clusters nog niet gekarakteriseerd: metabolieten zijn bekend 
voor slechts zes clusters. In deze studie werd hoge-resolutie (Orbitrap) en multi-stage (ion 
trap) MS gebaseerde metabolomics toegepast om de metabolieten geassocieerd met het A. 
flavus cluster 27 polyketidesynthase (pks) gen te identificeren. Een aantal bekende stoffen 
werden geproduceerd door wild-type en mutant A. flavus. Vier metabolieten, asparasone A 
en zijn nieuw geïdentificeerde derivaten, waren alleen aanwezig in het wild-type, en dit 
suggereert dat pks 27 een belangrijke rol speelt in hun productie. Bovendien werd het 
fragmentatiegedrag van asparasone A toegelicht voor de eerste keer. Er werd ook 
vastgesteld dat asparasone A een sclerotiaal pigment is.  
De focus van Hoofdstuk 5 was de verbetering van de LC-MS analyse van het mycotoxine 
patuline dat meestal door Penicillium spp. wordt geproduceerd. Methoden voor gelijktijdige 
analyse van patuline en andere toxische secundaire schimmelmetabolieten, die in de 
literatuur beschreven worden, zijn schaars en vereisen polariteit omschakeling van de MS; 
patuline werd weggelaten in sommige vorige multi-mycotoxine LC-MS/MS methoden. In dit 
werk werd een nader onderzoek van de electrospray ionisatie (ESI) van patuline uitgevoerd 
met als doel dit toxine op te nemen in één run multi-analiet LC-ESI+-MS/MS methode. 
Adductvorming van patuline bleek de enige mogelijkheid om het doel van de studie te 
bereiken. Door het combineren van de gunstige eigenschappen van ion trap en Orbitrap MS 
werd een fragmentatie route voorgesteld die de identificatie van het adduct heeft bevestigd. 
Verder werden patuline en 22 andere toxische secundaire metabolieten met succes 
opgenomen in één LC-ESI+-MS/MS methode. De ontwikkelde methode werd gevalideerd 
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voor vloeistoffen van transdermale penetratie studies met het oog op de inschatting van de 
blootstelling aan mycotoxinen via de dermale route.  
Het probleem van ergotalkaloïden, toxische secundaire metabolieten van Claviceps spp., in 
granen en graanproducten werd in detail bestudeerd in Hoofdstuk 6. In eerste instantie 
werd een snelle LC-MS/MS methode ontwikkeld en gevalideerd voor de bepaling van de zes 
belangrijkste ergotalkaloïden en hun overeenkomstige epimeren in granen en 
graanproducten. De methode is toepasbaar op een breed range van graan matrices als ook 
gras- en maïskuilen met de lage detectie- en kwantificatielimieten als groot voordeel. 
Nauwkeurig onderzoek van de methodeparameters, die ongewenste epimerisatie van de 
ergotalkaloïden tijdens de analyse kunnen minimaliseren, werd voorgesteld. Een 
systematische evaluatie van matrix effecten in de LC-MS analyse van deze contaminanten 
werd uitgevoerd die bruikbare tips opleverde in de keuze van geschikte extractie, 
chromatografie en detectie condities om MS signaalonderdrukking of -versterking te 
verminderen en accuraatheid te bevorderen. Als gevolg worden nauwkeurige kwantitatieve 
resultaten bekomen. De ontwikkelde methode werd verder toegepast op een Europese 
survey over het voorkomen van ergotalkaloïden in granen en graanproducten bestemd voor 
menselijke consumptie en diervoeding. Representatieve gegevens over het voorkomen van 
deze ergotalkaloïden werden verzameld en statistisch geëvalueerd. Het patroon van 
ergotalkaloïden werd bepaald in de monsters van verschillende voedingsmiddelen en 
diervoeders.  
Een methode voor de bepaling van de 12 ergotalkaloïden in bufferoplossingen werd 
ontwikkeld. De methode werd gevalideerd en toegepast op een in vitro binding 
effectiviteitsstudie van een klei-gebaseerde binder voor ergotalkaloïden, met ergometrine, 
ergosine en ergocornine als modelstoffen.  
Tot slot werd een holistische benadering op basis van hoge resolutie en multi-stage MS 
voorgesteld voor de identificatie van minder bestudeerde of nieuwe ergotalkaloid derivaten. 
Met behulp van ion trap MS werd het fragmentatiegedrag van ergoamides, ergopeptines en 
ergopeptams vastgesteld. Door het toepassen van deze strategie werden een aantal van 
ergotalkaloïden in graan monsters geïdentificeerd.  
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Appendices 
Appendix I: Response surface plots for recovery of ergometrine (a), ergometrinine (b), 
ergosine (c), ergosinine (d), ergotamine (e), ergotaminine (f), ergocornine (g), ergocorninine 
(h), ergokryptine (i), ergokryptinine (j), ergocristine (k), ergocristinine (l), methylergometrine 
(m), dihydroergotamine (n) as a function of extraction solvent volume and pH of the 
NH4HCO3 solution in the extraction solvent, and solvent evaporation temperature and 
extraction time. 
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Appendix I (continued) 
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Appendix II: Response surface plots for the ratio between ergometrinine (Emn) and 
ergometrine (Em) (a), ergosinine (Esn) and ergosine (Es) (b), ergotaminine (Etn) and 
ergotamine (Et) (c), ergocorninine (Econ) and ergocornine (Eco) (d), ergokryptinine (Ekrn) and 
ergokryptine (Ekr) (e), ergocristinine (Ecrn) and ergocristine (Ecr) (f) as a function of 
extraction solvent volume and pH of the NH4HCO3 solution in the extraction solvent, and 
solvent evaporation temperature and extraction time. 
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Appendix II (continued) 
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Appendix III: Robustness evaluation of extraction buffer pH and concentration, shaking time, 
drying temperature and extraction volume for ergometrine (a), ergometrinine (b), ergosine 
(c), ergosinine (d), ergotamine (e), ergotaminine (f), ergocornine (g), ergocorninine (h), 
ergokryptine (i), ergokryptinine (j), ergocristine (k), ergocristinine (l), methylergometrine (m), 
dihydroergotamine (n). The 95 % confidence interval is shown. 
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pH extraction buffer [Step 2] Buffer concentration [Step 2]  
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Appendix III (continued) 
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pH extraction buffer [Step 1] Buffer concentration [Step 1]  
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Appendix III (continued) 
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(mL) 
(g) 
pH extraction buffer [Step 1] Buffer concentration [Step 1]  
(mol/L)  
Shaking time (min) 
pH extraction buffer [Step 2] Buffer concentration [Step 2]  
(mol/L)  
Drying temperature (°C) 
Extraction volume [Step 1]  
(mL) 
Extraction volume [Step 2]  
(mL) 
(h) 
pH extraction buffer [Step 1] Buffer concentration [Step 1]  
(mol/L)  
Shaking time (min) 
pH extraction buffer [Step 2] Buffer concentration [Step 2]  
(mol/L)  
Drying temperature (°C) 
Extraction volume [Step 1]  
(mL) 
Extraction volume [Step 2]  
(mL) 
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Appendix III (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
Continue 
(i) 
pH extraction buffer [Step 1] Buffer concentration [Step 1]  
(mol/L)  
Shaking time (min) 
pH extraction buffer [Step 2] Buffer concentration [Step 2]  
(mol/L)  
Drying temperature (°C) 
Extraction volume [Step 1]  
(mL) 
Extraction volume [Step 2]  
(mL) 
(j) 
pH extraction buffer [Step 1] Buffer concentration [Step 1]  
(mol/L)  
Shaking time (min) 
pH extraction buffer [Step 2] Buffer concentration [Step 2]  
(mol/L)  
Drying temperature (°C) 
Extraction volume [Step 1] 
 (mL) 
Extraction volume [Step2]  
(mL) 
(k) 
pH extraction buffer [Step 1] Buffer concentration [Step 1]  
(mol/L)  
Shaking time (min) 
pH extraction buffer [Step 2] Buffer concentration [Step 2]  
(mol/L)  
Drying temperature (°C) 
Extraction volume [Step 1]  
(mL) 
Extraction volume [Step 2]  
(mL) 
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Appendix III (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
(l) 
pH extraction buffer [Step 1] Buffer concentration [Step 1]  
(mol/L)  
Shaking time (min) 
pH extraction buffer [Step 2] Buffer concentration [Step 2]  
(mol/L)  
Drying temperature (°C) 
Extraction volume [Step 1]  
(mL) 
Extraction volume [Step 2]  
(mL) 
(m) 
pH extraction buffer [Step 1] Buffer concentration [Step 1]  
(mol/L)  
Shaking time (min) 
pH extraction buffer [Step 2] Buffer concentration [Step 2]  
(mol/L)  
Drying temperature (°C) 
Extraction volume [Step 1]  
(mL) 
Extraction volume [Step 2]  
(mL) 
(n) 
pH extraction buffer [Step 1] Buffer concentration [Step 1]  
(mol/L)  
Shaking time (min) 
pH extraction buffer [Step 2] Buffer concentration [Step 2]  
(mol/L)  
Drying temperature (°C) 
Extraction volume [Step 1] 
 (mL) 
Extraction volume [Step 2]  
(mL) 
 
333 
Appendices  
Appendix IV: Optimization of elution solvent composition applying a D-optimal design for 
ergometrine (a), ergometrinine (b), ergosine (c), ergosinine (d), ergotamine (e), ergotaminine 
(f), ergocornine (g), ergocorninine (h), ergokryptine (i), ergokryptinine (j), ergocristine (k), 
ergocristinine (l). The 95 % confidence interval is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elution solvent % NH3 in elution solvent 
(a) (b) 
Elution solvent % NH3 in elution solvent 
(c) 
Elution solvent % NH3 in elution solvent 
(d) 
Elution solvent % NH3 in elution solvent 
(e) 
Elution solvent % NH3 in elution solvent 
(f) 
Elution solvent % NH3 in elution solvent 
(g) 
Elution solvent % NH3 in elution solvent 
(h) 
Elution solvent % NH3 in elution solvent 
Elution solvent % NH3 in elution solvent 
(i) (j) 
Elution solvent % NH3 in elution solvent 
(k) 
Elution solvent % NH3 in elution solvent 
(l) 
Elution solvent % NH3 in elution solvent 
 
334 
 Appendices 
Appendix V: Robustness evaluation indicating the change of recovery for ergometrine (a), 
ergometrinine (b), ergosine (c), ergosinine (d), ergotamine (e), ergotaminine (f), ergocornine 
(g), ergocorninine (h), ergokryptine (i), ergokryptinine (j), ergocristine (k), ergocristinine (l), 
methylergometrine (m), dihydroergotamine (n) as a function of pH and concentration of the 
buffer, shaking time and temperature of drying. The 95 % confidence interval is shown. 
 
   
 
   
 
   
 
   
 
   
 
  
 
Continue 
 
(a) 
(b) 
pH of extraction buffer Concentration of buffer (mol/L) 
(d) 
(c) 
Concentration of buffer (mol/L) 
Concentration of buffer (mol/L) 
Concentration of buffer (mol/L) pH of extraction buffer 
pH of extraction buffer 
pH of extraction buffer 
(e) 
(f) 
pH of extraction buffer 
pH of extraction buffer Concentration of buffer (mol/L) 
Concentration of buffer (mol/L) 
Shaking time (min) Temperature of drying (°C) 
Shaking time (min) Temperature of drying (°C) 
Shaking time (min) 
Shaking time (min) Temperature of drying (°C) 
Temperature of drying (°C) 
Shaking time (min) 
Shaking time (min) 
Temperature of drying (°C) 
Temperature of drying (°C) 
 
335 
Appendices  
Appendix V (continued) 
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
(g) 
(h) 
pH of extraction buffer 
pH of extraction buffer Concentration of buffer (mol/L) 
Concentration of buffer (mol/L) 
(i) 
(j) 
(k) 
(l) 
pH of extraction buffer 
pH of extraction buffer 
Concentration of buffer (mol/L) 
Concentration of buffer (mol/L) 
Concentration of buffer (mol/L) 
Concentration of buffer (mol/L) pH of extraction buffer 
pH of extraction buffer 
(m) 
(n) 
pH of extraction buffer 
pH of extraction buffer Concentration of buffer (mol/L) 
Concentration of buffer (mol/L) 
Shaking time (min) 
Shaking time (min) 
Temperature of drying (°C) 
Temperature of drying (°C) 
Shaking time (min) 
Shaking time (min) 
Temperature of drying (°C) 
Temperature of drying (°C) 
Shaking time (min) 
Shaking time (min) 
Shaking time (min) 
Shaking time (min) 
Temperature of drying (°C) 
Temperature of drying (°C) 
Temperature of drying (°C) 
Temperature of drying (°C) 
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